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Zusammenfassung I
Zusammenfassung 
 
Kaliumionenkanäle nehmen Einfluss auf den Zellzyklus und die Zellproliferation. In vitro 
Untersuchungen an Krebszellen und bösartigen Tumoren zeigen eine erhöhte Expression 
verschiedener Typen von K+- Kanälen, wie zum Beispiel spannungsabhängige Kv- Kanäle, 
Eag-1, Ca2+- abhängige BK- Kanäle und den 2P- Domänenkanal TASK-3. In der 
vorliegenden Arbeit untersuchten wir den Beitrag von K+- Kanälen zur Entwicklung von 
Karzinomen der Prostata und des Dickdarms. Funktionelle Untersuchungen wurden mittels 
Patch clamp und Ussingkammer an Zellinien und tierischen Geweben durchgeführt und 
rektale Potentialmessungen wurden an Mäusen in vivo vorgenommen. Mittels Aktivatoren 
und Inhibitoren von Kaliumkanälen, sowie der RNA- Interferenz Technik konnte der Beitrag 
der unterschiedlichen Kaliumkanaltypen ermittelt werden. Weiterhin wurde die Expression 
der Kanalproteine mit semiquantitativer und real-time PCR, Westernblot und 
Immunhistochemie untersucht. 
Ca2+- abhängige Kaliumkanäle (BK) unterstützen das Wachstum von Zellen des 
Prostatakarzinoms 
KCNMA1 kodiert für die α- Untereinheit des großen Ca2+- abhängigen (BK) K+- Kanals und 
liegt in Spätstadien hormoninsensitive Prostatakarzinome in amplifizierter Form vor. Im 
Gegensatz hierzu zeigten gutartige Prostatagewebe eine nur schwache Expression von BK. 
Die Rolle von BK Kanälen für die Proliferation von Zellen des Prostatakarzinoms wurde mit 
Hilfe von PC-3 Zellen untersucht. PC-3 Zellen repräsentieren das hormoninsensitive 
Prostatakarzinom und wurden mit hormonsensitiven LNCaP- Zellen und der gutartigen 
Zellinie BPH-1 verglichen. In PC-3 Zellen war die Expression von BK-Kanälen deutlich 
erhöht und selektive Blockade mit dem BK- Inhibitor Iberiotoxin oder siRNA hemmte BK- 
Kanalströme und die Proliferation von PC-3 Zellen. BK- Kanäle wurden in isolierten 
Membranen nachgewiesen und konnten durch den Inhibitor Paxillin und durch siRNA 
unterdrückt werden. Eine hormonelle Aktivierung der BK- Kanäle durch Östrogene wurde nur 
in LNCaP und BPH-1 Zellen beobachtet. Die Ergebnisse liefern eindeutige Hinweise für die 
Rolle von BK- Kanälen beim Prostatakarzinom. Die BK- Kanalexpression kann als 
prognostischer Marker beim Prostatakarzinom gewertet werden und könnte ein wichtiges 
Zielprotein für die Behandlung fortgeschrittener Prostatakarzinome darstellen. 
Der Elektrolyttransport und die Expression spannungsabhängiger Kaliumkanäle sind 
beim Kolonkarzinoms verändert  
Die Rolle von K+- Kanälen für die Proliferation des Kolonkarzinoms wurde an drei 
verschiedenen Modellen untersucht: 1) An der humanen Kolonkarzinomzelline T84. 2) Am 
Kolon von Karzinogen- behandelten Mäusen. 3) Am Kolon von Mäusen mit einem 
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genetischen Defekt des Tumorsuppressorgens APC. Neben der abnormalen 
Kaliumkanalexpression wurden Veränderungen in der Expression von Ionenkanälen 
festgestellt, die für den Elektrolyttransport im Kolonepithel in vivo von entscheidender 
Bedeutung sind.  
Histologische Veränderungen während der Karzinogenese im Mäusekolon 
Unter der Behandlung mit den chemischen Karzinogenen DMH und MNU, konnte in der 
frühen Phase histologisch eine Entzündung im Mäusekolon beobachtet werden, die bei 
weiterer Behandlung zu einer Veränderung der Mukosaarchitektur und schließlich zu einer 
Epitheldysplasie führte. Dies stellen typische Vorstufen während der Entwicklung von der 
normalen Mukosa hin zum Kolonkarzinom dar. Mutationen im Tumorsuppressorgen APC 
werden in nahezu allen Fällen des humanen Kolonkarzinoms sowie den erblichen Formen 
der Adenomatosis Polyposis Coli gefunden. Heterozygote Tiere mit einem Defekt im APC- 
Gen entwickeln multiple Darmneoplasien, die im fortgeschrittenen Stadium in intestinale 
Karzinome übergehen. Die Expression der karzinomrelevanten Proteine β-Catenin und 
Phospho-Akt war in den Polypen von Dünn- und Dickdarm der heterozygoten APCMin/+ Tiere 
erhöht.  
Veränderungen des Kochsalztransports während der Karzinogenese im Kolonepithel 
Die Behandlung mit den Karzinogenen DMH oder MNU führte in der frühen Phase zu 
entzündlichen Veränderungen im Kolon der Versuchstiere, die denen der DSS- induzierten 
Kolitis ähnlich waren. Weiterhin wurde eine Abnahme der amiloridhemmbaren Na+ 
Resorption und der cAMP- aktivierten Cl- Sekretion beobachtet. Da die Expression der 
zugrunde liegenden Transportproteine ENaC und CFTR unverändert war, sind die 
Transportstörungen wahrscheinlich ein Resultat der reduzierten Aktivität der Na+/K+- 
ATPase. Im Gegensatz zu den Karzinogen- behandelten Tieren, fand sich im gesamten 
Kolon von APCMin/+ Mäusen eine deutliche Zunahme der elektrogenen Na+- Resorption, 
welche durch eine erhöhte Expression der drei ENaC- Untereinheiten bedingt war. Die 
Zunahme von ENaC im Kolon von APCMin/+ Mäusen ist wahrscheinlich durch Aktivierung des 
intrazellulären mTOR-Akt Signalweges und die reduzierte Apoptose bedingt. Die Ergebnisse 
könnten erklären, weshalb es bei der Kolitis häufig zu Diarrhöen kommt, wohingegen bei 
intestinalen Tumoren häufig ein Wechsel zwischen Obstipation und Diarrhöe auftritt.  
Pathologische Expression von K+- Kanälen beim Kolonkarzinom 
In der vorliegenden Arbeit konnten wir die Bedeutung von Kv und BK K+- Kanälen für die 
Proliferation von Kolonkarzinomzellen zeigen. In T84 Kolonkarzinomzellen fanden wir eine 
Vielzahl von K+- Kanälen, wie z.B. Kv1.3, Kv1.5, Kv3.3/3.4, KvLQT, Eag-1, Erg-1 und die 
kalziumabhängigen K+- Kanäle BK und SK4. Inhibitoren von Kv- Kanälen und siRNA für Eag-
1 unterdrückten die Zellproliferation, wohingegen Blocker und siRNA für Ca2+- abhängige K+- 
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Kanäle keinen Einfluss auf die Proliferation von T84- Zellen hatten. Kv- und Eag- Kanäle 
unterstützen die Regulation des intrazellulären pH und die Ca2+- abhängige 
Signaltransduktion. Eine erhöhte Aktivität von Kv Kanälen wurde auch im Dickdarm von 
DMH- und MNU- behandelten Tieren festgestellt. Die Effekte der Kv Kanalinhibitoren 4-AP 
und Astemizol auf den intestinalen Transport waren deutlich verstärkt bei den 
karzinogenbehandelten Mäusen. In der prämalignen Kolonschleimhaut von 
karzinogenbehandelten Mäusen finden sich daher Kv1.3, Kv1.5 und Kv3.1 sowie Mitglieder 
der Eag- Kaliumkanalfamilie, die als onkogene Ionenkanäle wahrscheinlich zur Entwicklung 
des Kolonkarzinoms beitragen. Im proximalen Kolon von APCMin/+ Mäusen wurde ebenfalls 
ein erhöhter Astemizol- sensitiver Transport beobachtet, was durch Aktivierung der 
mitogenen oder mTOR- abhängigen Signaltransduktion erklärt sein könnte. Akt aktiviert Erg, 
ein weiteres Mitglied der EAG Familie, wie auch BK Kanäle. Neben der Zunahme von Eag- 
Strömen wurde auch eine Zunahme der BK- Kanalaktivität im Kolon von APCMin/+ Mäusen 
festgestellt. Als Ursache für die Zunahme der BK- abhängigen Ströme wurde eine vermehrte 
Transkription der regulatorischen β1- und β2- Untereinheiten des BK- Kanals gefunden. 
Bemerkenswerterweise wurde auch in T84- Zellen eine Zunahme der Expression von β- 
Untereinheiten beobachtet. 
Expression von Eag-1 in  humanen Prostata-  und Kolonkarzinomen 
Im Gegensatz zum gesunden humanen Kolon fanden wir in Gewebsproben humaner 
kolorektaler Karzinome ebenfalls eine Expression von Eag-1. Unsere Untersuchungen 
zeigen, dass eine Amplifikation des Eag-1- Gens in humanen Kolonkarzinomproben mit einer 
reduzierten Lebenserwartung verbunden ist. Eag-1 könnte daher als diagnostischer und 
prognostischer Marker der Kolonkarzinomerkrankung dienen. Zusammengenommen 
konnten wir zeigen, dass Kaliumkanälen für die Entwicklung und das Wachstums von 
Prostata- und Kolonkarzinomen eine Bedeutung zukommt. Eine Beziehung zwischen Tumor 
und molekularer sowie funktioneller Expression von Kv- Kanälen, vor allem Eag-1, sowie 
Ca2+-abhängiger K+- Kanäle konnte in verschiedenen Modellen festgestellt werden. Wir 
konnten zeigen, dass diese Kanäle die Zellproliferation unterstützen und deshalb 
wahrscheinlich auch das Wachstum des Karzinoms fördern. BK- und Eag- Kanäle wurden 
als Marker für eine negative Prognose des Karzinompatienten identifiziert. Die vorliegenden 
Ergebnisse könnten somit hilfreich sein, um die Diagnose und Behandlung dieser Karzinome 
zu verbessern und könnten einen Beitrag zur Prognose der Patienten leisten. 
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CHAPTER 1  
 
INTRODUCTION 
 
Cancer is the second most common cause of death in developed countries. Although large 
progress was made in understanding the molecular process of cancer development, many 
details of carcinogenesis remain obscure and novel treatments are demanded. Meanwhile a 
wide spectrum of diagnostic and therapeutic procedures exist such as surgery, chemotherapy, 
radiation, hormone, and immune therapy. However, the overall mortality and morbidity of cancer 
remains very high. The present work tries to make a contribution to a better understanding of the 
carcinogenic process and may provide new avenues for diagnosis and treatment of colonic 
cancer. 
Oncogenesis is a complicated process, involving a series of genetic alterations and signal 
transduction pathways. Expression and activity of ion channels may be affected during tumor 
development and growth of cancer, among many other changes. The role of these ion channels 
for proliferation and development of cancer, however, remains obscure. About 10 years ago, 
Wonderlin and Strobel summarized the effects of ion channel inhibitors on proliferation of 
various malign cell types (Wonderlin and Strobl, 1996). It was shown that activation of K+ 
channels is crucial for progression through the G1 phase of the cell cycle. The review disclosed 
some essential details regarding the role of K+ channels in cell proliferation and cancer. Over the 
past 10 years, there were many more reports identifying expression of particular types of K+ 
channels in cancer (Table 1). It was, however, entirely unclear to what degree K+ channels 
contribute to the development of colonic and prostate cancer. 
 
 Table 1. K+ channels or currents identified in cancer. Genes are named according to the Human 
Gene Nomenclature Committee (HGNC name). 
 
 K+ channel HGNC name Type of tumor  Reference  
 Voltage-gated K+ channels (Kv)    
 Kv  human ovarian cancer 
small lung cancer 
myeloblastic leukemia 
hepatocarcinoma 
colonic cancer 
schwannoma 
Abdul and Hoosein, 2002b,  
Fieber, 2003, Pancrazio et al., 
1993, Renaudo et al., 2004,  
Xu et al., 1996, Yao and Kwan, 
1999, Zhanping et al., 2007,  
Zhou et al., 2003 
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 Table 1. K+ channels or currents identified in cancer (continued).  
 K+ channel HGNC name Type of tumor Reference  
 Kv1.3 KCNA3 oligodendrocyte progenitor cells 
glioma 
prostate cancer  
colonic cancer  
breast cancer  
melanoma  
Abdul et al., 2003,  
Abdul and Hoosein, 2002a, 
Abdul and Hoosein, 2002b, 
Pardo, 2004 
 
 
Kv1.5 KCNA5 gastric cancer human glioma 
Lan et al., 2005,  
Preussat et al., 2003 
 
 
Kv2.1 KCNB1 cervical carcinoma endometrial adenocarcinoma 
Suzuki and Takimoto, 2004a  
 Kv3.4 KCNC4 oral squamous cell carcinoma Chang et al., 2003  
 Family of voltage-gated K+ channels (ether à go-go)   
 Kv10.1 (Eag-1) KCNH1 breast cancer 
cervical cancer 
human melanoma,  
neuroblastoma 
Farias et al., 2004a,  
Meyer et al., 1999,  
Pardo et al., 1999 
 
 Kv11.1 (Erg-1) KCNH2 intestinal metaplasia  
primary leukemia 
endometrial tumors 
colonic cancer 
glioblastoma 
cervical carcinoma 
endometrial adenocarcinoma 
human mammary gland 
adenoma 
neuroblastoma 
atrial tumor cells 
Bianchi et al., 1998, 
Cherubini et al., 2000, 
Crociani et al., 2003, 
Lastraioli et al., 2004, 
Lastraioli et al., 2006,  
Masi et al., 2005,  
Pillozzi et al., 2002,  
Smith et al., 2002,  
Suzuki and Takimoto, 2004a, 
Wang et al., 2002 
 
 Ca2+-activated K+ channels  
 Large 
conductance 
Ca2+-activated 
K+ channels 
(BK) 
KCNMA1 breast cancer 
human glioma 
prostate cancer 
human astrocytoma 
Basrai et al., 2002, Chang  
et al., 2003, Coiret et al., 
2007, Gessner et al., 2005, 
Ouadid-Ahidouch et al., 
2004a, Weaver et al., 2004 
 
 Intermediate 
conductance 
Ca2+-activated 
K+ channels  
(IK or SK4) 
KCNN4 breast cancer 
human glioma 
human melanoma 
human bronchial carcinoma 
pancreatic cancer 
Cruse et al., 2006, Jager  
et al., 2004, Meyer et al., 
1999, Ouadid-Ahidouch et al., 
2004b, Weaver et al., 2004 
 
 Small 
conductance 
Ca2+-activated 
K+ channels 
(SK1, SK2,SK3) 
KCNN1, 
KCNN2, 
KCNN3 
mammary cancer 
human glioma 
human melanoma  
Meyer et al., 1999,  
Potier et al., 2006,  
Weaver et al., 2004 
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 Table 1. K+ channels or currents identified in cancer (continued).  
 K+ channel HGNC name Type of tumor  Reference  
 Two-pore domain K+ channels  
 TASK-3 KCNK9 breast cancer 
lung cancer 
primary mouse embryo 
fibroblasts 
colonic cancer 
(Kim et al., 2004, Mu et al., 
2003a, Patel and Lazdunski, 
2004) 
 
 Inward rectifier K+ channels    
 Kir2.1 KCNJ2 human lung cancer (Sakai et al., 2002)  
 Kir3.1 KCNJ3 breast cancer 
lung cancer 
(Plummer, III et al., 2004, 
Plummer, III et al., 2005, 
Stringer et al., 2001) 
 
 Kir4.1 KCNJ10 glioma (Nathke, 2006)  
 ATP-sensitive 
K+ channels 
(Kir6.1/Kir6.2) 
KCNJ8/KCNJ
11 
human breast cancer  (Klimatcheva and Wonderlin, 
1999, Woodfork et al., 1995) 
 
 
Expression and function of K+ channels in intestinal epithelial cells 
Potassium channels are the largest and most diverse family of plasma membrane channels. 
They have essential functions in any cell type. In epithelial cells of the gastrointestinal tract, K+ 
channels play an important role in i) absorption of nutrients and electrolytes, ii) secretion of K+, 
iii) regulation of cell volume and pH, and iv) cell proliferation, differentiation, and apoptosis 
(O'Grady and Lee, 2005, Warth and Barhanin, 2003). Potassium channels, typically located in 
the basolateral membrane of epithelial cells, provide the driving force for nutrient absorption and 
electrogenic transport. In both Na+ absorbing and Cl- secreting epithelia, K+ efflux via basolateral 
K+ channels helps to sustain the negative membrane voltage necessary for Na+ entry or Cl- exit 
across the luminal membrane. Large-, intermediate-, and small-conductance Ca2+-ativated K+ 
channels, as well as KATP and 239B-sensitive KvLQT1 K+ channels have been identified in small 
and large intestine (Warth and Barhanin, 2003). 
Apart from the kidneys, the colonic epithelium contributes to K+ homeostasis by fine tuning 
luminal K+ secretion and absorption. Potassium absorption is mediated by the H+/K+-ATPase on 
the luminal side of the colonic epithelium and is regulated by aldosterone and nutritional K+ 
intake (Lomax et al., 1994, Sandle and Butterfield, 1999). Luminal nucleotides induce K+ 
secretion via activation of large conductance Ca2+-activated K+ channels (BK) (Hay-Schmidt et 
al., 2003, Puntheeranurak et al., 2006, Sausbier et al., 2006) (Figure 1). Besides BK, there is 
evidence for a pH sensitive ROMK-type K+ channel located on the luminal side (Warth and 
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Bleich, 2000). Similar to the small intestine, basolateral K+ channels in the colonic epithelium are 
essential to maintain a hyperpolarized membrane voltage and the electrical driving force for Cl- 
secretion and Na+ absorption (Bleich and Warth, 2000, Devor et al., 1997). Basolateral K+ 
channels are activated either by an increase in intracellular Ca2+ or cAMP (Bleich et al., 1996, 
Kunzelmann and Mall, 2002, Mall et al., 1998, Sandle et al., 1994). So far, three types of K+ 
channels have been identified on the basolateral side; KvLQT1, BK, and SK4. These channels 
have been studied in detail. Thus, KvLQT1 (KCNQ1) has a very low single channel conductance 
and is blocked by 293B. It can be activated by either cAMP or Ca2+. In the colon, KCNQ1 
coassembles with the regulatory subunit KCNE3 to produce an instantaneous K+ current. It is 
essential for basolateral K+ exit (Bleich and Warth, 2000) (Figure 1). BK channels have also 
been detected in mammalian colon. Expression of BK channels is high in the surface epithelium 
cells but reduced in lower crypt cells. (Burckhardt and Gögelein, 1992, Hay-Schmidt et al., 2003, 
Klaerke et al., 1996) However, this pattern of expression may change during inflammatory 
processes (Sandle et al., 2007). BK channels are inhibited by paxillin and iberiotoxin. Moreover, 
SK4 is another type of basolateral K+ channel expressed in the colonic epithelium. It is an 
intermediated conductance Ca2+-activated K+ channel identified in murine and rabbit colon. SK4 
is activated by increase in intracellular Ca2+ and 1-EBIO, and is inhibited by clotrimazole and 
TRAM-34 (Warth et al., 1999). 
K+ channel activity is also critical for cell volume regulation (Sarkadi and Parker, 1991). When 
swollen due to hypotonic stress, cells are able to re-adjust their volume by a mechanism known 
as regulatory volume decrease (RVD). RVD is accomplished by activation of both Cl- and K+ 
channels, thereby releasing KCl and water from the cell. SK4 channels have been identified in 
small intestine (Okada et al., 2001) and colon (Umesaki et al., 1979) to contribute to cell volume 
regulation. The osmotic swelling results in an increase in the cytosolic Ca2+ concentration, which 
subsequently activates SK4 (Okada et al., 2001). 
Apart from cell volume regulation, K+ channels control cell signaling via intracellular Ca2+. The 
cell-negative K+ diffusion potential provides the driving force for both Ca2+ release from 
intracellular endoplasmic reticulum and Ca2+ influx through membrane localized Ca2+ channels 
(Schreiber, 2005). 
Beyond these well recognized functions, epithelial K+ channels have been implicated in cell 
migration, proliferation, differentiation, and apoptosis in various cell types, including those of 
intestinal epithelia. After injury, early mucosal repair occurs by epithelial cell migration to reseal 
superficial wounds.  Epithelial migration is activated by a rise in cytosolic Ca2+ concentration due 
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Figure 1. Simplified transport model of the mammalian colonic epithelium. Electrogenic Na+ absorption via 
the epithelial Na+ channel (ENaC) takes place in the surface epithelium and upper crypts of the distal 
colon. Electroneutral NaCl absorption (parallel Na+/H+ and Cl-/HCO3- exchange) dominates in the proximal 
colon. Large conductance Ca2+-activated K+ channels (BK) are located in the luminal and basolateral 
membrane of surface epithelial cells. Expression of BK channels is more pronounced in the distal colon 
when compared to the proximal colon. BK channels are responsible for K+ secretion and maintain the 
driving force for Na+ absorption. Cl- secreting cells are located predominately in the crypt base. Cl- is taken 
up into the cell by the basolateral Na+-K+-2Cl- cotransporter NKCC1, and is secreted via luminal cystic 
fibrosis transmembrane conductance regulator (CFTR) Cl- channels. Cl- secretion is maintained by 
basolateral KvLQT1/KCNE3 and SK4 channels and is paralleled by secretion of K+ via luminal K+ channels 
and Na+ transport through the paracellular shut (modified from Kunzelmann and Mall, 2002). 
 
to activation of Kv channels (Rao et al., 2002). Although K+ channels have a clear role in 
proliferation and differentiation, as outlined in the next chapter, they paradoxically also have a 
central function during apoptosis of intestinal cells (Grishin et al., 2005). Thus, K+ efflux 
increases twofold in apoptosis-induced IEC-6 rat epithelial cells. K+ channel inhibitors prevent 
DNA fragmentation, caspase activation and loss of the mitochondrial membrane potential, 
resulting in attenuation of apoptotic cell death. Obviously, activation of large K+ currents that lead 
to cell shrinkage in conjunction with apoptotic stimuli causes programmed cell death (review 
Kunzelmann, 2005). 
 
K+ channels and cell proliferation 
It has been shown that K+ channels support cell proliferation. While K+ transport affects many 
cellular parameters like membrane potential, cytosolic Ca2+, pH, and cell volume, a cell cycle 
specific function has also been attributed to K+ channels. According to this, K+ channels are 
expressed in a cell cycle-dependent manner. 
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Cell cycle, growth factors and K+ channel activity 
Cyclic oscillations in K+ channel activity, which parallel the cell cycle, have been described for a 
number of somatic cell types including embryonic cells (Bregestovski et al., 1992, Day et al., 
1993, Day et al., 1998, Meyer and Heinemann, 1998, Takahashi et al., 1993, Wonderlin and 
Strobl, 1996). During early mouse development, BK channel activity is oscillating with the cell 
cycle, being low in S and G2, and high in M and G1 phases (Day et al., 1993). Apart from BK, 
ether à go-go-related (Erg) K+ channels are also regulated in early mouse embryogenic 
development (Winston et al., 2004). High levels of Erg mRNA are detected in fertilized oocytes, 
but levels decline during embryonic development. Subcellular and membrane localization of Erg 
channels varies at different stages, and is changed by treatment with specific Erg inhibitors. 
Interestingly, these blockers reduce the transition to the blastocyst stage and the number of cells 
per blastocyst. Thus, both BK and Erg channels play a significant role in early embryonic 
development. 
The functional importance of K+ channels for cell cycling is further supported by inhibition of cell 
cycle initiation and/or procession due to application of K+ channel inhibitors. For instance, 
tetraethylammonium (TEA), a non-specific K+ channel blocker, inhibits proliferation in B 
lymphocytes by suppressing both K+ currents and DNA synthesis. Interestingly, TEA inhibits 
proliferation by stopping the cell cycle in the G1 phase, but has otherwise no influence on the 
transition from G0 to G1 phase (Amigorena et al., 1990). The same antagonist also induces G1 
arrest in oligodendrocyte progenitor cells. G1 phase blockers such as rapamycin and 
deferoxamine mimic the anti-proliferative effects of K+ channel blocker (Ghiani et al., 1999). In 
addition, TEA causes accumulation of p27 and p21, cyclins and cyclin-dependent kinase (Cdk) 
inhibitors. p27 and p21 bind and inactivate the G1/S-phase cyclin-Cdk complex (cyclin E-Cdk2) 
and the S-phase cyclin-Cdk complex (cyclin A-Cdk2), thereby arresting the cell in the G1 phase. 
Accumulation of p27 and arrest of the cell in the G1 phase by the Kv blocker 4-aminopuridine (4-
AP) has been reported for small cell lung cancer, leukemic Jurket cells, and myeloblastic cells 
(Renaudo et al., 2004, Xu et al., 1996). Taken all this together, activation of Kv channels is 
required for cells to progress through the G1 phase of the cell cycle. Other studies show a role of 
human Erg K+ channels for transition from G1 to S phase (Shao et al., 2005). 
 
Control of K+ channel activity by growth factors 
Growth factors such as insulin, insulin-like growth factor-1 (IGF-1), transforming growth factor-β1 
(TGFβ1) and epidermal growth factor (EGF) activate receptor tyrosine kinases and stimulate cell 
proliferation. The same mitogens also control K+ channel expression and activity. Insulin 
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increases BK channel activity in the native hippocampus and in recombinant BK-expressing 
HEK293 cells (O'Malley and Harvey, 2004). Channel activation is attenuated by specific 
inhibitors of mitogen-activated protein kinase (MAPK) but not by inhibitors of phosphotidylinositol 
3-kinase (PI3K), indicating insulin-induced activation of BK channels via stimulation of the MAPK 
pathway. In human myeloblastic ML-1 cells, Kv channel activity is modulated by the insulin - 
PI3K - Akt pathway, controlling cell proliferation (Guo et al., 2005). IGF-1 activates Kv channels 
in HEK293 cells via the PI3K pathway, resulting in enhanced proliferation (Gamper et al., 2002). 
The effects of IGF-1 on K+ currents are blocked by inhibitors of PI3K and are mimicked by 
overexpression of phosphoinositide-dependent protein kinase-1 (PDK1) or serum- and 
glucocorticoid-dependent kinase-1 (SGK1). Both PDK1 and SGK1 are downstream targets of 
PI3K (Figure 2). Importantly, IGF-1-induced proliferation of HEK293 cells is inhibited by both K+ 
channel blockers and inhibitors of PI3K. TGFβ1 stimulates BK channels through MAPK and 
PI3K signaling cascades (Lhuillier and Dryer, 2002). TGFβ1 evokes phosphorylation of the 
proto-oncogen Akt (protein kinase B) and activates MAPK/Erk kinase (MEK). Inhibition of PI3K 
by wortmannin and LY294002 suppresses the stimulatory effects of TGFβ1 on BK channel and 
Akt phosphorylation. PI3K and Erk represent parallel signaling cascades activated through 
TGFβ1, which both stimulate BK channels (Figure 2). The epidermal growth factor EGF has also 
been shown to activate K+ channel activity in parallel to cell proliferation. EGF stimulation 
hyperpolarizes the membrane voltage of mouse fibroblasts (Magni et al., 1991) and mouse 
mammary epithelial cells (Enomoto et al., 1986). A similar hyperpolarization is obtained by 
application of Ca2+ ionophores, while the effects of EGF are blocked by charybdotoxin, TEA, or 
quinine. Thus, Ca2+-activated K+ channels may support EGF-induced cell proliferation. In 
summary, an increase in K+ channel expression and activity appears to be a downstream event 
of growth factor signaling. 
Ca2+ signaling and membrane voltage 
Ca2+ is a major intracellular messenger that is also crucial for cell proliferation. The intracellular 
Ca2+ concentration ([Ca2+]i) is tightly controlled and maintained at around 100 nM in resting cells. 
Increase in [Ca2+]i occurs by Ca2+ release from intracellular stores and Ca2+ entry from the 
extracellular space through different types of Ca2+ channels. In excitable tissues, Ca2+ influx 
occurs through voltage-gated Ca2+ channels. In non-excitable cells, Ca2+ entry occurs through 
store-operated Ca2+ channels (SOCs) and receptor-operated Ca2+ channels (ROCs) (Schreiber, 
2005). These channels are activated by depletion of intracellular Ca2+ stores (endoplasmic 
reticulum) and by ligand binding, respectively. A hyperpolarized membrane voltage is essential 
to provide the driving force for Ca2+ entry and Ca2+ release (Figure 3A). Oscillations of [Ca2+]i 
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have been observed during the cell cycle. These transient changes of [Ca2+]i occur at the exit 
from G0, during S phase, and at the end of M phase (Schreiber, 2005). Cytosolic Ca2+ activates 
gene transcription and triggers resting cells to re-enter the cell cycle and to initiate of DNA 
synthesis at the G1/S transition (Berridge, 1995). 
 
 
 
Figure 2. Growth factors stimulate cell 
proliferation by increasing expression and 
activity of K+ channels. Activation of 
receptor tyrosine kinase by growth factors 
triggers phosphatidylinositol 3-kinase 
(PI3K) and mitogen-activated protein 
kinase (MAPK). The PI3K generates 
phosphatidylinositol 3,4,5,-triphosphate 
(PIP3) which serves as a docking site for 
phosphatidylinositol-dependent protein 
kinase-1 (PDK1). Subsequently, serum- 
and glucocorticoid-dependent kinase-1 
(SGK1) and the protein kinase Akt are 
phosphorylated and activated by PDK1. K+ 
channels are regulated by phosphorylation 
via PDK1, SGK1, and Akt, which in turn 
stimulates cell proliferation. Activation of 
Ras is also triggered by receptor tyrosine 
kinase. Grb-2 adaptor protein binds to the 
receptor and to the Ras guanine 
nucleotide exchange factor (RasGEF). 
Ras, Raf (MAPKKK), MEK (MAPKK), and 
Erk (MAPK) are activated subsequently, 
which results in stimulation of K+ channels. 
A negative membrane voltage induced by K+ channels provides the driving force for Ca2+ influx. 
Thus, K+ channel blockers inhibit cell cycle progression due to membrane depolarization 
(Lepple-Wienhues et al., 1996, Nilius and Wohlrab, 1992). Growth hormones such as epidermal 
growth factor (Pandiella et al., 1989) and bradykinin (Lang et al., 1991) induce sustained 
oscillations of the negative membrane voltage by alternating between depolarization and 
hyperpolarization. These oscillations in response to growth factor stimulation are Ca2+ 
dependent and are blocked by K+ channel inhibitors. Thus K+ channels provide the physiological 
basic for intracellular Ca2+ oscillations. 
 
Regulation of intracellular pH 
Highly proliferative cancer cells produce a hypoxic and acidic microenvironment due to large 
amounts of metabolic acid, generated during glycolysis and synthesis of lactic acid. In tumor 
tissues extracellular pH (pHe) varies from 6.5 - 6.9, when compared to 7.0 - 7.5 in normal 
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tissues. In contrast, intracellular alkalinization has been demonstrated in tumors (Stubbs et al., 
1995). Even in an acidic extracellular environment, cancer cells maintain an intracellular pH, 
which is about 0.2 – 0.4 pH units more alkaline than that of normal cells (Webb et al., 1999). 
Intracellular alkalinization is induced by an outward transport of protons by the Na+/H+-
exchanger, vacuolar H+-ATPase, H+/Cl- symporter, and monocarboxylate transporter (lactate-
proton transporter) (Harguindey et al., 2005, Izumi et al., 2003). However, the Na+/H+-exchanger 
NHE1 is the main transporter, activated by growth factors and oncogens (Reshkin et al., 2000). 
Hyperactivity of NHE1 is observed during oncogenic transformation and development of 
malignant tumors. NHE1 exchanges intracellular H+ for extracellular Na+, and therefore largely 
relies on the driving force provided by a low intracellular Na+ concentration. Cells maintain the 
chemical gradient for Na+ by pumping Na+ out of the cell through the Na+/K+-ATPase. 
Subsequently intracellular K+ needs to be recycled through basolateral membrane K+ channels 
(Figure 3A). [Ca2+]i and pHi fluctuation during cell cycling are paralleled by fluctuations in [Na+]i 
and [K+]i (Morrill and Robbins, 1984). Therefore K+ channels substantially contribute to 
maintenance of intracellular pH. 
 
Cell volume regulation 
During cell cycle progression, large changes in cell volume occur. Cells must double their size 
before they divide, to maintain a constant average size over generations. Mitogens and growth 
factors activate NHE1, Na+-K+-2Cl- cotransporter (NKCC1), non-selective cation channels, and 
nutrient transporters thereby increasing cell volume (Lang et al., 2000). Cell swelling activates K+ 
and Cl- efflux by regulatory volume decrease (RVD). Thus, cells are capable of coping with 
changes in cell volume. The relationship between cell size and proliferation was investigated 
extensively in neuroblastoma and glioma cells. An intimate relationship was found between 
proliferation and cell volume, and either cell swelling or shrinkage was found to reduce 
proliferation.(Dubois and Rouzaire-Dubois, 2004). Thus, cell proliferation is optimal within a 
certain range of cell volume. One possibility to explain how changes in cell volume affect cell 
proliferation, is the macromolecular crowding theory (Dubois and Rouzaire-Dubois, 2004, Ellis, 
2001). Cell swelling and shrinkage lead to dilution and concentration, respectively, of cellular 
constituents, including macromolecules. Conformation and thus activity of macromolecules such 
as enzymes is largely dependent on their crowding and on the ratio of hydration versus 
osmotically active water. Relatively small changes in concentration lead to large changes in 
activity. Notably, K+ channel blockers like TEA, 4-AP, and Cs+ increase the cell volume and 
decrease the rate of cell proliferation. Proliferation is fully inhibited when cell volume increases 
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by 25% (Rouzaire-Dubois and Dubois, 1998). These effects on volume regulation demonstrate 
another mechanism by which K+ channels control cell proliferation. 
 
K+ channels and apoptosis 
Programmed cell death or apoptosis is induced by extrinsic and intrinsic pathways. The extrinsic 
or death receptor pathway, requires binding of ligands such as CD95, tumor necrosis factor α 
(TNF-α) or Fas-ligand. The intrinsic pathway or the mitochondrial pathway is triggered by 
mitochondrial membrane depolarization or DNA damage, disruption of the mitochondrial 
membrane and release of cytochrome c. As an early hallmark of programmed cell death, 
apoptotic cells show cell shrinkage, termed apoptotic volume decrease (AVD), due to efflux of 
K+, Cl-, and water (Figure 3B). Subsequent activation of caspase during the late phase of AVD 
leads to cleavage of nuclear lamin and DNA fragmentation via deoxyribonuclease activation. 
Consequently, apoptotic bodies are formed and digested by macrophages. AVD is inhibited by 
pharmacological blockers of K+ or Cl- channels, but not by broad spectrum caspase inhibitors 
(Maeno et al., 2000). Activation of apoptosis decreases [K+]i considerably. Reduction in K+ efflux, 
by elevating [K+]e or K+ channel blockers prevents cell shrinkage and inhibits cell death (Bortner 
et al., 1997). Conversely, increase in K+ efflux stimulates apoptosis. Interestingly, maintaining 
[K+]i at physiological concentrations (140 mM) or K+ channel blockers directly inhibit apoptotic 
enzymes and cytochrome c release, thereby preventing apoptosis (Grishin et al., 2005, Hughes, 
et al., 1997, Hughes and Cidlowski, 1999). In contrast, K+-ionophores (valinomycin) induce 
apoptosis in various cell types due to an increase in K+ efflux. Taken together, pronounced K+ 
efflux and reduced [K+]i is an initial step during programmed cell death. Various K+ channels 
have been implicated in apoptosis such as Kv, BK, two-pore K+ channels, hErg, ATP-sensitive K+ 
channels and inward rectifier K+ channels (reviewed in Burg et al., 2006). As mentioned before, 
Cl- channels are also activated during apoptosis. In apoptotic cortical neurons Cl- channel 
blockers inhibit outward rectifying Cl- currents, prevent AVD, and attenuate apoptotic cell death 
(Wei et al., 2004). Several types of Cl- channels are shown to contribute to cellular apoptosis 
such as CFTR (Barriere et al., 2001, Gottlieb and Dosanjh, 1996), Ca2+-activated Cl- channel 
(Elble and Pauli, 2001, Kim et al., 2003), cell volume regulatory Cl- channels (Lang et al., 2004), 
and outwardly rectifying Cl- channels (ORCC) (Szabo et al., 1998). 
 
Paradoxical role of K+ channels in cell proliferation and apoptosis 
Paradoxically, K+ currents have a role for proliferation and apoptosis. Even identical K+ channels 
were found to contribute to either proliferation or apoptosis. For instance, human Erg channels 
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facilitate tumor cell proliferation by TNF-α, and also promote H2O2-induced apoptosis in various 
tumors (Wang et al., 2002, Wang, 2004). The intermediate conductance Ca2+-activated K+ 
channel is important in AVD of human intestinal cells, but is also activated by growth factors 
(Okada et al., 2001, Tilly et al., 1993). The two-pore domain K+ channel TASK-3 has both an 
oncogenic potential in breast tumors, and a role during neuronal apoptosis (Patel and 
Lazdunski, 2004). 
 
Figure 3. Role of K+ channels in cell proliferation and apoptosis. In proliferative cells (A), mitogens 
activate Na+/H+ exchange (NHE), the Na+-K+-2Cl- cotransporter (NKCC1), and uptake of substrates. This 
leads to an increase in cell volume. H+ efflux via NHE and lactate-H+ transport causes cytosolic 
alkalinization, which triggers proliferation. Proliferating cells have a large Cl- conductance that is essential 
for regulatory volume decrease (RVD). K+ channels are also activated by mitogens and control RVD and 
oscillations of the membrane potential, which provides the driving force for Ca2+ entry through store-
operated Ca2+ channels (SOC) or receptor-operated Ca2+ channels (ROC). Intracellular K+ recycles 
through plasma membrane K+ channels to maintain the activity of the Na+/K+-ATPase and NKCC1. 
Therefore K+ channel activity indirectly supports cell proliferation via regulation of Ca2+ signaling, pH, and 
cell volume. B) Programmed cell death or apoptosis is induced by CD95 or Fas ligand. CD95 induces 
HCO3- efflux via HCO3- permeable anion channels and outwardly rectifying Cl- channels (ORCC), thus 
causing acidosis. Cellular acidosis occurs during early phases of apoptosis. Activation of death receptors 
also activates K+ and Cl- channels. K+ and Cl- efflux causes cell shrinkage. 
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How can these opposite functions be reconciled? Principally, many of the homeostatic 
parameters are fundamentally different in proliferative and apoptotic cells. Cell proliferation leads 
to an increase in cell volume, whereas apoptotic cell death is characterized by a decrease in cell 
volume or cell shrinkage. In proliferative cells, activation of K+ channels is necessary to maintain 
cell volume via RVD, whereas in apoptotic cells activation of K+ channels leads to AVD cell 
shrinkage. The [K+]i in apoptotic cells drops to values below 50 mM, suggesting that K+ efflux 
exceed that of water efflux, while a drop in [K+]i is not observed in proliferative cells (Yu et al., 
2001). Notably, proteolytic activation of caspases-3 and nuclease is facilitated by reduction of 
[K+]i (Hughes. et al., 1997). In general, the amplitude of K+ currents observed during apoptosis is 
much higher than that in proliferative cells (Patel and Lazdunski, 2004, Wang, 2004). Other 
noticeable differences concern intracellular Ca2+ signaling: Oscillatory Ca2+ rises are associated 
with proliferation and have not been observed during apoptosis (Berridge et al., 1998). Ca2+ 
release from endoplasmic reticulum (ER) is rapidly taken up by mitochondria and the ER. When 
mitochondria become overloaded with Ca2+, mitochondrial metabolism will be disturbed, which 
activates programmed cell death. Therefore, a steady and high [Ca2+]i increase appears to be 
necessary for apoptosis. 
 
Aims of the present study 
It was outlined above that K+ channels contribute to cell proliferation by controlling cell cycle 
transitions and affecting fundamental homeostatic parameters such as intracellular Ca2+, pH, 
and cell volume. However, the current knowledge is fragmentary and lacks of a deeper 
understanding of the underlying mechanisms. As another major concern, most studies have only 
been performed in cell cultures and little is known about the role of K+ channels for tumor 
development in vivo. The series of experimental work presented here, aimed in a better 
understanding of the role of K+ channels in prostate and particularly colonic cancer. The 
objectives were as follow: 
- To demonstrate the contribution of BK channels to proliferation of prostate cancer. 
- To clarify the expression of K+ channels and their functions in the premalignant colon and 
colonic cancer. 
- To elucidate more specifically the mechanisms by which Kv and EAG channels support 
cell proliferation in colonic cancer. 
- To study changes in ion transport during the development of colonic cancer 
- To investigate particularly the role of Eag-1 channels in human and mouse intestinal 
tumors.
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CHAPTER 2  
 
KCNMA1 gene amplification promotes tumor cell proliferation in 
human prostate cancer 
 
 
ABSTRACT 
 
Molecular mechanisms of prostate cancer progression are poorly understood. Here, we studied 
gene amplification of the large conductance calcium-activated potassium channel alpha subunit 
(KCNMA1), which is located at the chromosomal region 10q22. Fluorescence in situ 
hybridization (FISH) revealed KCNMA1 amplification in 16% of 119 late-stage human prostate 
cancers and in the hormone-insensitive prostate cancer cell line PC-3. In contrast, KCNMA1 
amplification was absent in 33 benign controls, 32 precursor lesions and in 105 clinically organ-
confined prostate cancers. Amplification was associated with mRNA and protein overexpression 
as well as increased density of BK channel protein and β-estradiol-insensitive BK currents in 
PC-3 cells as compared to non-amplified control cell lines. Specific blockade of BK channels by 
iberiotoxin or RNAi significantly inhibited K+ currents and growth of PC-3 cells. The data 
demonstrate that 10q22 amplification drives KCNMA1 expression and cell proliferation. Thus, 
KCNMA1 qualifies as a promising diagnostic and therapeutic target in patients with prostate 
cancer.  
 
 
Keywords: prostate cancer; progression; amplification; BK channel; KCNMA1  
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INTRODUCTION 
Prostate cancer is the most frequent malignant tumor among males in developed countries and 
the second leading cause for cancer-related death (Hsing et al., 2000). Androgen withdrawal is 
an effective therapy for patients with advanced prostate cancer, but progression to hormone 
independence occurs ultimately in almost all patients after a few months or years (Petrylak et al., 
2004). Although numerous non-hormonal agents have been evaluated in patients with hormone-
refractory prostate cancer, these agents have limited anti-tumor activity with modest or no effect 
on survival (Petrylak et al., 2004). Therefore, identification and selected inhibition of molecular 
targets that mediate progression of prostate cancer are highly warranted.  
The molecular mechanisms underlying progression to metastatic and hormone-refractory 
prostate cancer are poorly understood. High-level amplifications can pinpoint to genomic sites 
containing activated oncogenes with major biologic and therapeutic importance. We have 
recently identified an amplification at 10q22 prevailing in approximately 15% of hormone-
refractory prostate cancers and in the hormone-insensitive prostate cancer cell line PC-3 
(Bernardino et al., 1997, El Gedaily et al., 2001). Amplification of 10q22 appears to be absent or 
exceedingly rare in other tumor types, suggesting that this chromosomal region harbors genes 
that specifically drive progression of prostate cancer (Knuutila et al., 2000) 
The KCNMA1 gene is located at 10q22 and encodes the pore-forming α-subunit of the large 
conductance Ca2+-activated K+ channel (also known as BK-channel, Maxi K+ channel, slowpoke) 
that can tetramerize to a fully active BK channel (El Gedaily et al., 2001, Quirk and Reinhart, 
2001). In mammalian tissues, KCNMA1 is almost ubiquitously expressed along with four 
regulatory β-subunits KCNMB1-4 (Orio et al., 2002, Rebhan et al., 1997). 
Numerous functions have been attributed to BK channels, including modulation of smooth 
muscle tone of blood vessels and uterus (Amberg et al., 2003, Zhou et al., 2000), synaptic 
neurotransmitter release (Robitaille and Charlton, 1992) and epithelial transport (Kunzelmann 
and Mall, 2002). Most recently, attention has been drawn to the BK channel as a critical player in 
blood pressure regulation (Amberg and Santana, 2003) and in the neurotropic effect of ethanol 
(Davies et al., 2003). Hence, potassium channel-modulating agents have been suggested as 
therapeutic agents in neurological and cardiovascular disorders (Calderone, 2002). 
Apart from this, growing evidence exist that K+ channels may also be involved in oncogenesis. 
For example, BK channel activation has been shown to drive tumor cell proliferation in 
astrocytoma (Basrai et al., 2002). Moreover, a previous report has suggested a role of 
potassium channels for the proliferation of prostate cancer (Van Coppenolle et al., 2004). Here, 
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we demonstrate that KCNMA1 is amplified in a subset of late-stage prostate cancers in vivo, and 
that BK channel activity alters growth of human prostate cancer in vitro. 
 
MATERIALS AND METHODS  
FISH probes 
The bacterial artificial chromosome (BAC) RP11-428p16, which contains major parts of the 
KCNMA1 gene sequence, and the BAC RP11-417o11, which contains the whole genomic 
sequence of PLAU, were obtained from the Wellcome Trust Sanger Institute (Cambridge, UK). 
Growth conditions and DNA extraction were as recommended by the supplier. One microgram of 
purified plasmid DNA was labeled using a modified Bio Nick kit (Invitrogen, Carlsbad, CA, USA). 
The nucleotide solution of the nick kit was replaced by 0.2 mM each dCTP, dGTP, dTTP, 0.1 
mM dATP, 500 mM Tris-HCl (pH 7.8), 50 mM MgCl2, 100 mM mercaptoethanol, 100 mg/ml 
nuclease-free bovine serum albumin (BSA), 1 ml Digoxigenin (Roche Diagnostics, Basel, CH), 
and 1 ml DNA Polymerase 1 (Invitrogen) was added. Nick translation was performed at 16°C for 
90 min. The labeled FISH probes were purified by precipitation and re-dissolved in 50 µl H2O.  
Clinical specimens 
The 298 formalin-fixed and paraffin-embedded clinical specimens on the prostate tissue 
microarray were from the archive of the Institute for Pathology, University Hospital Basel, 
Switzerland. The tissue microarray was constructed as described previously (Kononen et al., 
1998). The size of each tissue spot was 0.6 mm. In addition, sections from eight frozen prostate 
tissue specimens were used for immunofluorescence. They were from four patients with 
hormone-refractory local recurrences treated by transurethral resection, two patients with 
clinically organ-confined disease treated by radical prostatectomy and from two patients with 
benign prostatic hyperplasia treated by transurethral resections. Specimens were kept 
anonymous, and the experiments were according to the guidelines of the ethical committee of 
the University of Basel.  
Fluorescence in situ hybridization  
Paraffin removal (3 × 5 min in Xylene followed by 2 × 2 min ethanol 95% and air-drying) and 
enzymatic tissue pretreatment (Vysis pretreatment solution, 80°C, 15 min) of tissue sections 
mounted on glass slides were performed in a VP2000 Processor device (Vysis, Downers Grove, 
IL, USA). Slides were rinsed in water for 2 min, incubated in protease K solution (Vysis) at 37ºC 
for 150 min and rinsed in water again. Subsequently, slides were dehydrated in an ascending 
ethanol series (70, 80, 95%) and air-dried. Then, a premixed hybridization cocktail containing 
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0.5 µl centromere 10 probe (CEP 10 Spectrum orange labeled; Vysis), 1.5 µl KCNMA1 probe 
(digoxigenin labeled), 1 µl Cot DNA (Invitrogen) and 7 µl hybridization buffer (Vysis) was added 
to each slide. For probe and target DNA denaturation, slides were heated to 72°C for 10 min. 
Probes were allowed to hybridize overnight at 37°C in a humidified chamber. The next day, 
slides were washed in 2 ×
 
standard sodium citrate, 0.3%NP40, pH 7 - 7.5 at 72°C for 2 min. The 
KCNMA1 probe was detected using the Dig detection kit (Roche Diagnostics). Amplification was 
defined as a signal ratio of gene probe/centromere 10 ≥ 2 and at least five gene signals.  
Cell lines and cell culture  
We used the cell lines PC-3, LNCaP and BPH-1. PC-3 was originally established from a lumbar 
vertebral metastasis of a 62-year-old Caucasian man after treatment with diethylstilbestrol and 
bilateral orchiectomy (Kaighn et al., 1979). LNCaP cells were isolated from a needle aspiration 
biopsy of the left supraclavicular lymph node metastasis of a 50-year-old Caucasian man 
(Horoszewicz et al., 1980). BPH-1 originates from a 68-year-old patient with transurethral 
resection of the prostate for benign prostatic hyperplasia. The donor had not undergone 
hormonal therapy and did not have malignant disease. The cells were immortalized with a virus 
carrying the SV40T antigen and selected for resistance to geneticin. This cell line does not 
express androgen receptor and prostate specific antigen (Hayward et al., 1995). 
For the growth assays, 6×25,000 cells were plated on a six-well plate (Falcon, Becton-Dickinson, 
Franklin Lakes, NJ, USA). PC-3 and BPH-1 were grown in 3 ml Opti-MEM (Invitrogen) + 10% 
fetal calf serum (FCS, BioConcept, Allschwil, CH). After 1 day, the medium was changed to Opti-
MEM + 1% FCS. At day 2, the medium was changed to Opti-MEM + 0.4% Albumax (Invitrogen) 
containing iberiotoxin (Sigma, Fluka Production GmbH, St Louis, MO, USA) or 17β-estradiol 
(Sigma, Fluka Production GmbH). Iberiotoxin (IBMX) was diluted in phosphate-buffered saline 
(PBS) to a final concentration of 20 nM.17β-estradiol was diluted in 70% ethanol to a final 
concentration of 1 nM. In contrast to PC-3 and BPH-1, LNCaP did not grow in Opti-MEM + 0.4% 
Albumax. Thus, the effects of estradiol and IBTX on growth of LNCaP were assayed in Opti-
MEM + 5% FCS + 0.2% Albumax. This medium contains reduced serum and still allows growth 
of LNCaP. After two days of growth, cell numbers were counted using a Neubauer Chamber. 
The growth rate k was calculated as N(t) = N0*e
kt 
, t = time in days.  
Western blot and immunofluorescence  
Cells were lysed in sample buffer containing 1% sodium dodecyl sulfate (SDS) and 100 mmol/l 
dichlorodiphenyltrichloroethane. Protein concentrations were determined according to a modified 
Laury method. Lysates of PC-3 cells were resolved by 7% SDS-PAGE, transferred to Hybond-P 
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(Amersham Pharmacia Biotech, Freiburg, BRD) and incubated with anti-KCNMA1 polyclonal 
antibody (generous gift by Professor Dr P Ruth, Institute of Pharmacy, University of Tübingen, 
Germany). Proteins were visualized using a sheep anti rabbit immunoglobulin G, conjugated to 
horse radish peroxidase and ECL Advance Detection Kit (Amersham Pharmacia Biotech). For 
immunocytochemistry, PC-3, BPH-1 and LNCaP cells were grown on glass cover slips, washed 
three times in PBS and fixed in methanol at -20°C. After washing in PBS, cells were incubated 
for 10 min in blocking buffer containing 10% BSA and 10% fish skin gelatine (both from Sigma). 
Cells were incubated overnight at 4°C in blocking solution, containing the primary antibody 
(1:1000 dilutions). Subsequently, cells were washed in PBS and incubated with the fluorescein 
isothiocynate (FITC)-linked secondary antibody for 1 h at 37°C. Tissues were counter stained 
with 4',6-diamidino-2-phenylindole dihydrochloride (DAPI) solution (Sigma) and embedded in 
Mowiol (Sigma). Immunofluorescence was detected using an Axiovert 200 microscope and 
MetaFluor imaging software. Immunofluorescence on frozen tissue sections was performed as 
described previously (Sausbier et al., 2006).  
RNA interference (RNAi)  
Transfection was performed following the siRNA transfection protocol for Lipofectamine 2000 
(Qiagen, KJ Venlo, NL, USA). Briefly, 50,000 cells were plated in six-well plates (Falcon, Becton-
Dickinson) one day before transfection. The transfection was performed in Opti-MEM 
(Invitrogen) for 4 h. The transfection mixture contained 5 µl of siRNA and Lipofectamine, each, in 
totally 3 ml Opti-MEM. After 4 h, the transfection mixture was replaced by Opti-MEM +
 
10% FCS. 
The siRNA sequences were: K1 gactggcagagtcctggttgt, K2 gtgggtctgtccttccctact, K3 
gaccgtcctgagtggccatgt, K4 acgcc cttagaggtggctaca.  
Semiquantitative RT–PCR  
Cells washed with PBS were lysed in 350 microl RLT buffer (RNAeasy minikit, Qiagen). RNA 
extraction was done according to the protocol of Qiagen. cDNA synthesis was performed with 
0.25 mg of total RNA using the superscript2 cDNA synthesis kit (Invitrogen). RT-PCR was 
performed using the LightCycler-system and the LightCycler FastStart DNA Master Hybridization 
Probes kit (Roche Diagnostics). Primers for G6PD and KCNMA1 hybridization products were 
obtained from TIB MolBiol (Berlin, BRD). PCR primers were: KCNMA1: KCNMA1_s: 
cctggcctcctccatggt, KCNMA1_a: ttctgggcctccttcgtct, G6PD: G6ex7,8 R ttct gcatcacgtcccgga, 
G6ex6 S accactacctgggcaaggag. Hybridization probes were: KCNMA1: KCNMA1_fl: 
agcgtccgccagagcaagat, KCNMA1_lc: atgaagaggcccccgaagaaagt, G6PD: G6ex_FL: 
cagatggggccgaagatcctgtt, G6ex_LC: caaatctcagcaccatgaggttctgcac. PCR conditions were: 
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activation: 10 min 95°C PCR cycle: 5 s at 95°C, annealing 5 s at 57°C, elongation 15 s at 72°C, 
40 cycles. Raw data for KCNMA1 expression were corrected by comparing to the related G6PD 
controls. Then these corrected values were compared to each other to obtain relative 
expression.  
Patch clamp experiments  
Cell culture dishes were mounted on the stage of an inverted microscope (IM35, Carl Zeiss AG, 
Oberkochen, BRD) and kept at 37°C. Patch clamp experiments were performed in the fast 
whole cell and cell excised inside/out configuration. The patch pipettes had an input resistance 
of 2-4 MΩ when filled with a solution containing (mmol/l) KCl 30, K-gluconate 95, NaH2PO4 1.2, 
Na2HPO4 4.8, ethyleneglycol tetraacetate 1, CaCl2 0.726, MgCl2 1.034, D-glucose 5, adenosine 
triphosphate 1 (32 Cl). The pH was adjusted to 7.2, the Ca2+
 
activity was either 0.1 or 1 µmol/l. 
The access conductance was between 30 and 120 nS. In regular intervals, membrane voltages 
(Vm) were clamped in steps of 10 mV from -50 to +50 mV and whole cell conductances were 
calculated according to Ohm’s law. Currents (voltage clamp) and voltages (current clamp) were 
recorded using a patch clamp amplifier (EPC 7, List Medical Electronic, Darmstadt, Germany), 
the LIH1600 interface and PULSE software (HEKA) as well as Chart software (AD-Instruments). 
Data were analyzed using PULSE and Origin software. In membrane patches containing several 
BK channels, channel activity was determined by multiplying single channel Po with the number 
of active channels in the membrane patch. NS1619, IBTX, paxillin and ´17β-estradiol were from 
Sigma.  
Statistical analysis  
Statistical significance was verified in the Figures 2, 5, and 6 with an analysis of variance test 
using JMP-IN software (release 5.1, SAS Institute GmbH, Heidelberg, BRD). Statistical 
significance was assumed when P < 0.05; n = 3 for these figures. For all patch clamp 
experiments, Students t-test P-values < 0.05 were accepted to indicate statistical significance 
(*). 
 
RESULTS  
KCNMA1 amplification and overexpression of BK channels 
Human prostate cell lines were analyzed for KCNMA1 amplification by fluorescence in situ 
hybridization (FISH). Amplification, defined as a signal ratio of the KCNMA1 gene/centromere of 
chromosome 10 ≥ 2 and at least five gene signals, was present in the hormone-insensitive  
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Figure 1. FISH with KCNMA1-specific BAC RP11-428P16. a) Metaphase control: Green KCNMA1 signals 
and red centromere signals on chromosome 10. b) BPH-1, transformed benign prostate hyperplasia cell 
line, showing two signals for BAC probe and centromeric probe, each. c) PC-3, tumourigenic prostate 
cancer cell line with KCNMA1 amplification at 10q22: two clusters of green probe signals and two red 
signals of centromere 10 (arrows). d) Tumor cells from clinical prostate cancer with normal probe copy 
number. e) and f) Prostate cancers with amplification. Dense clusters of green probe signals but only rare 
red centromeric signals (arrows). Blue channel: DAPI. Green channel: FITC (BAC RP11-428P16). Red 
channel: Spectrum Orange (centromere 10). Magnification 
 
× 1000. 
 
prostate cancer cell line PC-3 but not in the hormone-sensitive prostate cell lines BPH-1 or 
LNCaP (Figure 1). To explore whether this amplification also prevails in vivo, a series of 298 
formalin-fixed and paraffin-embedded human prostate specimens was analyzed on a tissue 
microarray. We found amplification in 16.0% of 119 advanced prostate cancers including 
untreated locally aggressive tumors (20%), distant metastases (13%) and local recurrences 
(22%) from hormone-refractory tumors but not in benign prostatic hyperplasia, precursor lesions 
(high-grade prostatic intraepithelial neoplasia) and clinically localized prostate cancers (Table 1). 
These results suggest that amplification of KCNMA1 is associated with progression to late-
stage, metastatic and hormone-refractory human prostate cancer. The FISH results of KCNMA1 
were compared with PLAU, a previously suggested candidate target gene at 10q22 (Helenius et 
al., 2001). Comparable to KCNMA1, PLAU amplification was present in PC-3 but not in BPH-1 
and LNCaP. Analysis of 133 specimens revealed a similar prevalence and distribution of PLAU 
amplification among the different tumor stages as KCNMA1 amplification (Table 1). PLAU 
KCNMA1 amplification in prostate cancer 
 
20 
amplification was absent in specimens of benign prostatic hyperplasia and in clinically localized 
prostate cancers but present in untreated locally aggressive tumors (14%), lymph node 
metastases (13%), distant metastases (13%) and in hormone-refractory local recurrences 
(12%). The difference in the prevalence of amplification of these two genes in the different 
subgroups of tumors stages was statistically not significant.  
 
 Table 1. Prevalence of KCNMA1 and PLAU amplification in prostate cancer 
 Category KCNMA1  PLAU 
  Number 
of cases 
KCNMA1 
amplification 
(N) 
KCNMA1 
amplification 
(%) 
 Number 
of 
cases 
PLAU 
amplification 
(N) 
PLAU 
amplification 
(%) 
 BPH 33 0 0  24 0 0 
 High-grade PIN 32 0 0  - - - 
 T1a/b 43 0 0  17 0 0 
 T2 62 0 0  7 0 0 
 T3/4 10 2 20  7 1 14.3 
 LN metastases 17 0 0  8 1 12.5 
 Distant 
metastases  47 7 13  30 4 13.3 
 Hormone-
refractory local 
recurrences 
45 10 22.2  43 5 11.6 
 Abbreviations: BPH, benign prostatic hyperplasia; LN metastases, pelvic or paraortal lymph node 
metastases; PIN, prostatic intraepithelial hyperplasia; T1a/b, incidentally detected prostate cancer in 
transurethral resection for presumed BPH; T2, clinically organ confined prostate cancer treated by 
radical prostatectomy; T3/4, clinically non-organ confined, locally advanced prostate cancer treated 
with palliative transurethral resection. FISH analysis on a prostate-specific tissue microarray (TMA). 
The BAC RP11-428P16 was used as KCNMA1-specific probe, the BAC RP11-417O11was used as 
PLAU-specific probe and the centromeric probe for chromosome 10 as a reference. The total number 
of specimens evaluable for KCNMA1 and PLAU was 298 and 133, respectively. Amplification was 
defined as a ratio between gene and reference of X2 and at least five gene signals. 
 
To study whether amplification of KCNMA1 results in overexpression, we compared the mRNA 
levels of KCNMA1 in the amplified PC-3 cell line with the non-amplified cell lines BPH-1 and 
LNCaP using semiquantitative reverse transcriptase-polymerase chain reaction (RT-PCR). 
Expression of KCNMA1 was significantly higher in PC-3 as compared to LNCaP and BPH-1, 
suggesting that KCNMA1 amplification drives over-expression of the channel protein (Figure 2a). 
In fact, increased levels of KCNMA1 protein in PC-3 as opposed to the control cell lines were 
documented by immunofluorescence (Figure 2b). The fluorescence intensity (mean of optical 
density ± error of the mean) was significantly higher in PC-3 (27,759 ± 2061; 10 cells) than in 
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LNCaP (10,806 ± 259; 12 cells) and BPH-1 (317 ± 19.2; 13 cells; P<0.0001; stains were 
repeated twice). Immunofluorescence on human prostatic tissue revealed strong BK expression 
in smooth muscle cells of the fibromuscular stroma. This is in line with previous reports showing 
strong expression in smooth muscle of other sites such as blood vessels and colonic wall 
(McCobb et al., 1995, Sausbier et al., 2006). BK expression also prevailed in all six prostatic 
adenocarcinomas and the intensity varied from weak to moderate (Figure 3). None of the tumors 
met the criteria for KCNMA1 gene amplification by FISH. One tumor had increased gene copy 
number of KCNMA1 (5-7 gene signals and 4-5 reference signals) and showed moderate BK 
expression (Figure 3a). However, expression at a similar level was also found in tumors with a 
normal gene copy number (Figure 3f). Benign prostatic glands showed weak expression of BK. 
 
 
     b 
 
         PC-3                LNCaP            BPH-1 
 
 
Figure 2. Expression of 
KCNMA1. a) mRNA expression 
of KCNMA1 was significantly 
enhanced in the amplified 
prostate cancer cell line PC-3 as 
compared to the non-amplified 
cell lines LNCaP (P = 0.0002) 
and BPH-1 (P = 0.0001). Figure 
is drawn to be relative to the 
expression in PC-3. (n = 3 for 
each group). b) Immuno-
fluorescence of the prostate 
cancer cell lines PC-3, LNCaP 
and BPH-1. Protein expression 
of KCNMA1 was strong in PC-3 
cells, weak in LNCaP and 
indiscernible in BPH-1 (P < 
0.0001). Magnification × 1000. 
Stains were repeated twice.  
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Figure 3. Immunofluorescence of anti-BK channel antibody on human prostate cancer tissue. Antibody 
labeled in green (FITC), nuclei counterstained in blue (DAPI). a) Well-detectable BK channel staining in 
the cytoplasm of hormone-refractory prostate cancer (long arrow), and strong staining in surrounding 
smooth muscle cells (short arrow). This tumor showed increased KCNMA1 gene copy number by FISH. b) 
Negative control on the same specimen as (a). Absence of staining indicates specificity of the antibody. c) 
Bundle of smooth muscle cells in the same specimen as a). Note the very intense expression of the BK 
channel at the cellular membrane (short arrow). d) Hormone-refractory prostate cancer infiltrating between 
smooth muscle cells. Note the intense staining of the smooth muscle cells (short arrow) and the very weak 
staining of the tumor cells (long arrow). This tumor had normal KCNMA1 gene copy number by FISH. e) 
Benign prostatic gland. Weak cytoplasmic immunofluorescence (long arrow). The bright spots in the 
cytoplasm represent autofluorescent lipofuscin granules that are typically present in benign prostatic 
glands (arrowhead). f) Hormone-insensitive prostate cancer infiltrating between smooth muscle cells. 
Well-detectable cytoplasmic and membranous immunofluorescence in tumor cells (long arrows) and 
strong positivity in adjacent smooth muscle cells (short arrow). This tumor had normal KCNMA1 gene 
copy number by FISH. Magnifications: (a)-(d) × 1000, (e)-(f) × 630. 
 
BK channel currents in prostate cancer cells 
The prostate cell lines PC-3 and BPH-1 were used as in vitro models to study the influence of 
KCNMA1 currents for cell proliferation. Functional expression of BK channels in PC-3 and BPH-
1 cells was examined in patch clamp experiments. Iberiotoxin (IBTX), a well-known and highly 
specific inhibitor of the BK channel (Galvez et al., 1990), reversibly inhibited whole cell current 
(Im) and conductance (Gm) in PC-3 (Figure 4a and b). Inhibition of whole cell currents was 
paralleled by a depolarization of the membrane voltage (Vm). Other than in PC-3 cells, IBTX had 
only minor effects IBTX had only minor effects on the whole cell current of LNCaP the benign 
BPH-1 cells and did not depolarize the membrane voltage (Figure 4c). Whole cell patch clamp 
experiments were performed in the same media as proliferation assays. Under these 
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Figure 4. BK currents in prostate cancer cells. a) Continuous recording of the whole cell current (Im, upper 
trace) and membrane voltage (Vm, lower trace) in a fast whole cell recording of a PC-3 cell. Symbol on top 
indicates configuration and concentrations of K+. IBTX (20 nmol/l) reduced the outward current and 
depolarized Vm. b) Concentration dependence of the inhibitory effect of IBTX on the whole cell 
conductance (Gm) of PC-3 cells. c) Summary of the whole cell conductances (Gm) of PC-3, BPH-1 and 
LNCaP cells and effects of IBTX (20 nmol/l) on Gm as compared to negative control (con). IBTX 
significantly reduced Gm in PC-3 and LNCaP (P<0.001 and P<0.02, respectively). d) Summary of the 
whole cell conductances (Gm) of PC-3 and BPH-1 cells and effects of 17β-estradiol (E, 10 mmol/l). 17β-
estradiol leaded to a significantly increased Gm in BPH-1 (P<0.01). e) Single BK channel currents in inside 
out membrane patches at different clamp voltages. Channel openings are indicated by brief downward 
current deflections, while ---c indicates the closed state of the channel. Symbols indicate configuration and 
concentrations of K+. *Significance (paired t-test); (n) = number of experiments. 
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“proliferative” conditions, the membrane voltage (Vm) of both BPH-1 (-18 ± 1.8 mV, n = 13) and 
PC-3 (-23 ± 2.0 mV, n = 17) cells was depolarized. Although depolarization of Vm allows for 
activation of BK channels, IBTX inhibited membrane conductance was only found in PC-3 cells 
but not in BPH-1 cells. In Ringer solution both PC-3 and BPH-1 cells were hyperpolarized to -58 
± 2.1 mV (n = 14) and -59 ± 3.8 mV (n = 17) and IBTX sensitive membrane conductance was 
reduced (data not shown). Other Ca2+-activated K+ channels such as small and intermediate 
conductance channels showed negligible contribution to the whole cell conductance of PC-3 and 
BPH-1 cells (data not shown). 
The whole cell K+ conductance could not be augmented by the BK channel activator 17β-
estradiol in PC-3 (Valverde et al., 1999a), but was further enhanced along with a 
hyperpolarization of the membrane voltage in BPH-1 (Figure 4d). The results suggest a high 
activity of BK channels in PC-3 that cannot be further increased by 17β-estradiol. These findings 
were supported by inside/out excision of membrane patches from PC-3 cells into a bath solution 
containing high Ca2+ concentration. Under these conditions, large conductance BK channels 
were regularly detected in PC-3 (Figure 4e), but only occasionally found in membrane patches of 
BPH-1. The open probability (Po) of the single channel was enhanced at depolarized membrane 
voltages, and the single channel conductance was about 220 pS at symmetrical K+ 
concentrations of 150 mM, which is characteristic for BK channels. 
 
Impact of BK channel activity on proliferation of prostate cancer cells 
We examined the response of PC-3, BPH-1 and LNCaP to modulation of BK channel activity 
(Figure 5). The basal growth rate was higher in PC-3 than in BPH-1 and was significantly 
inhibited by the BK channel inhibitor IBTX (P = 0.015). This indicates a central role of BK 
channels for proliferation of PC-3 under normal growth conditions (Figure 5a). In contrast, there 
was no significant effect of IBTX on the growth of BPH-1 and LNCaP (P > 0.05. Figure 5b and 
c). 17β-estradiol stimulated growth of BPH-1 (P = 0.0021) and LNCaP (P = 0.0039) but not PC-3 
cells (Figure 5a-c). The growth effect of 17β-estradiol was abolished by IBTX both in BPH-1 and 
LNCaP. This finding suggests that the steroid exerts its stimulatory effects on cell proliferation in 
BPH-1 and LNCaP through activation of BK channels. In contrast, rapidly growing PC-3 cells 
proliferate independently of 17β-estradiol, as the abundantly expressed BK channels operate 
already at the high activity. 
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Figure 5. Growth rates of PC-3, BPH-1 and LNCaP cells in response to IBTX and 17β-estradiol (E). a) 
Growth of PC-3 cells was reduced in response to IBTX (P = 0.015) and was not significantly influenced by 
17β-estradiol. b) BPH-1 cells showed increased growth in response to 17β-estradiol (P = 0.0021), which 
was prevented by IBTX (P = 0.0175). (c) LNCaP cells showed increased growth in response to 17β-
estradiol (P = 0.0039), which was prevented by IBTX (P = 0.026). Con = untreated control, IBTX = 
iberiotoxin, E = 17β-estradiol, E + IBTX = 17β-estradiol + iberiotoxin. y-axis: growth rate k as N(t) = N0 × 
ekt. N(t): number of cells at time t, N0 = number of cells at time 0, t in days. 
 
The role of BK channels for proliferation of prostate cancer cells was further substantiated by 
gene-specific mRNA silencing using RNA interference (RNAi). Four different types of anti-
KCNMA1 small interference RNA molecules (siRNA K1-K4) were transfected into PC-3 cells, 
which all significantly reduced KCNMA1 mRNA expression and cell proliferation. The most 
potent KCNMA1-siRNA (K2) inhibited mRNA expression (Figure 6a) and cell proliferation (Figure 
6b) by 80-90%, when compared to non-transfected cells (c-si) or cells transfected with 
scrambled sequence siRNA (scr). Expression of KCNMA1 protein was largely reduced in siRNA 
K2-treated cells, when compared to non-transfected cells or cells transfected with scrambled 
sequence siRNA (Figure 6c). In whole cell patch clamp experiments, inhibition of the membrane 
conductance and depolarization of the membrane voltage by IBTX was significantly reduced in 
RNAi-treated cells (Figure 7a). The BK-inhibitor paxillin rather than IBTX was used for analysis 
of excised inside out membrane patches as paxillin is applicable to the cytosolic side of the 
membrane. Analysis of excised inside out membrane patches of RNAi-treated cells 
revealedlargely attenuated BK channel activity (nPo) and a reduced effect of the BK channel 
blocker paxillin (Figure 7b). Inhibition of BK channel activity by paxillin was much reduced in 
RNAi-treated PC-3 cells and was not detectable in BPH-1 cells (Figure 7c). Taken together, the 
present data indicate a crucial role of KCNMA1 for proliferation of advanced and hormone-
refractory prostate cancer cells. 
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Figure 6. Inhibition of KCNMA1 expression by RNAi in PC-3. a) RNAi reduced KCNMA1 mRNA 
expression to 15–50% compared to non-transfected cells (c-si) or cells transfected with scrambled 
sequence RNAi (scr) (P = 0.005 or P = 0.0021, respectively).Figure is drawn to be relative to the 
expression in the control (c-si). b) KCNMA1-RNAi using all four active siRNA K1-4 had a pronounced 
inhibitory effect on PC-3 cell growth. y-axis shows total number of cells per well. c) Western blot analysis 
of non-transfected (c-si) PC-3 cells and PC-3 cells which have been transfected with scrambled sequence 
(scr) and KCNMA1-RNAi (K2). 
 
DISCUSSION  
There is mounting evidence that K+ channels play a crucial role in oncogenesis, and their 
potential as therapeutic targets in cancer has been recognized (Conti, 2004, Pardo et al., 1999, 
Pei et al., 2003, Wang, 2004). Here, we demonstrate that the large conductance Ca2+-activated 
potassium channel (KCNMA1) is amplified at 10q22 in 16% of late-stage, metastatic and 
hormone-refractory human prostate cancers. In the cell line PC-3, amplification of KCNMA1 is 
associated with overexpression of mRNA and protein, and a high density of BK channels in the 
cellular membrane as opposed to non-amplified cell lines. Importantly, growth inhibition by 
specific blockade of KCNMA1 activity using IBTX and RNAi in the amplified prostate cancer cell 
KCNMA1 amplification in prostate cancer 
 
27
line PC-3 strongly argues for an oncogenic effect of KCNMA1 amplification and functional 
overexpression. Expression of BK channel protein is not restricted to cell lines in vitro but also 
present in human prostate cancers in vivo. As well-detectable BK expression was found in 
tumors without KCNMA1 amplification, factors other than increased gene dosage must also be 
involved in the regulation of BK expression in prostate cancer.  
 
 
 
Figure 7. Inhibition of KCNMA1 currents 
by RNAi.  a) Summary of the whole cell 
conductances (Gm) and membrane 
voltages (Vm) of non-transfected (c-si) PC-
3 cells and PC-3 cells which have been 
transfected with anti KCNMA1-RNAi. GIBTX 
= Gm under inhibition with IBTX, VIBTX = 
Vm under inhibition with IBTX (P < 0.001 
and P < 0.0007, respectively). b) Multiple 
BK channels in inside out membrane 
patches at 0 mV clamp voltage. ---c 
indicates current level when all channels 
are closed. BK channels are much more 
abundant in non-transfected (c-si) when 
compared with RNAi-transfected PC-3 
cells. The BK channel inhibitor paxillin 
had a more pronounced effect in non-
transfected (c-si) cells. c) Product of open 
probability and number of channels (nPo) 
in non-transfected (c-si) and RNAi-
transfected PC-3 cells as well as BPH-1 
cells. The Po was significantly reduced by 
paxillin (Pax) in non-transfected (c-si) PC-
3 cells and in PC-3 cells treated by RNAi 
(P < 0.001 and P < 0.02, respectively). 
The effect of paxillin was significantly 
greater in non-transfected PC-3 cells (c-
si) than in RNAi-transfected PC-3 cells (#; 
P< 0.03). *Significance (paired t-test); 
(n)=
 
number of experiments. Con=
 untreated controls.  
 
The oncogenic role of KCNMA1 found in this study is in line with the previously reported growth 
inhibition of human astrocytoma by IBTX (Basrai et al., 2002, Weaver et al., 2004). Interestingly, 
the intermediate conductance K+ channel (IK) rather than KCNMA1 has been proposed to be 
important for PC-3 and LNCaP cells by Parihar et al. (Parihar et al., 2003). Parihar et al. 
performed the efflux experiments under non-proliferative conditions, that is, in Ringer solution 
rather than in growth medium. In Ringer solution, however, the cells were hyperpolarized and 
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thus BK channels and other voltage-gated K+ channels show little activity (O'Grady and Lee, 
2005, Pardo, 2004). The present data suggest that analysis of ion channels relevant to 
proliferation should be conducted under proliferative conditions, that is, in the presence of 
serum-containing culture media. Serum and glucocorticoid-inducible kinase, phospho-inositide-3 
kinase and the mitogen-activated protein kinase pathway are activated by serum and have been 
shown to stimulate BK channels (Henke et al., 2004, O'Malley and Harvey, 2004). 
The role of estrogens in prostate cancer is controversial and is also challenged by the present 
results. Despite the traditional use of estrogens for the treatment of prostate cancer, it is now 
known that estrogens can also induce neoplastic transformation in the prostate (Ho, 2004). In 
addition, 17β-estradiol directly activates BK channels by binding to the β1-regulatory subunit, as 
shown in vascular smooth muscle cells (Valverde et al., 1999a). The present data provide 
evidence that 17β-estradiol stimulates growth of prostate cells through activation of BK 
channels. This growth stimulation by 17β-estradiol was pronounced in BPH-1 and LNCaP, but 
was absent in PC-3 cells. Missing activation of BK and lack of stimulation of cell proliferation by 
17β-estradiol in PC-3 cells suggests that BK channels operate at maximal activity in these cells 
owing to overexpression driven by amplification. Interestingly, it has recently been shown that a 
proliferative effect of 17β-estradiol in the breast cancer cell line MCF-7 is also mediated by BK 
channels independently of estrogen receptor (Coiret et al., 2005). PC-3 and BPH-1 are known to 
express estrogen receptor alpha and beta, whereas LNCaP only expresses the estrogen 
receptor beta (Lau et al., 2000). Thus, 17β-estradiol might stimulate growth of BPH-1 and 
LNCaP by binding to the estrogen receptors. Alternatively, one could hypothesize that the 
growth effect of 17β-estradiol in LNCaP is due to altered ligand binding of the mutated androgen 
receptor (Veldscholte et al., 1992). However, the prevention of the growth stimulation of estradiol 
by IBTX suggests that the BK channel activity plays a central role in this growth stimulation. This 
is also in accordance with the previously shown direct activation of BK channels by 17β-estradiol 
(Kuruma and Hartzell, 2000, Valverde et al., 1999a). Taken together, activation of BK channel 
might be a major target of 17β-estradiol in prostate cancer in the absence of KCNMA1 
amplification and overexpression. However, it is likely that BK channels are modulated by a 
complex network of different molecules and molecular pathways (O'Malley and Harvey, 2004, 
Olsen et al., 2005).  
There is increasing evidence that gene amplification leads to growth advantage of tumor cells, 
as a set of multiple genes rather than a single gene is overexpressed (Kauraniemi et al., 2001, 
Reiter et al., 2000). Along this line the urokinase-type plasminogen activator gene (uPA; syn. 
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PLAU) has previously been suggested as amplification target at 10q22 in human prostate 
cancer (Helenius et al., 2001, Helenius et al., 2006). As expected, PLAU amplification 
preferentially occurred in advanced prostate cancer at a similar prevalence as amplification of 
KCNMA1 in our study. Prosaposin (PSAP) at 10q22, which has growth- and invasion-promoting 
activities, is another gene that has recently been found to be amplified in PC-3 and a few 
prostate cancer xenografts and lymph node metastases by single nucleotide polymorphism array 
and quantitative real-time PCR analysis (Koochekpour et al., 2005). Notably, PLAU stimulates 
Ca2+-activated K+ channels in the human promyelocytic cell line U937 (Christow et al., 1999), 
suggesting synergistic effects of co-amplification of KCNMA1 and PLAU. This challenges new 
promising studies on the interaction between KCNMA1 and other genes within the amplified 
chromosomal region at 10q22.  
In summary, the data presented in this study unmask KCNMA1 as an amplified target gene at 
10q22 that confers growth advantage to prostate cancer cells. Thus, BK channel may be a 
suitable pharmacological target in patients with late-stage prostate cancer that show 
amplification and overexpression of KCNMA1.  
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CHAPTER 3  
 
Voltage-gated K+ channels support proliferation of colonic carcinoma 
cells 
 
 
ABSTRACT 
 
Plasma membrane potassium (K+) channels are required for cell proliferation. Evidence is 
growing that K+ channels play a central role in the development and growth of human cancer. 
Here we examine the contribution and the mechanism by which K+ channels control proliferation 
of T84 human colonic carcinoma cells. Numerous K+ channels are expressed in T84 cells, but only 
voltage-gated K+ (Kv) channels influenced proliferation. A number Kv channel inhibitors reduced 
DNA synthesis and cell number, without exerting apoptotic or toxic effects. Expression of several 
Kv channels such as Eag-1, Kv3.4 and Kv1.5 was detected in patch clamp experiments and in 
fluorescence based assays, using a voltage sensitive dye. The contribution of Eag-1 channels to 
proliferation was confirmed by siRNA, which abolished Eag-1 activity and inhibited cell growth. 
Inhibition of Kv channels did not interfere with the ability of T84 cells to regulate their cell volume, 
but restricted intracellular pH regulation. In addition, inhibitors of Kv channels as well as siRNA 
for Eag-1 attenuated intracellular Ca2+ signaling. The data suggest that Kv channels control 
proliferation of colonic cancer cells by affecting intracellular pH and Ca2+ signaling. 
 
 
Key words: Eag, voltage-gated K+ channels, colonic carcinoma cells, T84, proliferation, growth, 
Ussing chamber, patch clamp 
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INTRODUCTION 
Apart from their specific epithelial transport function, membrane ion channels are essential for 
maintaining cellular homeostasis and signaling. Thus they contribute to the control of essential 
parameters such as cell volume, intracellular pH and intracellular Ca2+ concentration. K+ 
selective ion channels form the largest ion channel protein family, which may be subdivided into 
voltage-gated, Ca2+-dependent, 2-pore domain, and inward rectifier K+ channels. It has recently 
been suggested that in addition to the physiological parameters controlled by K+ channels, they 
also affect mitotic cell cycling, proliferation and development of cancer. A role of K+ channels for 
proliferation and tumor cell growth has been demonstrated for a number of carcinoma, like those 
of prostate, colon, lung, breast and others (Wang, 2004). K+ channels of different subfamilies 
have been correlated with tumor proliferation, including Ca2+-activated K+ channels, Shaker-type 
voltage-gated K+ channels, the ether à go-go (Eag-1) family of voltage-gated K+ channels and 
the 2P-domain K+ channels (O'Grady and Lee, 2005, Pardo, 2004, Wang, 2004, Wonderlin and 
Strobl, 1996). It is not known currently, why different types of K+ channels induce proliferation in 
the different cancer models. Most of the previous studies describe expression of a particular type 
of K+ channel in a cancer cell line and correlate expression and functional activity of the channel 
with proliferation. However, mammalian cells always express a whole array of various types of 
K+ channels, and it is not clear to what degree these individual K+ channels contribute to 
proliferation, or if there is a specific association between particular K+ channel subtypes and 
proliferation. Moreover the mechanisms by which these K+ channels facilitate cell proliferation 
remain obscure.  
Colonic carcinomas belong to the most frequent cancers in human. A previous study found a 
correlation between the activity of voltage-gated K+ channels and proliferation and metastasis of 
a colonic cancer cell line and native colonic cancers, respectively (Abdul and Hoosein, 2002b, 
Lastraioli et al., 2004). Interestingly Ca2+ influx into colonic cancer cells was affected by voltage-
gated K+ channels in one study (Abdul and Hoosein, 2002b). Identification of K+ channels which 
are relevant for the growth of colonic carcinomas may provide novel therapeutic targets (Conti, 
2004, Schonherr, 2005). Moreover, K+ channels abnormally expressed in colonic cancer cells, 
could be potentially useful as markers for malign transformation. In the present study, we 
therefore screened T84 colonic carcinoma cells for expression of a broad spectrum of K+ 
channels. We then tried to identify the K+ channels that have an impact on proliferation of these 
cells. Using a variety of K+ channel blockers and siRNA, we found that voltage-gated K+ 
channels take part in controlling cell proliferation, while other K+ channel subtypes do not. A 
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further aim of this study was to uncover how these channels affect proliferation. The data 
suggest that voltage-gated K+ channels control basic cellular properties like intracellular Ca2+, 
elicited by agonist stimulation of the cells, and regulation of the intracellular pH. Both effects are 
likely to be due to the hyperpolarizing effect of Kv channels on the membrane voltage.  
 
MATERIAL AND METHODS 
Cell culture and proliferation studies 
Human colorectal carcinoma epithelial T84 cells (American Type Culture Collection, Rockville, 
MD, USA), were grown in DMEM/Ham's F-12 medium (1:1), supplemented with 10% fetal 
bovine serum (FBS), 2 mM glutamine, 100 U/ml penicillin and 100 µg/ml streptomycin 
(Pen/Strep) (GIBCO, Germany) in a 5% CO2 atmosphere at 37°C. Cells were seeded on bovine 
plasma fibronectin (Invitrogen, Germany) and bovine dermal collagen (Cellon, Luxembourg) 
coated plastic dishes or glass cover slips. For proliferation assays, T84 cells were plated at a 
density of 2000 cells / 0.35 cm2 on coated 96 well plates (Sarstedt, Nürnberg, Germany). After 2 
days, cells were incubated with inhibitors of potassium channels dissolved in serum reduced 
Opti-MEM 1 medium (GIBCO, Germany). After additional 2 days, cell proliferation was assessed 
by 5-bromo-2´-deoxyuridine (BrdU) incorporation and cell counting. BrdU incorporation was 
determined using an immunoassay cell proliferation ELISA kit (Roche, Germany), according to 
the manufacturer’s protocol. For cell counting, cells were fixed with 3.7% formaldehyde and 
0.5% Triton X-100 in ringer solution (mmol/l: NaCl 145; KH2PO4 0,4; K2HPO4 1,6; Glucose 5; 
MgCl2 1; Ca2+-Gluconate 1,3, pH 7.4) for 30 minutes and stained with Mayers Hemalaun (Merck, 
Darmstadt, Germany). Digital images were obtained and nuclei were counted using imaging 
software. Toxicity of the blockers was assessed by counting non-stained dead cells in the 
supernatants (Trypan Blue). Each experiment was performed in triplicate.  
Expression of potassium channels in T84 cells and real time PCR analysis 
Total RNA was isolated from T84 cells using NucleoSpin RNA II columns (Macherey-Nagel, 
Germany). Total RNA (1 µg) was reverse transcribed for 1 h at 37°C using random primer and 
RT (M-MLV Reverse Transcriptase, Promega, Germany). RT-PCR was used to detect 
expression of the mRNAs for potassium channels. The oligonucleotide primers were designed 
for the mRNA of each gene product as follow 
 
name gene accession 
number 
sense and antisense primer size of PCR 
product (bp) 
Kv1.3 KCNA3 NM_002232 5´- GCCATCCTCTACTACTATCAG -3´ 
5´-CCACATGTCGATCAGGTTC -3´ 
532 
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name gene accession 
number 
sense and antisense primer size of PCR 
product (bp) 
Kv1.5 KCNA5 NM_002234 5´- CTACTTCGACCCCCTGAG -3´ 
5´- GCTCGAAGGTGAACCAGATG -3´ 
555 
KvLQT KCNQ1 NM_000218 5´- CCACGGGGACTCTCTTCTG -3´ 
5´- GGCACCTTGTCCCCATAG -3´ 
504 
Kv3.3 /  
Kv3.4 
KCNC3 / 
KCNC4 
NM_004977 5´- GACGTGCTGGGCTTCCTG -3´ 
5´- GCTTC TGCTTGGCCATGG -3´ 
442 
Kv4.1 KCND1 NM_004979 5´- GGAAGAATACGCTGGACCG -3´ 
5´- GCGGCATGGGATGGTCTC -3´ 
472 
Kv5.1 KCNF1 NM_002236 5´- GAGTCGTCGTGCCCGGC -3´ 
5´- GTCTCTGGATGGCTCTGCTC -3´ 
530 
Kv9.3 KCNS3 NM_002252 5´- GTGCAGCCTGATCTTCCTC -3´ 
5´- GTGTCAAACTTCTCCAGCTC -3´ 
540 
Eag-1 KCNH1 NM_002238 5´- GCATGAACTACCTGAAGACG -3´ 
5´- CTTCTCAATGTCTG TGGATGG -3´ 
488 
Erg-1 KCNH2 NM_000238 5´- CAATGCCAACGAGGAGGTG -3´ 
5´- GGAGAGACGTTGCCGAAG -3´ 
468 
Elk-1 KCNH8 NM_144633 5´- GCCCGAACTGAAGTCATGC -3´ 
5´- CAAAATAAGCCAGTCCCAGC -3´ 
522 
Kir6.1 KCNJ8 NM_004982 5´- GTTTGGAGTCCACTGTGTGTG -3´ 
5´- CAGAATAACTATGACCTCCAAG -3´ 
548 
TWIK1 KCNK1 NM_002245 5´- GCTTCGGCTTCCTGGTGC -3´ 
5´- GACAAACCCAAGGAGCACG -3´ 
505 
TASK2 KCNK5 NM_009740 5´- GGCCATCACAGGGAACCAG -3´ 
5´- GCCAGGCC AGCCCCAAG -3´ 
496 
TWIK2 KCNK6 NM_004823 5´- GATCTTTGCCCACCTCGAG -3´ 
5´- GATGCTGGGAAACAAAGGAG -3´ 
520 
BK channel 
α-subunit 
KCNMA1 NM_002247 5´- GTGGATGAAAAAGAGGAGGC -3´ 
5´- CAAATGGATGAACCCGGCTG -3´ 
528 
BK channel 
β3-subunit 
KCNMB3 NM_014407 5´- CGACCTGCACTGCCATCC -3´ 
5´- GGGCACC ACCTAGCAGAG -3´ 
398 
BK channel 
β4-subunit 
KCNMB4 NM_014505 5´- CCAGG TCTACGTGAACAAC -3´ 
5´- CTGTTGCCACTGAGGGATG -3´ 
520 
SK4 KCNN4 NM_002250 5´- GATTTAGGGGCGCCGCTGAC -3´ 
5´- CTTGCCCCACATGGTGCCC -3´ 
520 
 
The PCR reactions were performed at 94°C for 2 min, 35 cycles at 94°C for 30 sec, annealing 
temperature 60°C for 30 sec and 72°C for 1 min. PCR products were visualized by loading on 
agarose gels and were verified by sequencing. 
Real-time PCR was performed in a Light Cycler (Roche, Germany), using the Quanti Tect SYBR 
Green PCR Kit (Quiagen, Germany). Each reaction contained 2 µl Master Mix (including Taq 
polymerase, DNTPs, SYBR Green buffer), 1 pM of each primer (Eag-1: 5´- GGAGTTCCA 
GACGGTGCAC -3´, 5´- CCTCATCATCTTGGATCACC -3´, 116 bp; β-actin , ACTB, NM 001101: 
5´- CAACGGCTCCGGCATGTG -3´, 5´- CTTGCTCTGGGCCTCGTC -3´, 151 bp), 2.5 mM 
MgCl2 and 2 µl cDNA. After 10 minutes at 94°C for activation of Taq polymerase, cDNA was 
amplified by 15 s at 94°C, 10 s at 60°C, and 20 s at 72°C, for 50 cycles. The amplification was 
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followed by a melting curve analysis to control of the PCR products. As negative controls, water 
instead of cDNA was run with every PCR experiment. To verify accuracy of the amplification, 
PCR products were further analyzed on ethidium bromide stained 2% agarose gels. Analysis of 
the data was performed using Light Cycler software 3.5.3. Standard curves for Eag-1 channel 
mRNA and β-actin mRNA were produced by using cDNA of 16HBE cells at different dilutions. 
The ratio of the amount of Eag-1 to β-actin mRNA was calculated for each sample.  
Downregulation of Eag-1 expression by small interfering RNA 
Duplexes of 21-nucleotide siRNA with 3'-overhanging TT were designed according to Ahn et al 
2003 (Ahn et al., 2003) and synthesized by IBA (Göttingen, Germany). The sense strand of the 
siRNA used to silence the Eag-1 gene was 5´-GACACGAUUGAAAAAGUGCTT-3´, 
corresponding to positions 268-286 of the Eag-1 mRNA, relative to the start codon. The sense 
strand of the siRNA used to silence the potassium channel SK4 gene was 5´-
GCGCUUGCUGGAGCAGGAGTT-3´, corresponding to positions 48-66 of the SK4 mRNA 
relative to the start codon. A control siRNA oligonucleotide, Lmo2, designed to silence the LIM 
domain only 2 T-cell oncogenes (Mus musculus), has no target gene in T84 cells and was used 
as a negative control for transfection. It had the sequence 5´-GCCAUCGACCAGUACUGGCTT-
3´ (positions 133-151 relative to the start codon) of the Lmo2 gene. Transfection of T84 cells was 
carried out in Opti-MEM 1, one day after seeding using Oligofectamine (Invitrogen, Karlsruhe, 
Germany). After a 48 h rest, T84 cells were used for proliferation assays, patch clamp, real time 
PCR and western blot. 
Detection of Eag-1 protein by Western blot 
Lysates of T84 cells were resolved by 7% SDS-PAGE, transferred to Hybond-P (Amersham 
Biosiences, Germany) and incubated with mouse anti-Kv10.1 (Eag-1) antibodies (alomone labs, 
Jerusalem, Israel). Proteins were visualized using a goat anti-mouse IgG conjugated to 
horseradish peroxidase (Acris Antibodies, Germany) and ECL Advance Detection Kit 
(Amersham Biosiences, Germany).  
Measurement of the intracellular Ca2+ concentration, pH, cell volume and membrane potential 
T84 cells were loaded with 2 µM Fura-2 AM (Molecular Probes, USA) in Opti-MEM 1 medium 
with 2.5 mM probenecid (Sigma, Germany) for 1 h at room temperature. For fluorescence 
measurements of the intracellular Ca2+ concentration [Ca2+]i, cells were perfused with ringer 
solution containing 2.5 mM probenecide (Sigma, Deisenhofen, Germany) at 37°C. Fluorescence 
was measured continuously using an inverted microscope IMT-2 (Olympus, Nürnberg, 
Germany) and a high speed polychromator system (VisiChrome, Visitron Systems, Germany). 
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Fura-2 was excited at 340/380 nm and emission were recorded between 470 and 550 nm using 
a CCD camera (CoolSnap HQ, Visitron Systems, Puchheim, Germany). [Ca2+]i was calculated 
from the ratio of 340/380 nm fluorescence values (after subtraction of background fluorescence). 
The formula used for calculation of [Ca2+]i was [Ca2+]i = Kd x (R-Rmin)(Rmax-R) x (Sf2/Sb2) where R 
is the observed fluorescence ratio. The values Rmax, Rmin (maximum and minimum ratios) and 
the constant Sf2/Sb2 (fluorescence of free and Ca2+-bound fura-2 at 380 nm) were calculated 
using 2 µmol/l ionomycin (free acid, Calbiochem, Merck Biosciences, Bad Soden, Germany), 5 
µmol/l nigericin (Sigma, Germany), 10µmol/l monensin (Sigma, Deisenhofen, Germany) and 5 
mmol/l EGTA to equilibrate intracellular and extracellular Ca2+ in intact fura-2-loaded cells. The 
dissociation constant for the fura-2-Ca2+ complex was taken as 224 nmol/l.  
For assessment of intracellular pH, cells were incubated in standard bath solution (mM: 145 
NaCl, 0.4 KH2PO4, 1.6 K2HPO4, 5 glucose, 1 MgCl2, 1.3 Ca-gluconate, pH 7.4) containing 8 µM 
BCECF-AM and 0.05 % Pluronic for 30 - 60 min at room temperature (RT). For cell volume 
measurements T84  cells were loaded with 2.5 µM calcein-AM and 0.025 % Pluronic in standard 
bath solution for 30 - 60 min at RT. Excitation wavelengths of 488/440 and 500 nm were used 
for BCECF and calcein loaded cells, respectively. Emission wavelengths were > 520 nm for 
BCECF fluorescence and 520-550 nm for calcein fluorescence. We screened for the effect of K+ 
channel blockers on the membrane voltage, using the voltage sensitive dye FMP (Baxter et al., 
2002). Cells were incubated with FMP (FLIPR Membrane Potenial Assay Kit, Molecular Devices, 
Ismaning, Germany) in ringer solution at room temperature. FLIPR was exited with 485 nm and 
emission was detected between 515 and 560 nm. All experiments were controlled and analyzed 
using the software package Meta-Fluor (Universal imaging, USA). All optical filters and dichroic 
mirrors were from AHF (Tübingen, Germany).  
Patch clamp 
Cell culture dishes were mounted on the stage of an inverted microscope (IM35, Zeiss) and kept 
at 37 °C. The bath was perfused continuously with Ringer solution at about 10 ml/min. Patch-
clamp experiments were performed in the fast whole-cell configuration. Patch pipettes had an 
input resistance of 2-4 MΩ, when filled with a solution containing (mM) KCl 30, K-gluconate 95, 
NaH2PO4 1.2, Na2HPO4 4.8, EGTA 1, Ca-gluconate 0.758, MgCl2 1.034, D-glucose 5, ATP 3. pH 
was adjusted to 7.2, the Ca2+ activity was 0.1 µM. The access resistance was measured 
continuously during the recordings and was 8.3-14.2 MΩ. Currents (voltage clamp) and voltages 
(current clamp) were recorded using a patch-clamp amplifier (EPC 7, List Medical Electronics, 
Germany), the LH1600 interface and PULSE (HEKA, Germany) and Chart (AD-Instruments, 
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Germany) software. In regular intervals, membrane voltages (Vc) were clamped in steps of 10 
mV from -50 to +50 mV relative to resting potentials. The membrane conductance Gm was 
calculated from the measured current (I) and Vc values, according to Ohm’s law. 
Materials and statistical analysis 
All compounds used were of highest available grade of purity. 4-AP, TPeA, astemizole, 
calciseptine, EIPA, carbachol, quinidine, and terfenadine were all from Sigma (Deisenhofen, 
Germany). BDS-I, charybdotoxin, and iberiotoxin were from Alamone labs (Jerusalem, Israel). 
Clotrimazole was from Calbiochem (Merck Biosciences, Bad Soden, Germany). Scyllatoxin was 
from Latoxan (Valence, France). TRAM-34 was a generous gift by Dr. H. Wulff (Department of 
Medical Pharmacology and Toxicology, University of California Davis, San Francisco, USA). 
293B, AVE0118 and AVE1231 were gifts from Aventis Pharma (Frankfurt, Germany). All other 
chemicals were obtained from Merck (Darmstadt, Germany). The acetomethyl ester (2´,7´)-
bis(carboxyethyl)-5(6)-carboxyfluorescein (BCECF-AM), calcein (calcein-AM), Fura2-AM and 
Pluronic were all from Molecular Probes (U.S.A.). Student’s t-test (for paired or unpaired 
samples as appropriate) and analysis of variance (ANOVA) was used for statistical analysis. 
P<0.05 was accepted as significant. 
 
RESULTS 
Expression of cancer related K+ channels in T84 colonic carcinoma cells 
We broadly screened T84 cells for expression of K+ channels, based on previous reports 
indicating a role of K+ channels for proliferation of cancer cells (database SAGEmap of the 
Cancer Genome Anatomy Project, http://cgap.nci.nih.gov, (Lal et al., 1999) and recent 
publications. RT-PCR detected transcripts of a number of voltage-gated (Kv) K+ channels (Figure 
1A). Moreover, the ATP sensitive K+ channels Kir6.1 and the two-pore (2P)-domain K+ channels 
TWIK1, TWIK2 and TASK2 are expressed in T84 cells (Figure 1B). Although, transcripts of the α-
subunit of the large conductance Ca2+ sensitive (BK) channel could not be detected, the two β-
subunits β3 and β4 are expressed in these cells, along with intermediate conductance Ca2+-
activated SK4 K+ channels (Figure 1C). Taken together, several K+ channels are expressed in 
T84 colonic carcinoma cells, which may potentials support cell proliferation. 
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Figure 1. Expression of K+ channels in T84 cells. Expression of (A) voltage-gated (Kv3.3/3.4, Kv4.1, Kv5.1, 
Elk1, KvLQT1, Eag-1, Kv9.3), (B) inward rectifier (Kir6.1), two pore domain (TWIK1, TASK2, TWIK2), and 
(C) large (BKβ3, BKβ4) and small (SK4) conductance Ca2+-activated K+ channels, after reverse 
transcription (RT). 
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 Table 1.  Inhibition of T84 cell proliferation by K+ channel blocker. 
 Inhibitor Blocked channels Concentration BrdU incorporation cell number 
      (% of control)   (% of control) 
 293B KvLQT 10 µM 
1 µM 
0.1 µM 
0.01 µM 
0.001 µM 
  79.0 ± 4.9 (3)* 
  79.3 ± 1.4 (3)* 
  80.7 ± 2.5 (3)* 
  82.2 ± 5.1 (3) 
  84.6 ± 5.9 (3) 
  88.0 ± 1.3 (3)* 
  90.8 ± 0.5 (3)* 
  97.1 ± 0.9 (3) 
  99.7 ± 1.4 (3) 
  99.3 ± 1.3 (3) 
 4-AP Kv channels 2 mM 
1 mM 
0.5 mM 
0.05 mM 
0.005 mM 
  72.2 ± 8.1 (3)* 
  84.4 ± 5.9 (4) 
  89.6 ± 0.2 (3) 
  88.1 ± 4.0 (4) 
  92.8 ± 3.2 (5) 
  73.8 ± 3.4 (5)* 
  80.5 ± 3.5 (5)* 
  83.2 ± 3.9 (5)* 
  87.2 ± 3.5 (5) 
  92.6 ± 2.1 (5) 
 Astemizole 
 
Eag-1, Elk, Erg 5 µM 
0.5 µM 
0.05 µM 
0.005 µM 
0.5 nM 
  83.5 ± 5.1 (7)* 
  84.3 ± 3.0 (6)* 
  90.3 ± 2.8 (7) 
  91.3 ± 3.1 (7) 
  94.1 ± 3.1 (6) 
  81.5 ± 2.1 (8)* 
  85.1 ± 2.7 (7)* 
  88.5 ± 1.0 (9)* 
  91.4 ± 1.1 (9)* 
  96.5 ± 1.0 (8) 
 AVE0118 Kv1.5, 4.3, 2.1, 3.1 50 µM 
5 µM 
0.5 µM 
0.05 µM 
0.005 µM 
  67.6 ± 8.1 (5)* 
  76.1 ± 7.4 (4) 
  86.5 ± 4.2 (4) 
  89.1 ± 7.2 (4) 
  94.8 ± 7.3 (4) 
  60.0 ± 4.3 (5)* 
  80.7 ± 2.4 (4)* 
  82.4 ± 1.2 (5)* 
  87.1 ± 2.3 (5)* 
  93.4 ± 2.4 (6) 
 AVE1231 Kv1.5, 4.3, 2.1, 3.1 50 µM 
5 µM 
0.5 µM 
0.05 µM 
0.005 µM 
  59.7 ± 7.8 (3)* 
  89.9 ± 2.3 (4) 
  92.7 ± 1.0 (3) 
  95.0 ± 1.2 (4) 
100.4 ± 0.6 (4) 
  61.6 ± 3.1 (3)* 
  80.8 ± 1.6 (3)* 
  85.2 ± 2.0 (3)* 
  86.9 ± 0.2 (3)* 
  95.0 ± 1.8 (3) 
 Charybdotoxin BK, SK4, Kv1.3 100 nM 
10 nM 
1 nM 
0.1 nM 
0.01 nM 
  79.7 ± 4.5 (3)* 
  87.8 ± 3.6 (3) 
  89.2 ± 3.8 (3) 
  91.5 ± 4.2 (3) 
  91.4 ± 2.3 (3) 
  89.2 ± 3.1 (3) 
  92.3 ± 2.3 (3) 
  92.3 ± 1.7 (3) 
  95.9 ± 1.5 (3) 
  97.3 ± 6.1 (3) 
 Clotrimazole SK4 1 µM 
0.1 µM 
0.01 µM 
0.001 µM 
10 nM 
  84.9 ± 7.7 (3) 
  92.6 ± 6.4 (3) 
  99.0 ± 6.9 (3) 
  94.8 ± 10.1 (3) 
  93.0 ± 4.2 (3) 
  79.1 ± 6.4 (3) 
  80.5 ± 6.0 (3) 
  86.0 ± 7.6 (3) 
  88.9 ± 4.8 (3) 
  76.4 ± 11.2 (3) 
 Iberiotoxin BK 1 nM 
0.1 nM 
0.01 nM 
0.001 nM 
  93.5 ± 4.3 (4) 
  96.0 ± 5.0 (4) 
  94.2 ± 1.4 (4) 
  96.7 ± 8.2 (4) 
  85.3 ±  9.8 (3) 
  86.3 ±  9.8 (3) 
  94.1 ±  4.8 (3) 
  97.8 ±  4.5 (3) 
 Scyllatoxin SK-family 10 nM 
1 nM 
0.1 nM 
0.01 nM 
0.001 nM 
  89.8  ± 8.6 (3)  
  99.6  ± 7.7 (3)  
  97.2  ± 5.6 (3)  
  96.1  ± 2.6 (3)  
102.8 ± 4.6 (3) 
110.7 ± 13.1 (3) 
108.8 ± 12.9 (3) 
103.5 ±   1.3 (3) 
105.8 ±   4.2 (3) 
117.6 ± 10.4 (3) 
 TRAM-34 SK4 100 nM 
10 nM 
1 nM 
0.1 nM 
  89.7 ± 3.8 (3)  
  94.5 ± 3.0 (3)  
  90.5 ± 3.1 (3)  
  94.7 ± 1.4 (3) 
  94.0± 3.4 (3)  
  93.2± 6.1 (3)  
  95.8± 3.8 (3)  
  93.0± 0.5 (3) 
 * Significant difference when compared to control (ANOVA). Experiments were performed in 
triplicates, and numbers of different experiments are given in parentheses. 
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Figure 2. Inhibition of proliferation of T84 cells by Kv channel blockers. Cell proliferation of T84 cells was 
assessed by BrdU incorporation and cell counting. The K+ channel blockers TPeA (A), terfenadine (B), 
BDS-I (C), and quinidine (D) caused dose dependent inhibition of proliferation. E) Additional activation of 
SK4 channels by riluzole further enhanced proliferation. Asterisks indicate significant differences when 
compared to control (ANOVA). Experiments were carried out in triplicates. (number of experiments). 
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Inhibition of T84 cell proliferation by blockage of Kv channels 
In order to identify K+ channels which affect cell proliferation, we used a variety of inhibitors 
(Table 1, Figure 2 and 3). Cell proliferation was assessed independently, by quantifying DNA 
replication (BrdU incorporation) and by cell counting. Potential toxicity of the K+ channel blockers 
was assessed by trypan blue staining. At the concentrations used in this study, the channel 
inhibitors caused no toxic effects on T84 cells. Concentration dependent inhibition of cell 
proliferation was found for the non-selective Kv channel blockers TPeA and Quinidine (Grace 
and Camm, 1998, Patel et al., 2000), for the toxin inhibitor BDS-1, which blocks Kv3.4 channels 
(Diochot et al., 1998), and for the Eag-1 blocker terfenadine (Garcia-Ferreiro et al., 2004) (Figure 
2A-D). Other Kv inhibitors such as 4-AP (5 µM - 2 mM), AVE0118 or AVE1231 (0.5 nM - 50 µM) 
and the KvLQT blocker 293B (1 nM - 10µM) also inhibited cell proliferation, albeit at higher 
concentrations (Table 1). Inhibitors of Ca2+-activated K+ channels, such as charybdotoxin, 
clotrimazole, iberiotoxin, scyllatoxin and TRAM-34 did not affect proliferation (Table 1). Thus, 
Ca2+-activated K+ channels do not seem to support proliferation. Surprisingly, activation of SK4 
channels by riluzole (Cao et al., 2002) enhanced proliferation (Figure 2E). These experiments 
suggest that only endogenous Kv channel activity supports proliferation of T84 colonic carcinoma 
cells, however, when up-regulated other K+ channels such as intermediate conductance SK4 
channels may also enhance proliferation. Endogenous Kv channels not only support proliferation 
of T84 cells, but also that of other colonic cell lines, like HT29. Proliferation of HT29 cells was 
inhibited between 60-80% (n = 4) by 4-AP and astemizole. Moreover, Kv channels have been 
identified recently in human and murine colonic cancers (unpublished observations). 
 
Kv channels are active in colonic carcinoma cells 
We screened for the effects of K+ channel blockers in a fluorescence based assay, using the 
voltage sensitive dye FMP. After loading of the cells with FMP, the Kv channel blocker 4-AP (50 
µM) enhanced fluorescence intensity, due to depolarization of the membrane voltage. The 
effects of individual blockers were analyzed as fraction of the effect of BaCl2 (5 mM), which 
induced maximal depolarization. The largest changes were observed for the Kv channel blockers 
4-AP (50 µM), quinidine (10 µM), terfenadine (10 µM) and astemizole (5 µM). This demonstrates 
a contribution of Kv channels to the overall K+ conductance in T84 cells (Figure 3A, right panel). 
K+ channel blockers were also applied in whole cell patch clamp experiments. The blockers were 
used at lower concentration range, in order to achieve best specificity. As shown in Figure 3B 
and C, K+ channel blockers had small but significant effects on whole cell conductance and  
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Figure 3. Effects of Kv channel blockers on membrane voltage whole cell conductance. A) Uptake of the 
voltage-sensitive fluorescence dye FMP. Loading of T84 cells with FMP induced fluorescence. 4-AP (50 
µM) further increased fluorescence intensity due to depolarization of Vm. BaCl2 (5 mM) completely 
inhibited K+ channels, thereby inducing maximal depolarization and further fluorescence increase. The 
right panel shows the summary of the effects of the K+ channel blockers TPeA (50 µM), quinidine (10 µM), 
terfenadine (10 µM), astemizole (5 µM), 4-AP (50 µM), 293B (10 µM), TRAM-34 (100 nM) and 
clotrimazole (100 nM) on FMP fluorescence, relative to the effects of BaCl2. B) Effect of TPeA and 
terfenadine on whole cell currents obtained in T84 cells and summary I/V curves in the absence or 
presence of the inhibitor. C) Summary of the effects of the K+ channel blockers on whole cell conductance 
and membrane voltage, at concentrations as indicated above. Concentrations for the other inhibitors were: 
BDS-I (10 nM), charybdotoxin (100 nM), iberiotoxin (10 nM), AVE0118 (10 µM) and AVE1231 (10 µM). 
IC50 values were determined experimentally (in bold) or were obtained from literature. Asterisks indicate 
significant differences when compared to control (paired Student´s t-test). (number of experiments). 
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membrane voltage (Vm). Blockers were typically applied in the presence of Ringer solution; 
however, similar effects were also observed when blockers were examined in the presence of 
culture medium (Opti-MEM 1), i.e. under proliferation assay conditions (data not shown). Taken 
together Kv channels contribute only ~10-15% to the total membrane conductance, which is 
sufficient to support proliferation of T84 cells. Similar has been observed in previous studies 
(Kunzelmann, 2005). 
 
Down-regulation of Eag-1 inhibits proliferation  
Proliferation of T84 cells may be supported by a number of different Kv channels. Although patch 
clamping and expression studies suggested a dominant role of Eag channels, we used siRNA-
Eag-1 to specifically downregulate expression of Eag-1 protein. Quantitative analysis of gene 
expression using real-time PCR, indicated a significant loss of Eag-1 transcripts after treatment 
with siRNA-Eag-1 and reduced Eag-1 expression was verified by Western blotting (Figure 4A). 
We found that downregulation of Eag-1 expression inhibited proliferation, while mock 
transfection, unrelated siRNA (for Lmo2 oncogene) or siRNA inhibition of the Ca2+-activated K+ 
channel SK4 did not reduce cell proliferation (Figure 4B). In the FMP fluorescence assay we 
found a reduced effect of astemizole (5 µM) on membrane voltage, i.e. FMP uptake (∆FMP) 
(Figure 4C). Along this line suppression of astemizole sensitive Eag-1 conductance was 
detected in whole cell patch clamp experiments. In contrast TRAM-34 sensitive SK4 
conductance was eliminated by siRNA-SK4, which had no impact on proliferation of T84 cells 
(Figure 4D). Taken together, endogenous Eag-1 currents control proliferation of T84 colonic 
carcinoma cells, while endogenous SK4 currents are not relevant for cell growth. 
 
Kv channels control regulation of intracellular pH and Ca2+ signaling, but not cell volume 
Kv channels contribute to the negative membrane voltage, which may be crucial for volume and 
pH regulation, as well as proper Ca2+ signaling particularly during cell cycling (Kahl and Means, 
2003, Kunzelmann, 2005, Wakabayashi et al., 1997, Wonderlin and Strobl, 1996). We therefore 
asked if Kv channels enhance proliferation by affecting cell volume or pH regulation, or by 
supporting intracellular Ca2+ signaling. T84 cells were swollen by removing 120 mmol/l mannitol 
(Hypo), or were shrunken by adding 120 mmol/l mannitol (Hyper) to an isotonic Ringer solution. 
Swelling and shrinkage was assessed by changes in calcein fluorescence (Figure 5A). 
Repetitive exposure to hypotonic bath solution produced identical changes in cell volume (n=41, 
data not shown). Cell swelling was not different in the presence or absence of Kv channel  
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Figure 4. Downregulation of Eag-1 inhibits cell proliferation and astemizole sensitive currents. A) 
Suppression of Eag-1-mRNA and protein in T84 cells by siRNA-Eag-1 but not by unrelated siRNA (Lmo2; 
SK4), or in mock transfected cells. B) Inhibition of cell proliferation by siRNA-Eag-1, but not by unrelated 
control siRNA. C) Reduced astemizole sensitive FMP fluorescence (∆FMP) in siRNA-Eag-1 transfected 
cells, but not in control cells. D). siRNA-Eag-1 abolished astemizole sensitive Gm (left panel). In contrast, 
siRNA-SK4 abolished TRAM-34 sensitive Gm (right panel) which, however, did not affect proliferation of 
T84 cells (shown in B). Asterisks indicate significant difference when compared to control (ANOVA, 
Student’s t-test). Proliferation assays were carried out in triplicates. (number of experiments). 
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Figure 5. Kv channels affect pH regulation but not cell swelling. A) T84 cells were swollen (removal of 120 
mmol/l mannitol; Hypo) or shrunken (adding 120 mmol/l mannitol; Hyper), as assessed by changes in 
calcein fluorescence. Repetitive exposure to hypotonic bath solution produced identical changes in cell 
volume (n = 41, data not shown). B) Kv channel inhibitors 4-AP or TPeA did not affect cell swelling. C) 
Summary of the effects of 4-AP, astemizole and TPeA on cell swelling, as measured by calcein 
fluorescence. D) Original recording of intracellular pH and effect of astemizole on pH recovery from acid 
(NH4Cl) load. E) Summary of the effects of 4-AP and astemizole on pH recovery after acid load. F) Effect 
of the NHE1- inhibitor EIPA on cell proliferation. Asterisks indicate significant difference when compared 
to control (Student’s t-test). (number of experiments). 
 
blockers (Figure 5B, C). We further examined if pH recovery from an acid (NH4Cl; 20 mM) load 
and thus regulation (recovery) of intracellular pH is affected by inhibitors of Kv channels. To that 
end cells were acid loaded using a NH4Cl pulse. The slope for initially recovery from cellular 
acidification was determined in the absence or presence of Kv channel blockers. Repetitive 
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acidification under control condition showed similar recovery of the intracellular pH (n = 62, data 
not shown). Recordings of the intracellular pH and the summary for the recovery rates 
demonstrate impaired pH regulation in T84 cells when exposed to the Kv channel blockers 4-AP 
or astemizole (Figure5 D, E). These results indicate that Kv channels are important for pH 
regulation in colonic carcinoma cells. pH recovery is primarily due to the function of the Na+/H+ 
exchanger NHE (Kunzelmann, 2005, Schreiber, 2005). In fact, blockage of NHE by 5-(N-Ethyl-
N-Isopropyl) amiloride (EIPA) inhibited proliferation of T84 cells (Figure 5F). 
We further examined potential effects of Kv channels on intracellular Ca2+ signaling. As shown in 
Figure 6, baseline intracellular Ca2+ in resting cells was not affected by Kv channel inhibitors. We 
stimulated T84 cells with the muscarinic secretagogue carbachol (CCH, 100 µM). This induced a 
release of Ca2+ from intracellular stores (transient peak response) and a subsequent influx 
through store operated Ca2+ channels (Ca2+ plateau) (original traces in Figure 6). Both Ca2+ peak 
and plateau were significantly reduced in the presence of the non-selective Kv blockers 4-AP (50 
µM) and TPeA (5 µM) (Figure 6A). Similar effects on [Ca2+]i were observed with the Eag-1 
inhibitor astemizole (0.5 µM) and the Kv3.4 blocker BDS-I (10 nM) (Figure 6). Moreover, 
inhibition of Eag-1 expression by siRNA also attenuated Ca2+ signaling, while siRNA-
suppression of SK4 had no effects on the carbachol induced Ca2+ signaling (Figure 6B, C). The 
contribution of K+ channels to Ca2+ signaling was further confirmed by the nonselective K+ 
channel inhibitor Ba2+, which also attenuated Ca2+ signaling T84 cells (data not shown). Taken 
together, Kv channels affect intracellular Ca2+ signaling probably by their hyperpolarizing effects 
which provides a driving force for Ca2+ release and influx through store operated Ca2+ channels 
(SOCs) (Fischer et al., 1996, Kazerounian et al., 2005). Although upregulation of voltage-gated 
Ca2+ channels (VOCC) in T84 cells has been reported previously (Wang et al., 2000), they are 
probably of limited importance for proliferation since we did observe any impact of the VOCC 
inhibitor calciseptine had no effect on proliferation (Figure 7A). Moreover, agonist (carbachol) 
induced Ca2+ signaling was not affected by calciseptine in either T84 or HT29 cells (Figure 7B, C). 
 
DISCUSSION 
K+ channels and cancer  
Several types of K+ channels have been detected in human cancers (Kunzelmann, 2005). Ca2+-
activated K+ channels were found in prostate cancer (Abdul and Hoosein, 2002a), uterine cancer 
(Suzuki and Takimoto, 2004b), human gliomas (Patt et al., 2004), gastric cancer (Elso et al., 
2004) pituitary adenomas (Czarnecki et al., 2003) and colorectal cancer (Abdul and Hoosein, 
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2002a, Lastraioli et al., 2004, Yao and Kwan, 1999). In other tumors proliferation is supported by 
ATP sensitive Kir channels or two-pore (2P)-domain channels (Klimatcheva and Wonderlin, 
1999, Mu et al., 2003b, Patel and Lazdunski, 2004). Nevertheless, in the majority of cancer  
 
 
Figure 6. Kv channels affect carbachol induced Ca2+ signaling. A) Original recordings of [Ca2+]i in fura-2 
loaded T84 cells and effects of carbachol (CCH; 100 µM) and 4-AP on transient (store release; peak) and 
persistent (influx; plateau) Ca2+ increase. Right panel: Summary of the effects of 4-AP (50 µM) and TPeA 
(5 µM) on Ca2+ peak and plateau. B) Original recordings of the effects of carbachol and astemizole. Right 
panel: Summary of the effects of BDS-I (10 nM) and astemizole (0.5 µM) on Ca2+ peak and plateau. C) 
Original recordings of the effects of carbachol on control cells and cells treated with siRNA-Eag-1 or 
siRNA-SK4. Right panel: Summary of the effects of siRNA-Eag-1 or siRNA-SK4 on Ca2+ peak and 
plateau. Asterisks indicate significant difference when compared to control (ANOVA, Student’s t-test). 
(number of experiments). 
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cells, Kv channels were correlated to proliferation (Abdul and Hoosein, 2002b, Abdul and 
Hoosein, 2002c, Chang et al., 2003, Farias et al., 2004b, O'Grady and Lee, 2005, Pardo et al., 
1999, Pardo, 2004). Other data from human biopsies and carcinogen treated mice suggest high 
levels of Eag-1 protein in colonic cancers, which is not observed in the native colon (unpublished 
observation). Also in the present study we found a role of Kv channels for proliferation of cultured 
colonic carcinoma cells. Thus, the results obtained in T84 cells may be representative for the 
changes that occur in the native colon during carcinogenesis.  
 
 
Figure 7. Voltage-gated Ca2+ channels do not affect proliferation or Ca2+ signaling in colonic cancer cells. 
A) Cell proliferation of T84 cells was not affected by the inhibitor of L-type Ca2+ channels, calciseptine. 
Carbachol (CCH, 100 µM) induced Ca2+ increase in T84 (B) or HT29 (C) cells was not affected by 
calciseptine. (number of experiments). 
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Kv but not other K+ channels control proliferation in T84 cells  
Kv channels operate at rather depolarized membrane voltages (Vm), which are typically not found 
in terminally differentiated epithelial cells (O'Grady and Lee, 2005, Pardo, 2004). The 
depolarized Vm of carcinoma cells provides the basis for activation of Kv channels (Arcangeli et 
al., 1995). When studied under proliferative conditions, serum containing culture medium 
depolarizes Vm (Peres et al., 1988). In vivo, cells are exposed to 20-30 g/l protein present in the 
interstitial fluid, which may depolarize Vm and allow for activation of Kv channels in carcinoma 
cells in situ (Rutili and Arfors, 1977). Remarkably the contribution of Kv channels to the overall 
conductance in T84 cells was only 10-15%. However, this is in line with previous reports, which 
indicate that pro-proliferative K+ currents are often of smaller amplitude, while large K+ currents 
are detected during apoptosis (Kunzelmann, 2005, Lang et al., 2004). 
Because of the limited specificity of most K+ channel inhibitors (Elbashir et al., 2001), we also 
used siRNA to identify the K+ channels in charge of cell proliferation. Only Kv channels appear to 
affect cell proliferation, although other K+ channels are expressed and functional in T84 colonic 
carcinoma cells, such as SK4 channels. Obviously EAG-1 and other Kv channels operate well in 
proliferating T84 cells, while SK4 channels only support proliferation after additional activation by 
riluzole. Surprisingly, even the K+ ionophore valinomycin increased proliferation of T84 cells when 
applied at very low (100 fM) concentrations (unpublished data from the author’s laboratory). We 
suggest that the oncogenic potential of Kv channels is linked to the K+ channel function. This has 
been demonstrated recently for TASK3 channels (Pei et al., 2003). In principle, any type of K+ 
channel may be able to support proliferation, depending on additional cell specific properties that 
determine K+ channel activity. 
 
How do Kv channels control cell proliferation? 
The present study was performed to determine the mechanism by which K+ channels affect cell 
growth. Progression through the cell cycle is dependent on K+ channels and blocking of these 
channels causes inhibition of proliferation (Wonderlin and Strobl, 1996). This clearly suggests a 
cell cycle specific function of K+ channels. Apart from this specific role, Kv channels may also 
have homeostatic functions in T84 cells. The present data demonstrate an impact of Kv channels 
on intracellular Ca2+ signaling and pH regulation. The importance of pHi for cell proliferation and 
cancer development is well established (Wakabayashi et al., 1997). pHi is varying during the cell 
cycle and need to be tightly controlled, probably by the Na+/H+ exchanger NHE1 (Schreiber, 
2005). The experiments with the NHE-blocker EIPA presented here, clearly show the importance 
of NHE for cell proliferation. Na+/H+ exchange requires low intracellular Na+ concentrations, and 
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Vm need to stay hyperpolarized, Both is facilitated by the Na+/K+-ATPase in parallel with K+ 
channels. Kv channels may provide a K+ recycling pathway and hyperpolarize the membrane 
voltage, and may thus contribute indirectly to pH regulation.  
Equally important is the control of intracellular Ca2+ in proliferating cells, especially during the 
mitotic cell cycle (Schreiber, 2005). We found that agonist induced Ca2+ release and influx of 
Ca2+ through SOCs, dependents on the function of Kv channels. Thus Ca2+ dependent activation 
of ion currents was reduced significantly by 3.2 ± 0.5 nA (100 µM 4-AP, n=4) and 2.8 ± 0.4 nA (5 
µM astemizole, n=5). It has been demonstrated by others (Fischer et al., 1996) that 
depolarization of the membrane voltage reduces Ca2+ signaling. Since inhibitors of Kv channels 
depolarize Vm, this may explain why Ca2+ signaling is affected. Furthermore, a previous study 
demonstrated that activation of store operated Ca2+ Channels (SOCs) in T84 cells induces 
proliferation (Kazerounian et al., 2005). Moreover, capacitative Ca2+ influx through SOCs is 
reduced at acidic pH (Nitschke et al., 1996). Since Kv channels also affect intracellular pH, this 
may provide an independent mechanism, by which Kv channels affect intracellular Ca2+ 
signaling. Voltage-gated Ca2+ channels (VOCC) are probably not related to the effects of Kv 
channel inhibitors, although L-type Ca2+ channels are expressed in T84 colonic carcinoma cells 
(Wang et al., 2000). This is further substantiated by the fact that the L-type Ca2+ channel 
inhibitor calciseptine did not reduce proliferation or Ca2+ signaling (Figure 7). Taken together 
hyperpolarization of Vm by Kv channels may be necessary to maintain pH regulation and Ca2+ 
signaling, which allows progression through the G1 phase of the cell cycle (Kahl and Means, 
2003, Wonderlin and Strobl, 1996). 
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CHAPTER 4 
 
Expression of voltage-gated potassium channels in human and mouse 
colonic carcinoma 
 
ABSTRACT 
 
Purpose: Voltage-gated Kv potassium channels like ether à go-go (Eag) channels have been 
recognized for their oncogenic potential in breast cancer and other malignant tumors.  
Experimental design: We examined the molecular and functional expression of Kv channels in 
human colonic cancers and colon of mice treated with the chemical carcinogens 
dimethylhydrazine and N-methy-N-nitrosourea. The data were compared with results from 
control mice and animals with chemically induced DSS colitis.  
Results: Electrogenic salt transport by amiloride-sensitive Na+ channels and cyclic AMP-
activated cystic fibrosis transmembrane conductance regulator Cl- channels were attenuated 
during tumor development and colitis, while Ca2+-dependent transport remained unchanged. Kv 
channels, in particular Eag-1 were enhanced during carcinogenesis. Multiplex reverse 
transcription-PCR showed increased mRNA expression for Kv1.3, Kv1.5, Kv3.1 and members of 
the Eag channel family, after dimethylhydrazine and N-methy-N-nitrosourea treatment. Eag-1 
protein was detected in the malignant mouse colon and human colonic cancers. Genomic 
amplification of Eag-1 was found in 3.4% of all human colorectal adenocarcinoma and was an 
independent marker of adverse prognosis.  
Conclusions: The study predicts an oncogenic role of Kv and Eag channels for the development 
of colonic cancer. These channels may represent an important target for a novel 
pharmacotherapy of colonic cancer. 
 
 
Key words: DMH, MNU, DSS, voltage-gated K+ channel, Kv channel, Eag related K+ channel, 
colonic cancer 
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INTRODUCTION 
Membrane ion channels are essential for cell proliferation and have a role in the development of 
cancer. A substantial body of evidence exists that voltage-gated potassium (Kv) channels have 
an oncogenic function (Camacho, 2006, Kunzelmann, 2005, Pardo, 2004, Pardo et al., 2005). 
Moreover, during carcinogenesis changes in expression or activity of ion channels may affect 
electrolyte transport properties in epithelia, similar to the changes observed during inflammation 
(Kunzelmann, 2005). K+ channels are involved in the development of cancer of prostate, colon, 
lung and breast (Kunzelmann, 2005, Wonderlin and Strobl, 1996). K+ channels were identified in 
different cancer tissues, such as Ca2+-activated and voltage-gated K+ channels (Kv channel), the 
ether à go-go (Eag) family and 2P-domain K+ channels (Kunzelmann, 2005). However, Kv 
channels seem to play a central role in tumor cells, particularly in those of epithelial origin 
(Kunzelmann, 2005, Pardo, 2004, Pardo et al., 2005). Cell cycle-regulated Eag-1 channels, 
normally only expressed in excitable tissues and oocytes are also found in cancer cells 
(Camacho, 2006, Farias et al., 2004b, Pardo et al., 1999). Activation of these channels induces 
hyperpolarization of the plasma membrane, which may be essential for cell proliferation (Pardo, 
2004). Hyperpolarization of the membrane voltage facilitates Ca2+ signaling, and is necessary for 
regulation of intracellular pH and cell volume. All of these variables (Ca2+, pH, and volume) 
clearly affect cell proliferation (Kunzelmann, 2005, Pardo, 2004, Schreiber, 2005). 
Most studies on the oncogenic role of ion channels have been done in cell lines, leaving open 
their relevance for tumor development in vivo. We therefore designed the present study to 
examine the role of ion channels for tumor development in vivo in carcinogen-treated mice. 
Dimethylhydrazine (DMH) and N-methyl-N-nitrosourea (MNU) were used as carcinogenic 
agents. DMH is organotropic for the rodent colon. It is metabolized to methylazoxymethanol and 
methyldiazonium and causes methylation of nucleotides (Fiala, 1977). Rectal application of MNU 
causes direct alkylation of DNA and also induces colonic tumors (Frei et al., 1978, Narisawa et 
al., 1976). During the development of colon cancer, alterations in colonic electrolyte transport 
have been reported in previous studies (Bleich et al., 1997, Davies et al., 1987). Electrolyte 
transport appears to be affected in the premalignant colon, which may contribute to the 
irregularities in defecation, often observed in patients with human colonic cancer. We found that 
electrolyte transport was affected in colitis and during carcinogenesis. However, overexpression 
of cell cycle regulated Eag-1 K+ channels was only found in the pre-malignant mouse colon and 
in human colonic cancers. 
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MATERIAL AND METHODS 
Patients, tumor material for fluorescence in situ hybridization analysis, biological samples 
Three hundred eighty-six surgically resected colorectal adenocarcinomas were selected from the 
files of the Institutes of pathology of the University of Basel and from the Triemli Hospital, Zürich, 
Switzerland. Tissue microarray was constructed as previously described (Kononen et al., 1998). 
Specimens were kept anonymous, and experiments were conducted according to the guidelines 
of the ethical committee of the University of Basel. Pathologic tumor-node metastasis stage was 
determined according to the International Union Against Cancer. Colon biopsies were obtained 
from patients hospitalized at the Children’s Hospital of the University of Freiburg/Germany and 
the department of Internal Medicine of the University of Regensburg, according to the guidelines 
of the local ethical committee. 
DMH, MNU, and DSS treatment 
Animal studies were conducted according to the guidelines of the National Institute of Health 
guidelines for the care and use of animals in research and the German laws on protection of 
animals. C57BL/6NCrl mice were obtained from Charles River (Sulzfeld, Germany). DMH or 
control saline were dissolved in 0.9% saline and injected s.c. into the groin at a dose of 40 
mg/kg once a week for 5 wks. Proximal and distal colons were removed for RNA and protein 
isolation, histology and functional measurements. For MNU treatment, mice were anaesthetized 
by i.p injection of ketamine/xylazine (120 mg/8 mg/kg × bodyweight). MNU (2.6 mg/0.4 ml 0.9% 
NaCl solution) was given intrarectally twice a week for 2 weeks and once a week for additional 4 
weeks. For potential difference measurements, a catheter (PE-10 tubing) containing ringer 
solution was inserted 2 cm into the rectum and perfused continuously at a rate of 1 ml/h. The 
catheter was attached via an agar bridge to an AgCl- electrode. A s.c. needle positioned in the 
abdomen and connected via an agar bridge served as the reference electrode. For DSS 
treatment of BALB/cOlaHsd mice, 3 % DSS was added to drinking water for 7 to 10 days. 
Histology 
Mice were sacrificed under CO2 inhalation; the colon was removed and stripped mechanically 
from submucosal tissues. Tissues were fixed for 20 min with 4% paraformaldehyde, 0.1% 
glutaraldehyde, 15% picric acid in PBS (pH 7.4) followed by a 12 h incubation in 4% 
paraformaldehyde, 15% picric acid in PBS (pH 7.4) at 4°C. Tissues were washed in PBS and 
incubated in 10%, 20% and 30% sucrose solutions, dehydrated and embedded in paraffin. 
Paraffin-embedded tissues were cut with a rotary microtome (Leica Mikrotom RM 2165, Wetzlar, 
Germany). Sections were dewaxed and rehydrated and stained with hematoxylin and eosin. 
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Some tissues were chock frozen in iso-pentan, sectioned at 5 µm, fixed with 4% 
paraformaldehyde in PBS (pH 7.4) and stained with hematoxylin. 
Ussing chamber experiments 
Stripped colon was put into ice cold bath solution (mM: NaCl 145, KH2PO4 0.4, K2HPO4 1.6, d-
glucose 6, MgCl2 1, Ca-gluconate 1.3, pH 7.4) containing amiloride (20 µM) and indomethacin 
(10 µM). Tissues were mounted into an Ussing chamber with a circular aperture of 0.785 mm2. 
Luminal and basolateral sides of the epithelium were perfused continuously at a rate of 5 ml/min. 
Bath solutions were heated to 37°C, using a water jacket. Experiments were carried out under 
open-circuit conditions. Data were collected continuously using PowerLab (Spechbach, 
Germany). Values for transepithelial voltages (Vte) were referred to the serosal side of the 
epithelium. Transepithelial resistance (Rte) was determined by applying short (1 sec) current 
pulses (∆I = 0.5 µA). Rte and equivalent short circuit currents (ISC) were calculated according to 
Ohm’s law (Rte = ∆Vte/∆I, ISC = Vte/Rte).  
Crypt cell isolation and expression analysis of ion channels in colonic epithelial cells 
Colonic crypts were isolated from an inverted colon in Ca2+ free buffer solution. Total RNA was 
prepared from isolated crypts (NucleoSpin, Macherey-Nagel, Düren, Germany). After reverse 
transcription, semiquantitative multiplex reverse transcription-PCR was done. The primers as 
shown below were used.  
Primer Accession no. Sense(s) and antisense(as) primer 
mKv1.3 NM_008418 5´-GTACTTTGACCCACTCCGC -3´ (s)  
5´-GCAAGCAAAGAACCGCACC-3´ (as) 
mKv1.5 NM_145983 5´-GCTACTTCGATCCCTTGAG -3´ (s)  
5´-GCTCAAAAGTGAACCAGATC-3 (as) 
mKv3.1 NM_008421 5´-CCAGACGTACCGCTCGAC 3´ (s)  
5´-CGAACAGCGCCCAGATGC-3´ (as) 
mEag-1 NM_010600 5´-GGATTCTGCAAGCTGTCTG-3´ (s)  
5´-GTAGAAGGTCAGGATCAAG-3´ (as) 
hEag-1 NM 172362, NM 
002238 
5´-CGCATGAACTACCTGAAGACG-3´ (s)  
5´-TCTGTGGATGGGGCGATGTTC-3 (as) 
mErg-1 NM_172057 5´-CCTCGACACCATCATCCGC-3´ (s)  
5´-GTCCGCACAGATGATTCCC-3´ (as) 
mElk-1 NM_001031811 5´-GGTTTCCCCATAGTCTACTG-3´ (s)  
5´-CAAAATGAGCCAGTCCCAGC-3´ (as) 
mENaCα NM_011324 5´-CCTTGACCTAGACCTTGACG-3´ (s)  
5´-CGAATTGAGGTTGATGTTGAG-3´ (as) 
mENaCβ NM_000336 5´-CAATAACACCAACACCCACG-3´ (s)  
5´-GAGAAGATGTTGGTGGCCTG-3´ (as) 
mENaCγ NM_011326 5´-GCACCGACCATTAAGGACC-3´ (s)  
5´-GCCTTTCCCTTCTCGTTCTC-3´ (as) 
mCFTR NM_021050 5´-GAATCCCCAGCTTATCCACG-3´ (s)  
5´-CTTCACCATCATCTTCCCTAG -3´ (as) 
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PCR reactions were performed at 94°C for 2 min, 28 to 38 cycles at 94°C for 30 s, annealing 
temperature 56°C for 30 s, and 72°C for 1 min using GoTaq DNA Polymerase (Promega, 
Mannheim, Germany). Expression of mRNA of each gene product was normalized against β-
actin expression. 
Detection of Eag-1 protein 
Isolated crypt cells from distal and proximal colon were lysed and total protein (50 µg) was 
resolved by 7% SDS-PAGE, transferred by semi-dry blotting to Hybond-P (Amersham, Freiburg, 
Germany) and incubated with rabbit anti-Kv10.1 (Eag-1, Alomone labs, Jerusalem, Israel) and 
rabbit anti-actin antibodies (Sigma, Taufkirchen, Germany). Proteins were visualized using a 
goat anti-rabbit IgG conjugated to horseradish peroxidase (Acris Antibodies, Hiddenhausen, 
Germany) and Enchanced Chemiluminescence Advance Detection kit (Amersham). Signals 
were detected by Fluor-STM MultiImager system (Bio-Rad Laboratories, Hercules, CA) and 
analyzed with Multi-Analyst software (Bio-Rad). Expression of Eag-1 protein was normalized 
against actin protein expression. 
Fluorescence in situ hybridization (FISH) analysis 
The bacterial artificial chromosome RP11-75i2, containing parts of the Eag-1 gene sequence at 
1q32.2-3, was obtained from the German Resource Centre for Genome Research (Berlin, 
Germany). One microgram of purified plasmid DNA was labelled using a modified Bio Nick kit 
(Invitrogen, Carlsbad, CA). Nick translation was performed at 16°C for 90 min. The labeled FISH 
probe was purified by precipitation and redissolved in 50 µl H20. Paraffin removal (3 x 5min in 
Xylene followed by 2 x 2min ethanol 95% and air-drying) and enzymatic tissue pretreatment 
(Vysis pretreatment solution, 80°C, 15 min) of tissue sections mounted on glass slides was 
performed in a VP2000 Processor device (Vysis, Downers Grove, IL ). A premixed hybridization 
cocktail containing 0.5 µl centromere 1 probe (CEP 1 SpectrumOrange labeled; Vysis), 1.5 µl 
Eag-1 probe, 1 µl Cot DNA (Invitrogen), and 7 µl hybridization buffer (Vysis) was added to each 
slide with denatured target DNA. Probes were allowed to hybridize overnight at 37°C in a 
humidified chamber. After washing steps, Eag-1 probe was detected using the Dig detection kit 
(Roche Diagnostics, Indianapolis, IN). Amplification was defined as a signal ratio of Eag-1 probe 
/ centromere 1 of at least 2 and at least 4 gene signals. 
Materials and statistical analysis 
All used compounds were of highest available grade of purity. DMH, MNU, amiloride, 4-
aminopyridine, astemizole, carbachol, and 3-isobutyl-1-methylxanthine (IBMX) were from Sigma-
Aldrich (Taufkirchen, Germany). DSS was from ICN (Eschwege, Germany). Forskolin and 293B 
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were gifts from Aventis Pharma (Frankfurt, Germany). Student’s t-test (for paired or unpaired 
samples as appropriate) and analysis of variance (ANOVA) were used for statistical analysis. P 
< 0.05 was accepted as significant. Survival curves were plotted according to Kaplan-Meier. A 
log-rank test was applied to examine the relationship between alterations clinicopathological 
data or Eag-1 amplification status and overall survival. Patients were censored at the time of 
their last clinical control. Cox proportional hazard model with stepwise selection of the covariates 
was used to determine the parameters with greatest influence on the risk of recurrence and 
progression. 
 
RESULTS 
Histopathology 
From week 12 on, DMH-treated animals showed a significantly reduced weight increase. MNU-
treated mice also showed a reduced body weight and a growth delay compared to untreated 
mice. Frequently the animals developed diarrhea upon treatment with carcinogens. Six to eight 
weeks after DMH treatment, local mucosal infiltration of leucocytes indicated inflammatory 
processes in distal colon (Figure 1A and B). After 10 and 12 weeks changes of mucosal 
architecture such as tortuous crypts and crypt loss were observed in distal colon (Figure 1C). No 
obvious histological changes were found in the proximal colon. Rectal MNU application 4 times 
in 2 weeks induced hyperplastic crypts in distal colon, indicated by an increase of crypt heights 
and decreased number of globlet cells along the cryptal wall. Moreover nuclear to cytoplasmic 
ratio was increased (Figure 1D). Cellular redistribution and nuclear accumulation of β-catenin 
was not clearly correlated with carcinogen treatment and was therefore not used as an 
independent marker for carcinogenesis (data not shown). Mucosal infiltration by inflammatory 
cells was observed in the proximal colon. After 8 treatments (week 6), extension of the lamina 
submucosea and muscularis submucosea, and dysplasia of distal colonic mucosa were 
observed. Administration of DSS caused severe changes of the tissue architecture, ulceration, 
and inflammatory cell infiltration, areas of complete epithelial denudation as well as submucosal 
edema in distal and proximal colon. Thus, inflammation and carcinogenesis induced by 
chemicals is clearly demonstrated by histological changes. 
 
DMH, MNU and DSS treatment inhibits Na+ absorption and Cl- secretion 
In essence, electrogenic ion transport in the colon is due to Na+ absorption by amiloride 
sensitive Na+ channels (ENaC) and cyclic AMP- or Ca2+-induced Cl- and K+ secretion. The 
amount of electrogenic Na+ absorption is determined by inhibition with amiloride and calculation 
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of the amiloride sensitive short circuit current ISC Amil (Figure 2A). DMH treatment reduced ISC Amil 
in distal colon 6 and 8 weeks after the first DMH injection, which recovered at week 10 and 12 
(Figure 2A and B). Similar effects on amiloride-sensitive Na+ absorption were seen in MNU-
treated mice. Rectal potential difference measurements in vivo after 2 and 6 weeks of MNU 
treatment showed a reduced rectal potential different due to attenuate amiloride-sensitive 
transport (Figure 2C). Ussing chamber experiments and ISC measurements confirmed reduced 
Na+ absorption in distal colon of MNU-treated mice (19.6 ± 4.3 µA/cm2; n = 11), when compared 
to control mice (57.8 ± 9.6 µA/cm2; n = 13) (Figure 2D). In addition, in the inflamed colon, during 
treatment with DSS, amiloride-sensitive rectal potential different was significantly reduced from -
7.2 ± 0.58 mV (n = 7) to -4.9 ± 0.73 mV (n = 10).  
 
 
Figure 1. Effects of DMH, MNU, and DSS treatment on colon architecture. Α) hematoxylin and eosin 
staining of control distal colon. Β) infiltration by inflammatory cells of distal colonic mucosa after DMH 
treatment. C) loss of crypts in distal colonic mucosa of DMH-treated mice. D) hyperplastic crypts in distal 
colon after MNU treatment. Bars, 50 µm. 
 
Increase in intracellular cyclic AMP by IBMX (100 µM) and forskolin (2 µM) induced Cl- secretion 
(ISC cAMP) in proximal and distal colon, by activation of the cystic fibrosis transmembrane 
conductance regulator (CFTR). DMH caused a reduced ISC cAMP response in both proximal and  
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Figure 2. Change of amiloride-sensitive transport by carcinogens. Α) Ussing chamber recordings of the 
transepithelial voltage. Amiloride (Am, 20 µM), a specific inhibitor of epithelial Na+ channels reduced Vte 
and increased ∆Vte due to inhibition of Na+ absorption. The effect of amiloride on Vte was reduced after 6 
weeks of DMH treatment. Β) amiloride (20 µM)-sensitive ISC (ISC Amil) was reduced in Ussing chamber 
experiments 6 and 8 weeks after initial DMH injection. C) rectal potential difference (RPD) measurements 
showed reduced effects of amiloride (RPDAmil), 2 and 6 weeks after rectal application of MNU. D) Ussing 
chamber experiments confirmed reduced ISC Amil in distal colon, 6 weeks after rectal application of MNU. *, 
significant differences compared to control (Student´s t-test). Number of mice in brackets. 
 
distal colon at week 6 and 8. In contrast, later-stages (week 12) ISC cAMP was significantly 
elevated in proximal colon (Figure 3A and B). It is well known that basolateral cAMP-dependent 
activation of the cotransporter NKCC1, and 293B-sensitive KCNQ1 K+ channels (ISC 293B) 
facilitate CFTR-dependent Cl- secretion. Accordingly DMH treatment inhibited ISC 293B in cAMP 
stimulated proximal colon at week 6 and increased ISC 293B at week 12 (Figure 3C). Similar to 
DMH in the early phase, MNU and DSS also reduced cAMP-dependent Cl- secretion in rectal 
potential difference measurements (Figure 3D). This was further confirmed in Ussing chamber 
recordings. Here, cAMP-activated transport was significantly attenuated by 62.3 ± 5.3 µA/cm2 (n 
= 14) in MNU-treated animals and by 174.3 ± 18.2 µA/cm2 (n = 7) in DSS-treated mice. In 
contrast, Ca2+-activated Cl- secretion, stimulated by carbachol (CCH, 100 µM) and blockage by 
niflumic acid (NFA, 100 µM) remained unchanged (data not shown). Hence electrogenic Na+ 
absorption via ENaC and cAMP-dependent Cl- secretion by CFTR are changed during 
inflammation and carcinogenesis, whereas Ca2+-activated Cl- secretion remains unaffected. 
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Because both ENaC and CFTR are the major determinants for net fluid transport in the colon, 
these changes are likely to affect digestive functions of the colon. 
 
 
Figure 3. Treatment with DMH, MNU, and DSS reduced CFTR-dependent Cl- secretion. Α) IBMX and 
forskolin increased intracellular cAMP and activated CFTR-dependent Cl- secretion. In proximal colon, 
cAMP-induced ISC (ISC cAMP) was reduced 6 weeks after DMH injection, but was and elevated after 12 
weeks. B) Summary of the effects of DMH on ISC cAMP in distal colon. C) The 293B-sensitive ISC (ISC 293B) 
was reduced 6 weeks after DMH injection and was elevated after 12 weeks. D) Increase in rectal potential 
difference by IBMX and forskolin (RPDcAMP) was reduced in MNU- and DSS-treated mice, respectively. *, 
significant differences compared to control (Student´s t-test). Number of mice in brackets. 
 
Carcinogens induce voltage-gated K+ channels 
A major goal of the present study was to identify potential oncogenic ion channels during 
inflammation and carcinogenesis of the colonic epithelium. It is well established that proliferation 
of cancer cells and metastasis require the activity of plasma membrane K+ channels 
(Kunzelmann, 2005, Pardo, 2004). We investigated the function of Kv channels in the 
premalignant colon using the nonselective Kv channel inhibitor, 4-aminopyridine (4-AP, 100 µM) 
and the inhibitor of the Eag channel family, astemizole (5 µM). Application of both 4-AP and 
astemizole had only minor effects on ISC in control animals, but inhibited ISC significantly in 
proximal and distal colon of DMH-treated mice (Figure 4A and B). These results suggest that 
DMH treatment induced activation of Kv and Eag-related K+ channels in both distal and proximal 
colon. Similar results were obtained in distal colon of MNU-treated mice, where ISC 4AP was  
 
 
week 
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Figure 4. Treatment with carcinogens enhanced expression of voltage-gated K+ channels. In proximal (A) 
and distal (B) colon, application of 4-AP and astemizole indicated enhanced activity of voltage-gated K+ 
channels after treatment with carcinogens. C) Western blot analysis of Eag-1 (111 kDa) and β-actin (42 
kDa) expression in brain (positive control) and crypt cells of proximal and distal colon of control, DMH- and 
MNU-treated mice. D) Summary of the changes in Eag-1 expression (normalized against β-actin) in crypt 
cells of DMH-, MNU-, and DSS-treated mice. *, significant differences compared to control (Student´s t-
test). Number of mice in brackets. 
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significantly reduced by 4.3 ± 0.54 µA/cm2 (n = 14). The inflamed (DSS) colon did not exhibit Kv 
channel activity in Ussing chamber recordings and showed only small rectal potential difference 
changes upon application of 4-AP (data not shown). In summary, Kv channels and cell cycle-
regulated Eag channels were clearly detected in the premalignant colon, but were absent in the 
inflamed colon. 
 
Expression of ion channel mRNA in crypt cells of DMH-, MNU- and DSS-treated mice 
Because we detected changes in electrolyte transport and enhanced Kv channel activity in the 
premalignant colon, we investigated molecular expression of the underlying ion channels. Total 
RNA was prepared from freshly isolated crypt cells of proximal and distal colon of DMH-, MNU- 
and DSS-treated (each n=6) animals and control mice. Changes in ion channel expression 
relative to the control group were calculated. We found a small but significant increase in the 
 Table 1. Changes in ion channel mRNA expression in crypt cells of proximal and distal colon of DMH-, MNU-, and DSS-
treated mice 
 
 Gene DMH wk 6 DMH wk 8 DMH wk 10 DMH wk 12 MNU wk 6 DSS  
 Proximal colon       
    ENaC α NC (5/6) NC (4/6) NC (6/6) -0.57 ± 0.06 (4/5)* NC  (6/6) NC (4/6)  
    ENaC β -0.45 ± 0.08 (5/5)* NC (6/6) NC (6/5)  2.65 ± 0.97 (5/6)* NC  (5/6) NC (4/6)  
    ENaC γ NC (6/5) NC (6/4) NC (6/5)  9.75 ± 4.27 (5/5)* NC  (6/6)  2.21 ± 0.62 (4/6)*  
    CFTR NC (5/6)  -0.77 ± 0.07 (4/5)* NC (6/5) NC (6/6) NC  (6/6) NC (4/6)  
    Kv1.3 NC (5/6) 13.59 ± 4.27 (4/6)* NC (6/6) NC (5/6) NC  (6/6) NC (4/6)  
    Kv1.5 NC (6/6) NC (6/6) NC (6/6) NC (5/5)   3.13 ± 0.85 (5/6)* NC (4/6)  
    Kv3.1 NC (3/3)   6.19 ± 1.64 (3/3)* 1.36 ± 0.43 (6/6)*   4.03 ± 1.31 (4/5)*  1.41 ± 0.60 (6/6)* NC (4/6)  
    Eag-1 NC (5/6) NC (5/4) 2.04 ± 0.59 (4/4)*   8.15 ± 2.06 (4/5)* NC (6/6) NC (4/6)  
    Erg-1  1.96 ± 0.80 (6/6)*   6.44 ± 2.17 (3/3)* 8.64 ± 1.47 (3/3)* 30.38 ± 2.81 (3/3)* NC (6/6) NC (4/6)  
    Elk-1 NC (6/6)   1.09 ± 0.37 (5/5)* 2.83 ± 1.42 (5/3)*   2.25 ± 0.76 (4/5)*  -0.73 ± 0.14 (5/6)* NC (3/6)  
 Distal colon       
    ENaC α NC (6/6) NC (5/5) NC (6/6) -0.54 ± 0.08 (5/4)* NC (6/6) -0.79 ± 0.08 (4/5)*  
    ENaC β  -0.55 ± 0.09 (5/6)* NC (5/5) NC (6/6)  2.54 ± 0.56 (5/6)* NC (6/5) NC (4/6)  
    ENaC γ  NC (6/5) NC (5/5) NC (6/6)  5.60 ± 2.22 (5/5)* NC (6/5)  1.14 ± 0.47 (4/4)*  
    CFTR NC (5/6)  0.61 ± 0.11 (5/6)* NC (6/6) NC (6/6) NC (6/6) NC (4/6)  
    Kv1.3 NC (6/6) NC (6/6) NC (6/6) NC (5/6) 15.32 ± 7.48 (5/4)*  4.13 ± 1.57 (4/5)*  
    Kv1.5  7.52 ± 1.86 (6/6)* NC (6/6) NC (6/6) NC (5/5) NC (6/6) NC (4/6)  
    Kv3.1 NC (3/3)  1.80 ± 0.65 (3/3)* 0.93 ± 0.29 (3/3)*  1.06 ± 0.17 (3/3)* NC (6/5) NC (4/6)  
    Eag-1 NC (6/6) NC (5/5) NC (6/5)  2.65 ± 0.83 (4/4)* NC (6/6) NC (3/6)  
    Erg-1  4.44 ± 0.37 (3/3)* NC (5/5) 1.41 ± 0.22 (3/3)* 2.78 ± 2.12 (3/2)*   2.78 ± 1.14 (6/6)* NC (4/6)  
    Elk-1 NC (6/6) NC (6/6) NC (6/6) NC (6/6) NC (5/5) NC (4/6)  
         
 NOTE: Expression of mRNA was normalized against β-actin expression, and changes relative to the control group were 
calculated. Number of mice is given in parentheses.  
Abbreviation: NC, no change. 
* Significant difference compared to control (Student´s t-test). 
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mRNA expression for α, β and γ subunits of ENaC in DMH-treated animals. No changes in 
expression of CFTR could be detected (Table 1). Thus, changes in Na+ absorption and Cl- 
secretion due to the DMH treatment are not explained by changes in transcript expression of the 
respective ion channels but are due to other secondary changes (cf. discussion). Enhanced 4-
AP-sensitive K+ currents detected in carcinogen-treated animals may also be caused by 
enhanced expression of Kv channels. In fact, mRNAs encoding the channels Kv3.1, Kv1.3 and 
Kv1.5 were clearly upregulated in both distal and proximal colonic crypt cells of DMH- and MNU-
treated animals. Moreover, corresponding to the enhanced astemizole-sensitive currents (Figure 
4A and B), we detected enhanced mRNA expression of ether à go-go subtypes Eag-1, Erg-1 
and Elk-1 in the premalignant proximal and distal colon of DMH- and MNU-treated mice, but not 
in the inflamed (DSS) colon (Table 1). 
 
DMH and MNU treatment increased expression of Eag-1 protein 
Cell cycle dependent regulation of Eag-1 is well established, thus far, expression of the channel 
was only found in cancer cells but not in normal epithelial tissues (Pardo et al., 1999). Because 
DMH treatment induced an astemizole-sensitive ISC and increased Eag-1 mRNA expression in 
proximal and distal colon, we also examined protein expression in isolated crypt cells. In the 
control group, Western blot analysis showed no uniform Eag-1 expression in crypt cells (Figure 
4C). In contrast, in crypt cells of DMH-treated mice, Eag-1 protein was well detected in proximal 
and distal colon (Figure 4C). The carcinogen MNU enhanced Eag-1 expression in the proximal 
colon, while no changes were observed in the inflamed colon (DSS), as indicated by 
densitometric analysis relative to actin staining (Figure 4D). 
 
Eag-1 protein expression in human carcinomas and diverticulitis 
Eag-1 expression was analyzed by reverse transcription-PCR in biopsies of two colorectal 
carcinomas and the Eag-1 transcript variants 1 and 2 were found in the centre of the carcinoma 
as well as in the macroscopically unaffected periphery. However, no expression of Eag-1 mRNA 
was found in the colon of a healthy volunteer (Figure 5A). Expression of Eag-1 protein was 
analyzed in isolated crypt cells from patients, diagnosed with sigma diverticulitis, ulcerative 
colitis, colorectal adenocarcinoma, cecum carcinoma, and colonic neoplasm (Figure 5C). 
Samples were also obtained from patients with unrelated diseases, such as cystic fibrosis. No 
expression of Eag-1 was detected in these samples. The variability of the tissue sample quality 
was assessed by simultaneous detection of β-actin expression. In summary, expression of Eag-
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1 was detected in most carcinomas and in some patients diagnosed with diverticulitis, whereas 
the healthy colon does not seem to express cell cycle-regulated K+ channels (Figure 5B). 
 
 
Figure 5. Eag-1 is expressed in colonic crypt cells of patients with cancer and diverticulitis. Α) reverse 
transcription-PCR showed mRNA expression of the two variants of Eag-1 (variant 1, 560 bp, variant 2, 
479 bp) in the center and peripheral tissue of the cancer in two patients. In a colon biopsy of a healthy 
volunteer, no Eag-1 transcripts were detected. Β) total protein was isolated from T84 colonic cancer cells 
and from crypt cells derived from patients with different diagnosis. Colonic biopsies of healthy patients 
served as controls. C) Fluorescence in situ hybridization of a colorectal adenocarcinoma with Eag-1 
amplification. Tumor cell nuclei contain numerous Eag-1 signals (arrows), but only few reference signals 
in red (centromer 1; ×1000). Nuclei counterstained with DAPI (blue). D) Effect of Eag-1 gene amplification 
on overall survival in surgically resected colorectal adenocarcinoma. 
 
The Eag-1 gene is amplified in tumor specimens and is associated with adverse outcome 
Pathologic tumor-node-metastasis stage, histological grade, and International Union Against 
Cancer stage were strongly associated with overall survival (p < 0.0001 each; data not shown). 
Fluorescence in situ hybridization analysis showed amplification of the Eag-1 gene in 13 (3.4%) 
of the 386 tumor specimens (Table 2). A representative case with Eag-1 amplification is shown 
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in figure 5C. Univariate survival analysis revealed that Eag-1 amplification was significantly 
associated with adverse outcome (p = 0.0202; Figure 5D). If entered in a multivariate model 
(Cox proportional hazard), amplification of Eag-1 emerged as an independent prognostic marker 
(p = 0.0126, relative risk, 3.55) together with International Union Against Cancer stage (p < 
0.0001, relative risk, 15.56) and histological grade (p = 0.0167, relative risk, 1.77, n = 386). Thus 
expression of Eag-1 is associated with reduced overall survival in patients with colonic 
carcinoma. 
 
 Table 2. Clinicopathologic characteristics of colorectal 
adenocarcinomas (n=386) 
 
 Sex   
  M           200 (48.1%)  
  F           186 (51.8%)  
 Age (range), year 71.6 ± 1.1 (36-96)  
 Localization   
  Right colon           164 (43.4%)  
  Left colon           214 (56.6%)  
 pT   
  pT1               7 (1.8%)  
  pT2             64 (16.6%)  
  pT3           247 (64.0%)  
  pT4             68 (17.6 %)  
 pN   
  pN0           195 (50.5%)  
  pN1           107 (28.2%)  
  pN2             84 (27.7%)  
 pM   
  pM0           309 (80.1%)  
  pM1             77 (19.9%)  
 Stage   
  Stage I             53 (13.7%)  
  Stage II           129 (33.4%)  
  Stage III           127 (32.9%)  
  StageIV             77 (20.0%)  
 Grading   
  G1               2 (0.5%))  
  G2           290 (75.1%)  
  G3             94 (24.4%)   
 Follow-up (mo)   
  Mean (range)   37.7±3.4 (0-140)  
  Median             31.0  
 
DISCUSSION 
Effects of proinflammatory and carcinogenic chemicals 
For the present study, we used the mouse C57BL/6N strain, which shows a high incidence of 
colorectal tumors after DMH treatment (Diwan and Blackman, 1980, Greene et al., 1987). 
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Histological changes were identified early after DMH injection; however, definite cancers 
develop typically only after 24 weeks of treatment (Greene et al., 1987). Intrarectal infusion of 
MNU yielded a high incidence (up to 100%) of colonic cancer in previous studies with shrews 
(Yang et al., 1996). We detected initial inflammatory responses in both DMH- and MNU- treated 
animals, similar to the inflamed (DSS) colon. However, at later stages, carcinogens caused 
significant changes in mucosal architecture and expression of Kv3.1, Kv1.3 and Kv1.5 and, 
particularly, Eag channels. This was not observed in the DSS model. Thus, expression of 
oncogenic Eag channels seems to be a consequence of the carcinogen treatment and not 
simply a result from inflammation. This channel was also found in human colonic cancers, but 
not in normal tissues. It suggests that Eag has an oncogenic potential in the colonic epithelium. 
Interestingly, Eag was also detected in diverticulitis, which has the potential to change into 
colonic cancer. We hypothesize that expression of Eag in preneoplastic tissues supports 
malignancy and may drive the development towards colonic cancer. 
 
Electrolyte transport changes during carcinogenesis and colitis 
Several reports show altered electrolyte transport in early stages of tumor development. Using 
the present models, we confirm reduction of amiloride-sensitive Na+ absorption by treatment with 
DMH, MNU and DSS. Inhibition of amiloride-sensitive Na+ absorption was not explained by 
changes in the expression profile of the three Na+ channel subunits. A likely reason for reduced 
Na+ absorption is an attenuation of the Na+/K+-ATPase in the distal colon (Davies et al., 1991). 
The cAMP-induced Cl- secretion was reduced initially, but was up-regulated at later stages of 
DMH treatment. Stool irregularities, with changes from constipation to diarrhea, are often 
observed in patients with intestinal tumors or inflammatory bowel disease, and the present 
findings may therefore supply an explanation for these symptoms.  
 
Expression of Kv channels during inflammation and carcinogenesis 
Kv channels promote cell proliferation and support tumor development (Pardo, 2004, Pardo et 
al., 2005). In multiplex reverse transcription-PCR, we found enhanced expression of the 
channels Kv1.3, Kv1.5 and Kv3.1 (Table 1). Kv1.3 (gene locus KCNA3) is essential for 
lymphocyte proliferation and supports development of cancer in prostate, colon and breast. 
Kv1.5 (gene locus KCNA5) supports proliferation of gastric cancer (Abdul and Hoosein, 2002b, 
Kunzelmann, 2005). Moreover, expression of Kv1.5 correlates with the grade of malignancy of 
gliomas (Preussat et al., 2003). The apparent dissociation constants (Kd) of 4-AP for Kv1.3, Kv1.5 
and Kv3.1 channels are 195 µM, 270 µM, and 29 µM, respectively, which are in the range of the 
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4-AP concentration (100 µM) used in the present study (Grissmer et al., 1994). We suggest that 
Kv3.1 (gene locus KCNC1) is mainly responsible for the 4-AP-dependent inhibition of ion 
transport in the malignant colon. Thus, this is the first study which supplies evidence that Kv3.1 
channels are involved in development of cancer. Expression of Kv3.1 is normally restricted to 
central nervous system and to a subpopulation of T lymphocytes (Pardo, 2004). Kv3.4, another 
member of this subfamily of Kv channels, controls proliferation of oral and esophageal squamous 
carcinoma cells (Chang et al., 2003). 
 
An oncogenic role of EAG channels in the colon 
According to previous reports, expression of Eag-1 and Erg-1 channels is strictly limited to 
excitable tissues. In contrast, in malign epithelial tumors, the cell cycle-controlled Eag channel 
determines malignancy and metastasis of breast cancer (Camacho, 2006, Pardo et al., 1999, 
Pardo, 2004, Stuhmer et al., 2006). Crypt cells of carcinogen-treated mice showed expression of 
Eag-1, Erg-1 and Elk-1 in the present study. When normalized to the actin signal, expression of 
Eag-1 was somewhat larger in the distal colon when compared to the proximal colon of DMH-
treated animals. However, the difference was not statistically different. Moreover, expression of 
Eag-1 was found in human colorectal adenocarcinomas. Fluorescence in situ hybridization 
analysis showed amplification of the Eag-1 gene in 13 (3.4%) of the 386 tumor specimens. Eag-
1 amplification was significantly associated with adverse outcome. The low prevalence of Eag-1 
amplification does not question its importance, since mechanisms other than amplification may 
account for activation and over-expression in a larger fraction of tumours. For example, another 
potassium channel, KCNK9 at 8q24.3, was previously found to be amplified in about 10%, but 
overexpressed in 44% of breast cancers (Mu et al., 2003a). 
 
Taken together, carcinogenesis in the colon and colitis change expression of ion channels 
important for salt transport, which is likely to cause stool irregularities. Expression of the cell 
cycle-regulated K+ channel Eag-1 is closely correlated with malignancy in the human and rodent 
colon and Eag-1 gene amplification is associated with reduced surviving rate. These data 
suggested that Eag-1 expression is important for tumor development in the human colon. 
Because Eag-1 is already expressed at a premalignant stage, Eag-1 transcripts detected in 
rectal biopsies or stool samples may serve as early diagnostic and prognostic markers, as 
shown recently for cervical cancer (Farias et al., 2004b). The present data may also be useful in 
developing new therapeutic strategies for the treatment of colonic cancer. 
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CHAPTER 5 
 
Upregulation of colonic ion channels in APCMin/+ mice 
 
ABSTRACT 
 
Background & Aims: The adenomatosis polyposis coli (APC) tumor suppressor gene is 
mutated in almost all human colonic cancers. Disturbances in Na+ absorption have been 
observed in colonic cancer and ion channels such as ether à go-go (Eag) or Ca2+-sensitive BK 
channels have been recognized for their oncogenic potential.  
Methods: The APCMin/+ mouse model is characterized by reduced APC expression and multiple 
intestinal neoplasia (Min). The activity of colonic ion channels was assessed by 
electrophysiological and molecular techniques. 
Results: APCMin/+ mice developed polyps in proximal and distal colon and experienced a 
significant weight loss during an observation period of 21 weeks. Rectal potential measurements 
in vivo indicated an increase in amiloride-sensitive Na+ absorption in APCMin/+ mice. Quantitative 
Ussing chamber studies demonstrated enhanced Na+ absorption via epithelial Na+ channels 
(ENaC) and suggested enhanced activity of oncogenic BK and Eag-1 channels. Patch clamp 
experiments on mid crypt cells showed similar results for APCMin/+ and wt mice, suggesting that 
changes in channel activity take place in the surface epithelium. ENaC-mRNA and membrane 
protein expression was clearly enhanced in colonic surface epithelial cells.  
Conclusions: Reduced expression of the APC gene with upregulation of the downstream 
proteins Akt and mTOR augments the activity of ENaC and oncogenic potassium channels. 
These changes reflect an imbalance due to reduced apoptosis and enhanced mitotic activity, 
and may have implications for the clinical outcome. 
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INTRODUCTION 
Membrane ion channels have been demonstrated in previous studies to control cell proliferation. 
Changes in ion channel expression during development of cancer have been frequently 
observed (for review see (Kunzelmann, 2005). Ion channel activity determines homeostatic 
parameters such as membrane voltage, intracellular ion concentration, and cell volume. Ion 
channels also control cytosolic pH and cell signaling by changes in the intracellular Ca2+ 
concentration (Kunzelmann, 2005, Schreiber, 2005, Spitzner et al., 2007). Some ion channels, 
like Eag-1, fulfill specific tasks during the cell cycle (Pardo et al., 1999, Pardo, 2004). Voltage-
gated K+ channels are detected in breast and colonic cancer specimens and other malign tumors 
(Lastraioli et al., 2004, Ousingsawat et al., 2007, Pardo et al., 1999, Pardo, 2004, Spitzner et al., 
2007). Large conductance Ca2+-activated K+ channels are found in tumors of prostate, breast 
and colorectum (Bloch et al., 2007, Yao and Kwan, 1999). Previous in vitro studies demonstrate 
a contribution of K+ channels to proliferation of colonic cancer cells, and experiments performed 
on animal models suggest an oncogenic role of these K+ channels in vivo (Ousingsawat et al., 
2007). To fully appreciate the changes in ion channel currents occurring during carcinogenesis 
in the colon, further in vivo studies are required, ideally on a genetically well defined mouse 
model (Fodde et al., 1994). 
Previous studies utilized chemical tumor models in order to assess potential changes in ion 
conductances during carcinogenesis in vivo. Treatment of the animals with carcinogens like 
dimethylhydrazine or N-methyl-N-nitrosourea induces colonic cancer, which is paralleled by 
changes in ion channel expression (Fodde et al., 1994, Ousingsawat et al., 2007). While these 
studies supply some insight into carcinogenesis in vivo, the drawbacks are individual drug 
susceptibility and inflammation (Ousingsawat et al., 2007). Here we studied a well defined 
genetic mouse model that is based on a mutation in the adenomatous polyposis coli (APC) 
gene. Heterozygote APCMin/+ mice develop multiple intestinal neoplasia (Min) (Fodde et al., 
1994). Mutations in the human APC gene are responsible for familial adenomatous polyposis 
and are found in a large majority of colorectal cancers. We found that heterozygous APCMin/+ 
animals demonstrate a change in expression of epithelial colonic Na+ channels and show an 
increase in BK and Eag-1 channel conductance, similar to human colonic carcinoma. 
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MATERIAL AND METHODS 
Animals 
Heterozygous APCMin/+ pups (Fodde et al., 1994) (Jackson laboratory, USA) were weaned at 4-5 
weeks of age and genotyped by PCR. Animals were fed with complete chow with 15% corn oil 
(Sniff, Soest, Germany), which has an adverse effect on polyp numbers in these animals 
(Wasan et al., 1997). APCMin were sacrificed after a weight loss of 10%. Wild-type animals of the 
same age served as control. Animal studies were conducted according to the guidelines of the 
National Institute of Health and the German laws on protection of animals.  
Immunohistochemistry and histology  
Mice were sacrificed under CO2 inhalation; Proximal and distal colon were fixed for 20 min in 0.1 
M PBS with 4% paraformaldehyde. Sections were embedded in paraffin, cut in 5 µm serial 
sections (Leica microtome RM 2165, Wetzlar, Germany) and mounted on slides. Dehydrated 
sections were heat-induced for epitope retrieval for 20 min. After washing in PBS, sections were 
blocked and incubated in primary antibodies at 4°C overnight. Rabbit polyclonal anti-α ,anti-β, 
and anti-γ-ENaC antibodies (BABCO, Berkely, CA, USA) and the anti-BKα antibody (Alamone 
Labs, Israel) were used in a 1:50 dilution. The polyclonal anti-β-catenin antibody (Sigma, 
Taufkirchen, Germany) was used at 1:1,000 dilutions. ENaC and BK antibodies were detected 
using avidin-biotin complex (ABC) technique. After exposure to the primary antibody, sections 
were incubated in a biotinylated donkey anti-rabbit antibody diluted 1:400 (Santa Cruz 
Biotechnology, Heidelberg, Germany). After washes, the sections were incubated with di-
aminobenzidine. Tissues were counterstained with hematoxylin (Merck, Darmstadt, Germany) 
before mounting in Depex (SERVA Electrophoresis). Nuclei were stained with Hoe33342 
(Sigma-Aldrich, Taufkirchen, Germany) and then mounted in DakoCytomation media. 
Endogenous peroxidase activity was blocked by incubating in 3% H2O2 in PBS. Images were 
taken with Axiovert 200M/ApoTome (Zeiss, Munich).  
Rectal potential different (RPD) and Ussing chamber measurement  
For RPD measurements, mice were anaesthetized by intraperitoneal injection of 20 µl (75 
mg/ml) ketamine and 5 mg/ml xylazine. A catheter (polythene tube with OD 1 mm) perfused with 
standard ringer solution (3 ml/min) was attached to an AgCl electrode and inserted 2 cm into the 
rectum. A subcutaneous needle served as reference. For Ussing chamber measurement, 
stripped colon was put into ice cold ringer solution containing amiloride (20 µM) and 
indomethacin (10 µM) and tissues were measured in a perfused Ussing chamber as described 
previously (Ousingsawat et al., 2007).  
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Patch clamp experiments 
Crypts were isolated in Ca2+-free Ringer solution. Individual crypts were hold by pulled glass 
pipettes and whole cell patch clamp recordings were taken from mid and lower crypt cells using 
previously described protocols (Spitzner et al., 2007).  
Real time PCR and Western blotting 
Expression levels for mRNAs encoding Eag-1, BK, ENaC and β-actin were evaluated by real 
time PCR using Light Cycler (Roche, Mannheim, Germany) and Quanti Tect SYBR Green PCR 
Kit (Quiagen, Hilden, Germany) after isolating total RNA from colonic crypt cells using standard 
techniques. Further details regarding primers and real time PCR are given in Supplements. 
Lysates of isolated proximal and distal colonic crypt cells were resolved by 7% SDS-PAGE, 
transferred to Hybond-P (Amersham, Freiburg, Germany) and incubated with antibodies 
described above. Akt antibodies were from Cell Signaling, Frankfurt, Germany). Bands were 
visualized with goat anti-rabbit IgG conjugated to horseradish peroxidase (Acris, Hiddenhausen, 
Germany) and ECL using a Fluor-STM MultiImager (Bio-Rad, Hercules, USA). Expression levels 
were normalized to that of β-actin. 
Materials and statistical analysis 
All used compounds were of highest available grade of purity. Amiloride, paxillin, 4-AP, 
astemizole, carbachol, forskolin, UTP, NS1619, β-estradiol, IBMX were all from Sigma-Aldrich 
(Taufkirchen, Germany). Student’s t-test (for paired or unpaired samples as appropriate) and 
analysis of variance (ANOVA) were used for statistical analysis. P < 0.05 was accepted as 
significant. 
 
RESULTS 
Pathology of APCMin/+ mice  
APCMin/+ mice demonstrated a normal postnatal development but started to loose weight from 
week 12 on. APCMin/+ mice reached an age of 21.21 ± 0.81 weeks. By then they lost more than 
20% weight (23.22 ± 0.8 g; n = 23) compared to wt animals (36.66 ± 1.51 g; n = 32). Wt animals 
were sacrificed at an age of 23.3 ± 0.77 weeks. Every APCMin/+ animal had large visible polyps in 
proximal (0.47 ± 0.2) and distal (2.53 ± 1.0; n = 14) colon, but the number of polyps was much 
higher in small intestine and stomach (27.2 ± 7) (Figure 1A). Large intestinal polyps consisted of 
hyperplastic adenomas, which did not yet show signs of malignancy (Figure 1B). Although β-
catenin accumulation in crypts of APCMin/+ animals had been described in previously 
(Kongkanuntn et al., 1999), we found similar expression of β-catenin in wt and APCMin/+ animals 
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in proximal (Figure 1C) and distal (Figure 1D) colon. Confocal images of β-catenin staining 
demonstrate regular membrane staining in unaffected small (Figure 1E) and large (Figure 1F) 
intestinal mucosa, while the staining was more diffuse and cytosolic in the polyps (Figure 1E, F).  
 
 
 
Figure 1. Mucosal abnormalities in APCMin/+ mice. A) Macroscopic aspect of inverted proximal and distal 
colonic mucosa of wild type (wt) and APCMin/+ mice. Colonic mucosa of APCMin/+ mice shows several large 
polyps. B) Hematoxylin/eosin staining of a distal colonic polyp from an APCMin/+ animal. C) Staining of β-
catenin in unaffected proximal (C) and distal (D) colon of wt and APCMin/+ mice. Staining and confocal 
images of β-catenin in unaffected crypts and polyps from small (E) and large (F) intestine. 
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Enhanced Na+ absorption in APCMin/+ mice 
Rectal potentials were measured in vivo in anesthetized animals aged 9, 15 and 19 weeks 
(Tablae 1), using a fine polyethylene catheter (c.f. Methods). From week 15 on, APCMin/+ animals 
displayed increased lumen negative transrectal potentials (RPD), when compared to wt animals 
(Figure 2A, B). The RPD was mainly due to amiloride sensitive Na+ absorption (RPDam), since 
intrarectal application of amiloride via the catheter collapsed the lumen negative RPD. Thus, 
amiloride sensitive epithelial Na+ absorption is significantly enhanced in APCMin/+ animals (Figure 
2A, C).  
 
 Table 1. Rectal potential difference in wt and APCMin/+ mice under control conditions (RPD) and 
changes induced by rectal perfusion of amiloride (20 µM), forskolin 2 µM), ATP (100 µM), and 
Ba2+ (5 mM). Asterisks indicate significant difference when compared to wt animals. (Number of 
mice). 
 
 Rectal potential difference (mV)  
  9 weeks  15 weeks  20 weeks  
  wt 
(n=22-30) 
Apcmin/+ 
(n=10-19) 
 wt 
(n=19-25) 
Apcmin/+ 
(n=8-14) 
 wt 
(n=2-9) 
Apcmin/+ 
(n=4-5) 
 
 RPD -12.27 ± 0.9 -10.86 ± 0.8  -9.78 ± 0.4 -13.52 ± 1.7*  -8.52 ± 0.2 -14.11 ± 2.1*  
 RPDamil 7.41 ± 0.9 5.65 ± 0.5  4.06 ± 0.3 9.36 ± 1.6*  4.21 ± 0.6 9.76 ± 2.0*  
 RPDforsk 2.39 ± 0.3 2.06 ± 0.4  2.66 ± 0.4 2.16 ± 0.5  3.52 ± 0.5 3.24 ± 0.7  
 RPDATP 2.09 ± 0.2 2.04 ± 0.4  1.80 ± 0.3 1.82 ± 0.6  2.02 ± 1.4 1.31 ± 0.2  
 RPDBa+ 2.38 ± 0.2 2.58 ± 0.3  2.52 ± 0.2 1.66 ± 0.2*  2.27 ± 0.3 2.44 ± 0.7  
 
This was further quantified in continuous recordings of the transepithelial voltage, which is a 
measure for the epithelial transport. Electrogenic absorption of Na+ by ENaC is normally limited 
to distal colon. However, in APCMin/+ animals amiloride sensitive Na+ transport (short circuit 
current, Isc) was also detected in the proximal colon (Figure 3A, C). In distal colon of APCMin/+ 
animals, Na+ absorption was largely upregulated (Figure 3B, C). Other transport properties, like 
forskolin induced Cl- secretion by the cystic fibrosis transmembrane conductance regulator 
(CFTR) Cl- channel, and Ca2+ activated electrolyte transport in the distal colon were similar in 
APCMin/+ and normal animals (data not shown).  
 
Expression of oncogenic K+ currents in APCMin/+ mice 
Expression of cell cycle regulated Eag-1 and Ca2+-dependent BK channels has been reported 
for colonic cancer and other malignant tumors (Bloch et al., 2007, Ousingsawat et al., 2007, Yao 
and Kwan, 1999). Basolateral application of the Eag-1 inhibitor astemizole (5 µM) inhibited Isc in 
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proximal and distal colon of both APCMin/+ and normal mice, however, astemizole sensitive 
transport (Isc aste) was augmented in proximal colon of APCMin/+ mice (Figure 3D, E). 4-
aminopyridine (0.1 and 2 mM), which inhibits other types of voltage-gated K+ channels, had no 
effect on ion transport (data not shown). Luminal paxillin (5 µM) inhibited K+ secretion via BK 
channels to the same degree in wt (32.8 ± 12 µA/cm2; n = 13) and APCMin/+ (31.9 ± 19 µA/cm2; n 
= 6) mice, suggesting similar baseline activity for BK channels. However, the activator of BK 
channels NS1619 (10 µM) stimulated more K+ secretion in the distal colon of APCMin/+, when 
compared to wt animals (Figure 3F). Moreover, after activation of K+ secretion by carbachol (100 
µM), the BK channel inhibitor paxillin showed a stronger effect in APCMin/+ mice (19.5 ± 9.7 
µA/cm2; n = 3), compared to wt (7.2 ± 3.4 µA/cm2). 
 
 
 
Figure 2. Enhanced Na+ absorption APCMin/+ mice. A) Original recordings of the rectal potential difference 
(RPD) measured in wt and APCMin/+ mice. Inhibition of ENaC by luminal application of amiloride (am, 20 
µM) via the catheter reduced RPD, while forskolin (forsk, 2 µM) and barium (Ba, 5 mM) increase the rectal 
potential difference. ATP (100 µM) induced a brief and transient decrease in RPD due to activation of BK 
K+ channels. B) Summary of RPD measured in wild type (wt) and APCMin/+ mice at 9, 15 and 19 weeks of 
age. C) Summary of the amount of RPD inhibited by amiloride in wild type (wt) and APCMin/+ mice at 9, 15 
and 19 weeks of age. Asterisks indicate significant differences compared to control (Student´s t-test). 
(Number of mice). 
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Figure 3. Ion channels in the colon of APCMin/+ mice. A), B) Original recordings of the transepithelial 
voltage (Vte) measured in a perfused Ussing chamber. In APCMin/+ mice amiloride (am, 20 µM) slightly 
reduced Vte in the proximal colon (A) but had a large effect on Vte in distal colonic mucosa (B). C) 
Summary of the amiloride sensitive transport (Isc am) in proximal and distal colonic mucosa of wt and 
APCMin/+ mice. D) Original recordings of Vte and effects of the Eag-1-blocker astemizole (aste, 5 µM) in 
proximal colon. E) Summary of the astemizole sensitive transport (Isc aste) in proximal and distal colonic 
mucosa of wt and APCMin/+ mice. F) Summary of the K+ secretion activated by the BK channel activator 
NS1619 (10 µM) in proximal and distal colonic mucosa of wt and APCMin/+ mice. G), H) Whole cell patch 
clamp experiments from colonic mid crypt and crypt base epithelial cells. Original current tracings (left 
panels) and current voltage relationships (right panels) suggest cells with linear (G) and outwardly 
rectifying (H) whole cell currents. Asterisks indicate significant differences compared to control (Student´s 
t-test). (Number of mice). 
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Conductances properties were further examined in patch clamp experiments on mid and lower 
crypt cells. The baseline membrane voltage and conductance properties of epithelial cells from 
wt and APCMin/+ mice were indistinguishable (Table 2). We identified two populations of cells with 
either linear (Figure 3G) or outwardly rectifying (Figure 3H) whole cell currents. The frequency of 
both, however, was similar in APCMin/+ and wt mice. Moreover, cAMP- and Ca2+-activated 
currents were similar in wt and APCMin/+, and effects of paxillin, astemizole or 4-AP could not be 
detected (data not shown). Thus, Ca2+-activated BK channels and astemizole sensitive Eag-1 
channels must be expressed in the surface epithelium, which confirms previous results 
(Puntheeranurak et al., 2006).  
 
 Table 2: Whole cell conductance (Gm) and membrane voltage (Vm) of epithelial cells 
from colonic crypts of wt mice and APCMin/+ animals. (Number of mice). 
 
  Gm (nS)  Vm (mV)  
  wt APCMin/+  wt APCMin/+  
 Proximal colon 2.47 ± 0.41 (29) 2. 34 ± 0.3 (28)  -65.64 ± 2.74 (29) -66.7 ± 3.26 (28)  
 Distal colon 2.38 ± 0.24 (27) 3.01 ± 0.35 (37)  -68.71 ± 2.76 (27) -62.87 ± 3.01 (37)  
 
Enhanced expression of ENaC in APCMin/+ 
The large increase in Na+ absorption in the APCMin/+ colon may be due to an increase in ENaC-
activity or enhanced expression of the three α-, β-, γ-ENaC subunits. Immunostaining of all three 
ENaC-subunits was performed in proximal and distal colon (Figure 4). In contrast to wt animals, 
α-, β-, γ-ENaC were clearly detectable in proximal colon of APCMin/+ mice (Figure 4A), and in the 
distal colon of APCMin/+ mice expression of α-, β-, γ-ENaC was enhanced when compared to wt 
animals (Figure 4B). Thus, enhanced Na+ transport in the colon of APCMin/+ mice is due to an 
increase in ENaC expression. Quantification of total protein prepared from isolated colonic crypts 
showed an increase in γ-ENaC protein expression in proximal and distal colon of APCMin/+ mice 
(Figure 5D, E). Quantitative real time PCR analysis indicated enhanced expression of mRNA for 
β- and γ-ENaC in proximal and distal colon of APCMin/+ mice (Figure 5A, B).  
Upregulation of the protein kinase B (Akt) in tumors of APCMin/+ mice has been reported 
previously, and patients with colorectal carcinoma have elevated levels of Akt and cytoplasmic β-
catenin (Dihlmann et al., 2005, Moran et al., 2004). Because Akt increases ENaC activity (Lee et 
al., 2007), ENaC could be upregulated in the colon of APCMin/+ mice due to an increase in 
phospho-Akt. Western blot analysis indicated upregulation of activated Akt-P-Thr308 (p-Akt) in 
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APCMin/+ mice in tumor tissues (polyp), but not in unaffected colonic mucosa (crypt) of APCMin/+ 
and wt mice (Figure 6A), suggesting that Akt may play a minor role in activating ENaC in 
APCMin/+ mice. 
 
 
Figure 4 Expression of ENaC in the colon of APCMin/+ mice. Expression of α-, β-, and γ-subunits of the 
epithelial Na+ channel ENaC in proximal (A) and distal colon (B) of wt and APCMin/+ mice. No staining was 
obtained in the absence of primary antibodies (con). 
 
Enhanced K+ channel activity in APCMin/+ mice is not due to upregulation of BKα or Eag-1 
Currents through voltage-gated Eag-1 and large conductance Ca2+-activated BK channels are 
enhanced in the colon of APCMin/+ mice (Figure 3). Using real time RT-PCR, we found no 
increase in mRNA expression of the channel forming BKα subunit or Eag-1 in APCMin/+ mice 
(Figure 6B, C). Similarly, expression of Eag-1 protein was unchanged in APCMin/+ animals and no 
obvious difference was found for BKα localized in the membrane of colonic crypt cells of wt and 
APCMin/+ (Figure 6D, E). However, for BK channels the regulatory β1- and β2-subunits were 
found to be upregulated in the distal colon of APCMin/+ mice (Figure 6C), which probably explains 
the enhanced Ca2+ activated K+ currents in the distal colon of APCMin/+ mice (Figure 3F). 
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Figure 5. Expression of ENaC in the colon of APCMin/+ mice. A), B) Summary of the results from real time 
PCR analysis indicates upregulation of mRNA expression for β-ENaC and γ-ENaC in proximal and distal 
colon of APCMin/+ and control mice. C) Western blot analysis of the three α-, β-, and γ-subunits of the 
epithelial Na+ channel ENaC in isolated distal colonic crypts. (D), (E) Summary of the expression of α-, β-, 
and γ-ENaC in proximal and distal colon of wt and APCMin/+ mice. Asterisks indicate significant differences 
compared to control (Student´s t-test). Number of mice = 5. 
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Figure 6. Expression of Akt, Eag-1 and BK in the colonic epithelium of APCMin/+ mice. A) Western blot 
analysis of Akt and activated phospho-Akt (Akt-P-Thr308) in unaffected mucosa and polyps. B), C) 
Results from quantitative analysis of mRNA expression for Eag-1 and α/β subunits of BK channels in 
isolated crypts from proximal (B) and distal (C) colon. D), E) Western blot analysis of expression of Eag-1 
protein in isolated crypts from proximal and distal colon (D) and quantitative comparison between wild type 
and APCMin/+ mice (E).  F) Staining of α subunit of BK channels in colonic epithelium of APCMin/+ mice and 
control animals. Asterisks indicate significant differences compared to control (Student´s t-test). (Number 
of mice). 
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DISCUSSION 
Mutations in the APC gene reduce apoptosis and cause colonic cancer 
According to the classical Knudson’ two hit model both alleles of a tumor suppressor gene need 
to be mutated to trigger cancer. In contrast haploinsufficieny predicts a gene dosage effect along 
with additional oncogenic mutations, loss of tumor suppressors or epigenetic changes that are 
required for tumor formation (Fodde and Smits, 2002). Heterozygous mutations in the gene 
encoding the adenomatosis polyposis coli (APC) protein are found at early stages of sporadic 
colorectal cancers, and are the cause for familial adenomatosis polyposis (Nathke, 2006, Su et 
al., 1992). APC has a clear role in mediating phosphorylation and degradation of β-catenin. 
Consequently loss of APC leads to accumulation of β-catenin at adherens junctions and reduced 
ability of epithelial cells to traverse the crypts. APC mutations inhibit apoptosis by allowing 
constitutive survivin expression. Thus the cells remain in the crypts for an extended period of 
time, with the potential to receive additional toxic signals (Zhang et al., 2001). Genetic instability 
of those crypt cells is reflected by a high anaphase bridge index with enhanced tolerance (Aoki 
et al., 2003, Nathke, 2006).  
 
APCMin/+ reduced apoptosis and enhanced Na+ absorption 
We analyzed changes in colonic ion transport occurring in heterozygous APCMin/+ mice, since 
previous reports suggested a role of ion channels for cell proliferation and tumor formation 
(Kunzelmann, 2005). The remarkable upregulation of colonic Na+ absorption in APCMin/+ animals 
may be due to several reasons. i) Obviously the mammalian target of the rapamycin (mTOR) 
pathway is upregulated in APCMin/+, which may lead to enhanced transcription of α-, β-, γ-ENaC 
subunits (Land et al., 2007). Notably in preliminary experiments with APCMin/+ animals, which 
received the mTOR inhibitor rapamycin Na+ absorption and abnormal K+ channel expression 
was abolished (unpublished from the authors laboratory). ii) Although cytosolic accumulation of 
β-catenin and Akt-p-Thr308 were only observed in adenomas (Kongkanuntn et al., 1999, Moran 
et al., 2004), low levels of Akt-p-Thr308 in normal crypts of APCMin/+ mice may contribute to 
enhanced ENaC activity, due to a mechanism that involves phosphorylation of the ubiquitin 
ligase Nedd4-2 by Akt (Lee et al., 2007). iii) Expression of ENaC increases with differentiation 
and aging of the cells present in the surface epithelium. Reduced apoptosis in APCMin/+ may 
expand the pool of ENaC expressing epithelial cells in the surface epithelium and the upper 
crypt. 
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Role of Na+ absorption in colonic cancer 
In the present study the animals received a chow enriched with highly saturated lipids, known to 
promote epithelial lesions and neoplasia (Rao et al., 2001). High fat / low fiber diet is often 
accompanied by constipation representing another cancer promoting factor (Sonnenberg and 
Muller, 1993), although the role of chronic constipation for cancer development is discussed 
controversially (Chan et al., 2007, Kune et al., 1988). On the other hand, colonic polyposis and 
colorectal cancer is often accompanied by stool irregularities and constipation (Weitz et al., 
2005). The augmented Na+ absorption in APCMin/+ mice is likely to cause dehydration of the feces 
and constipation. Occasionally we observed symptoms of intestinal occlusion and rectal prolaps 
in APCMin/+ animals. Another mouse model of colonic carcinogenesis that made use of chemical 
carcinogens, also produced enhanced Na+ absorption (Davies et al., 1987). However reduced 
Na+ absorption has been found during acute application of the carcinogens, probably due to 
induction of an inflammation (Bleich et al., 1997, Ousingsawat et al., 2007). Colonic inflammation 
like in ulcerative colitis has been shown to reduce electrogenic Na+ transport and ENaC 
expression (Amasheh et al., 2004, Barmeyer et al., 2004). 
 
Enhanced Eag-1 and Ca2+-activated K+ currents in APCMin/+ mice 
Apart from the change in Na+ absorption, we present evidence for upregulation of potassium 
currents in the colonic epithelium of APCMin/+ mice. These Eag-1 and BK channels were shown to 
support proliferation of colonic cancer cells in vitro, and are expressed in samples of human 
colorectal cancer as well as colonic epithelium of carcinogen treated mice (Kunzelmann, 2005, 
Lastraioli et al., 2004, Ousingsawat et al., 2007, Pardo, 2004, Spitzner et al., 2007, Yao and 
Kwan, 1999). The present results provide further evidence for a contribution of K+ currents to 
development of cancer (Kunzelmann, 2005). How are these channels activated by APC, since 
we did not detect a change in transcripts or total protein for Eag-1. It is likely that Eag-1 is 
regulated by β-catenin or Akt, since a close member of the same family of voltage-gated K+ 
channels, Erg, has been shown to be activated by Akt (Zhang et al., 2003). It is know that 
mutations in the APC gene alter cell cycle regulation, probably through upregulation of Erk-
signaling (Dikovskaya et al., 2007). Since Eag-1 is a cell cycle regulated K+ channel, it is likely 
that these changes affect Eag-1 activity.  
Upregulation of Akt may also increase the activity of Ca2+-activated K+ channels, since 
membrane trafficking of BK channels was shown to be enhanced by Akt in a PI3-kinase 
dependent manner in neurons (Chae et al., 2005). PI3-kinase dependent regulation of BK was 
also found in mouse distal colon (Puntheeranurak et al., 2006). Apart from that β1 and β2 
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subunits of BK channels were largely increased in the distal colon of APCMin/+ animals (Figure 5). 
Both channel subunits are known to increase apparent Ca2+ and estradiol sensitivity of BK 
channels (Valverde et al., 1999b). Taken together, enhanced activity of cell cycle regulated Eag-
1 channels and large conductance Ca2+-activated K+ channels are closely correlated with 
malignancy, and are associated with adverse outcome and reduced overall survival of patients 
(Ousingsawat et al., 2007). Thus the present results may provide a basis for new therapeutic 
strategies for the treatment of colonic cancer. 
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SUMMARY 
 
Potassium channels have been reported to control cell cycling and proliferation. Cancer cells 
in vitro and native malignant tissues show increased expression of various types of K+ 
channels such as Kv, Eag-1, Erg-1, BK and TASK-3. Here, we demonstrate a contribution of 
K+ channels to proliferation and development of prostate and colonic cancer. Patch clamp 
and Ussing chamber experiments were performed in cell lines and animal tissues, and rectal 
potentials were measured in mice in vivo. With the use of K+ channel activators and blockers 
as well as RNA interference techniques, we were able to identify functional expression of 
several types of K+ channels. Moreover, semiquantitative RT-PCR, real time-PCR, Western 
blots, and immunohistochemistry were applied to quantify mRNA and expression of ion 
channel proteins. 
Large conductance Ca2+-activated K+ channels promote proliferation of human 
prostate cancer cells 
The KCNMA1 gene encoding the α-subunit of BK channels is amplified and BK channel 
expression was enhanced in late-stage, metastatic and hormone-refractory human prostate 
cancer tissues, whereas benign prostate tissues showed only a weak expression of BK 
channels. The role of BK channels for proliferation of late stage prostate cancer was 
examined in PC-3 cells, representing the hormone-insensitive prostate cancer, and was 
compared with hormone-sensitive prostate cancer cells (LNCaP) and the benign prostate 
hyperplasia cell line (BPH-1). PC-3 cells, but not LNCaP and BPH-1 cells, showed an 
amplification of the KCNMA1 gene and enhanced mRNA and protein levels for BK channels. 
Iberiotoxin, a specific BK channel blocker, inhibited whole cell currents and growth of PC-3 
cells. This inhibitory effect was mimicked by downregulation of BK mRNA. BK channels were 
detected in excised inside/out membrane patches from PC-3 cells and were suppressed by 
the inhibitor paxillin and by siRNA. The BK channel activator 17β-estradiol did not further 
stimulate whole cell currents or cell proliferation in PC-3 cells, indicating maximal channel 
activity and hormone insensitivity of the cells. On the contrary, 17β-estradiol significantly 
enhanced both currents and proliferation in LNCaP and BPH-1 cells. These results establish 
a role of BK channels for proliferation of prostate cancer cells. BK channel expression in late 
stage prostate cancer may be used as a prognostic marker and appears as a promising 
target for diagnosis and therapy of prostate cancer. 
Electrolyte transport and expression of voltage-gated K+ channel are different in 
colonic cancer 
The role of K+ channels for proliferation of colonic cancer was shown in 3 different models: i) 
T84 human colonic carcinoma cells, ii) mouse colorectal cancer induced by chemical 
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carcinogens, iii) genetic mouse model of colorectal cancer (APCMin/+). Alterations in colonic 
electrolyte transport were found during development of colonic cancer in vivo and the role of 
K+ channels for proliferation of colonic cancer cells was assessed in vitro. 
Abnormal colonic histology in cancer mouse models 
At early stages of dimethylhydrazine (DMH) and N-methy-N-nitrosourea (MNU) treatment, 
histology demonstrated inflammation of the mouse colon. At later stage of carcinogen 
administration, changes of mucosal architecture and dysplasia were clearly observable, 
indicating alterations of the colonic mucosa due to treatment by DMH or MNU. Mutations in 
the adenomatous polyposis coli (APC) tumor suppressor gene are found in almost all human 
colonic cancers, and in familiar adenomatous polyposis. Heterozygous APCMin/+ mice 
developed multiple intestinal neoplasias. Abnormal distribution of β-catenin and enhanced 
levels of phospho-Akt were detected in polyps of APCMin/+ mice. 
Changes in Na+ and Cl- transport in colonic cancer mouse models. 
Initial DMH or MNU treatment decreased amiloride-sensitive epithelial Na+ absorption in the 
colon. The initial inflammatory response in both DMH- and MNU-treated animals was similar 
to that observed in the colon of dextran sulfate sodium (DSS) treated animals. A reduced Na+ 
absorption was also detected in the inflamed DSS-colon, indicating that ENaC activity is 
reduced during inflammation. Similar to ENaC, cAMP-stimulated CFTR Cl- currents were 
reduced at early stage of DMH, MNU or DSS treatment. Reduced Na+ absorption and Cl- 
secretion in the inflamed colon are probably a result of reduced Na+/K+ ATPase activity. In 
contrast to carcinogen treated mice, amiloride-sensitive ENaC currents were significantly 
increased in the distal colon of APCMin/+ mice. Enhanced colonic Na+ absorption in APCMin/+ 
mice is due to an increase in mRNA and protein expression of ENaC, as identified by RT-
PCR, immunohistochemistry, and Western blotting. Upregulation of ENaC in APCMin/+ mice 
may be due to upregulation of the mammalian target of rapamycin (mTOR) and Akt, as well 
as reduction of apoptosis. Taken together, inflammation reduces Na+ absorption and 
promotes diarrhea, which is often observed during colitis. Conversely, colonic polyposis is 
often accompanied by stool irregularities. The increase in colonic Na+ absorption in APCMin/+ 
mice may contribute to dehydration of the feces and constipation. 
Mouse models for colonic cancer show pathological expression of K+ channels in the colonic 
epithelium 
We demonstrated a role of Kv and BK channels for development of colonic cancer both in 
vitro and in vivo. In T84 human colonic cancer cells, we detected molecular and functional 
expression of voltage-gated K+ channels ( Kv1.3, Kv1.5, Kv3.3/3.4, KvLQT, Eag-1, Erg-1) and 
Ca2+-activated K+ channels (BK, SK4). Kv channel blockers inhibited cell proliferation in a 
concentration-dependent manner. Downregulation of Eag-1 expression by siRNA 
Summary 
 
85
significantly reduced proliferation, while blockers of Ca2+-activated K+ channels and siRNA 
inhibition of SK4 did not affect proliferation of T84 cells. The results indicate that only Kv 
channels (Kv3.4, Kv1.5 and Eag-1) support proliferation of T84 cells. These channels assist in 
regulation of intracellular pH and cellular Ca2+ signaling, since the blockers 4-AP and 
astemizole reduced pH regulatory capacity and attenuated Ca2+ release from intracellular 
stores as well as Ca2+ influx through stored-operated Ca2+ channels. We also found 
enhanced Kv channel activity in the colon of DMH- and MNU animals. The inhibitory effects 
of the Kv blockers 4-AP and astemizole were significantly higher in the carcinogen treated 
animals. Thus, Kv1.3, Kv1.5, Kv3.1 and members of the EAG-family are enhanced in the 
premalignant colon induced by chemical carcinogens. In the APCMin/+ model, increased 
astemizole-sensitive transport was observed in the proximal colon, indicating the presence of 
EAG family members. Apart from EAG, BK channel currents were significant increased in the 
distal colon of APCMin/+ mice. Enhanced BK channel activity in APCMin/+ mice is likely due to 
an increase in transcription of the regulatory β1 and β2 subunits. Notably, high mRNA 
expression of BK channel β-subunits was also observed in T84 cells. The increase in EAG 
and BK channel activity was probably due to upregulation of Akt and mTOR. Akt has been 
shown to activate Erg, a member of the EAG family, as well as BK channels.  
Eag-1 and BK expression in human colorectal and prostate carcinomas 
Eag-1 protein and mRNA was also detected in colonic crypt cells from patients with 
colorectal carcinomas, but was not expressed in the healthy colons. The Eag-1 gene is 
amplified in human colonic cancers and is associated with reduced overall survival of the 
patients. This may serves as an early diagnostic and prognostic marker for cancer patients. 
Taken together, evidence is presented for a role of K+ channels during development and 
growth of prostate and colonic cancer. Molecular and functional expression of Kv channels, 
particularly Eag-1, and Ca2+-activated K+ channels was detected in the different models. 
These channels were shown to support proliferation and are therefore likely to support 
progression of premalignant tissues towards cancer. Both BK and Eag-1 are markers of 
adverse prognosis in patients. The present data may therefore be useful in improving 
diagnosis, and treatment, and may have a prognostic value in patients with prostate and 
colonic cancer. 
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Appendix I.  K+ channel families. 
The table shows the 4 major families of K+ channels: voltage-gated K+ channels (Kv), Ca2+-
activated K+ channels (KCa), two-pore domain K+ channels (K2P), and inwardly rectifying K+ 
channels (Kir). Classification according to the International Union of Pharmacology (IUPHAR) 
and the Human Gene Nomenclature Committee (HGNC). The table also shows other commonly 
used names along with the chromosomal localization (Goldstein et al., 2005, Gutman et al., 
2003, Gutman et al., 2005, Kubo et al., 2005, Wei et al., 2005). 
 
 
IUPHAR HGNC 
Gene chromo-
somal 
localization 
Other names comments 
 Voltage-gated potassium channel family (Kv)  
 Kv1.1 KCNA1 12p13.3 HuK (I), MBK1, MK1, RCK1, 
RBK1, HBK1 
 
 Kv1.2 KCNA2 1p13 HuK (IV), MK2, BK2, RCK5, 
RAK, BGK5, Xsha2, NGK1, 
HBK5 
 
 Kv1.3 KCNA3 1p13.3? MK3, MBK3, RCK3, hPCN3, 
HuK (III), HLK3, RGK5, KV3, 
HGK5, n-channel 
 
 Kv1.4 KCNA4 11p14.3-15.2 HuK (II), hPCN2, HK1, 
RCK4, RHK1, RK4, RK8, 
MK4 
 
 Kv1.5 KCNA5 12p13.3 HpCN1, HK2, HCK1, KV1, 
fHK, RK3, RMK2, HuK (II) 
 
 Kv1.6 KCNA6 12p13.3 HBK2, MK1.6, RCK2, KV2  
 Kv1.7 KCNA7 19q13.3   
 Kv1.8 KCNA10 1p13.1 Kv1.10, Kcn1 
6TM1P Kv channel, Shaker-
related family, can co-assemble 
with other Kv1 family members in 
heteromultimers 
 
 
       
       
 Kv2.1 KCNB1 20q13.2 hDRK1, DRK1  
 Kv2.2 KCNB2 8q13.2 CDRK 
6TM1P Kv channel, Shab-related 
family  
       
       
 Kv3.1 KCNC1 11p15 NGK2, KV4, KShIIIB, Raw2, 
type l channel in T cells 
 
 Kv3.2 KCNC2 12q14.1 RKShIIIA, Raw1, Kv3.2a, 
rKv3.2β and rKv3.2c 
 
 Kv3.3 KCNC3 19q13.3-4 HKv3.3, mKv3.3, RKShIIID, 
Kv3.3β 
 
 Kv3.4 KCNC4 1p21 Raw3, HKShIIIC, mKv3.4 
6TM1P Kv channel, Shaw-related 
family 
 
       
       
 Kv4.1 KCND1 Xp11.23 mShal  
 Kv4.2 KCND2 7q31 Shal1, RK5  
 Kv4.3 KCND3 1p13.3  
6TM1P Kv channel, Shal-related 
family 
 
       
       
 Kv5.1 KCNF1 2p25 KH1, IK8 no own function, modifier of the 
Kv2 channels 
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 IUPHAR HGNC 
Gene chromo-
somal 
localization 
Other names comments 
       
 Kv6.1 KCNG1 20q13 KH2, K13  
 Kv6.2 KCNG2 18q22-18q23   
 Kv6.3 KCNG3 2p21   
 Kv6.4 KCNG4 16q24.1  
no own function, modifier of the 
Kv2 channels 
 
       
       
 Kv 7.1 KCNQ1 11p15.5 KvLQT, slow delayed 
rectifier 
has associated subunits: 
KCNQ1/KCNE1, KCNQ1/KCNE3 
 
 Kv7.2 KCNQ2 20q13.3 KQT2 has associated subunits: 
KCNQ2/KCNQ3, 
KCNQ2/KCNE2 
 
 Kv7.3 KCNQ3 8q24  has associated subunits 
KCNQ3/KCNQ2, 
KCNQ3/KCNQ5 
 
 Kv7.4 KCNQ4 1p34  has associated subunits: 
KCNQ4/KCNQ3 
 
 Kv7.5 KCNQ5 6q14  has associated subunits: 
KCNQ5/KCNQ3 
 
       
       
 Kv8.1 KCNV1 8q22.3-24.1 Kv2.3, HNKA  
 Kv8.2 KCNV 9p24.2  
no own function, modifier of the 
Kv2 channels  
       
       
 Kv9.1 KCNS1 20q12   
 Kv9.2 KCNS2 8q22   
 Kv9.3 KCNS3 2p24  
no own function, modifier of the 
Kv2 channels  
       
       
 Kv10.1 KCNH1 1q32-41 eag1a, eag1b, KCNH1a, 
KCNH1b, 
  
 Kv10.2 KCNH5 14q32.1 eag2   
       
       
 Kv11.1 KCNH2 7q35-36 erg1, HERG, Hergb  
 Kv11.2 KCNH6 17q23.3 erg2  
 Kv11.3 KCNH7 2q24.2 erg3 
Kv11.1, Kv11.2, and Kv11.3 can 
form heteromultimers  
       
       
 Kv12.1 KCNH8 3q24.3 elk1, elk3   
 Kv12.2 KCNH3 12q13 elk2, BEC1   
 Kv12.3 KCNH4 17q21.2 elk1, BEC2   
       
 Ca2+-activated potassium channel (KCa)  
 KCa1.1 KCNMA1 10q22.3 Slo, Slo1, BK, BKCa, maxi K
+ 
channel, large Ca2+-
activated K+ channel 
7TM/1P maxi-KCa channel, has 
associated subunit 1-4 
(KCNMB1-KCNMB4) 
 
       
       
 KCa2.1 KCNN1 19p13.1 SKCa1, SK1  
 KCa2.2 KCNN2 5q2.2.3 SKCa2, SK2  
 KCa2.3 KCNN3 1q21.3 SKCa3, SK3, hKCa3 
6TM/1P SKCa channel 
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 IUPHAR HGNC 
Gene chromo-
somal 
localization 
Other names comments 
       
 KCa3.1 KCNN4 19q13.2 IKCa1, SK4, IK1, KCa4 6TM/1P IKCa channel  
       
       
 KCa4.1 KCNT1 9q34.3 Slack, Slo2.2, KCNT1   
 KCa4.2 KCNT2 1q31.3 Slick, Slo2.1, KCNT2   
       
       
 KCa5.1 KCNU1 8p11.2 Slo3, KCNMC1, Kcnma3   
       
 Two-pore potassium channels  
 K2P1.1 KCNK1 1q42-43 TWIK-1, KCNK1, hOHO
  
 K2P2.1 KCNK2 1q41 TREK-1, KCNK2, TPKC1 
 K2P3.1 KCNK3 2p23 TASK-1, KCNK3,  
 K2P4.1 KCNK4 11q13 TRAAK, KCNK4 
 K2P5.1 KCNK5 6p21 TASK-2, KCNK5 
 K2P6.1 KCNK6 19q13.1 TWIK-2, KCNK6, TOSS 
 K2P7.1 KCNK7 11q13 KCNK7, kcnk8 
 K2P9.1 KCNK9 8q24 TASK-3, KCNK9 
 K2P10.1 KCNK10 14q31 TREK-2, KCNK10 
 K2P12.1 KCNK12 2p22 THIK-2, KCNK12 
 K2P13.1 KCNK13 14q24 THIK-1, KCNK13 
 K2P15.1 KCNK15 20q12 TASK-5, KCNK15, KT3.3 
 K2P16.1 KCNK16 6p21 TALK-1, KCNK16  
 K2P17.1 KCNK17 6p21 TASK-4, KCNK17, TALK-2  
 K2P18.1 KCNK18 10q26.11 TRESK-1/TRESK-2, 
KCNK18 
4TM/2P (TASK, TWIK, TREK) 
 
       
 Inwardly rectifying potassium channel  
 Kir1.1 KCNJ1 17q24 ROMK, ROMK1 2TM/1P Kir channel, 6 splice 
variants exsit, denoted as Kir  
1.1a - f 
 
       
       
 Kir2.1 KCNJ2 17q23 IRK1  
 Kir2.2 KCNJ12 17p11.1 IRK2, RB-IRK2, MB-IRK2, 
hIRK 
 
 Kir2.3 KCNJ4 22q13.10 IRK3, HIR, HRK1, BIRK2, 
BIR11, hIRK2, MB-IRK3, 
CCD-IRK3, mKir 2.3  
2TM/1P Kir channel  
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 IUPHAR HGNC 
Gene chromo-
somal 
localization 
Other names comments 
       
 Kir2.4 KCNJ14 19q13.1-13.3  IRK14   
       
       
 Kir3.1 KCNJ3 2q24.1 GIRK1, KGA  
 Kir3.2 KCNJ6 21q22 GIRK2, hiGIRK2  
 Kir3.3 KCNJ9 1q21-23 GIRK3  
 Kir3.4 KCNJ5 11q24 GIRK4 
G-protein-gated Kir channel 
 
       
       
 Kir4.1 KCNJ10 1q22 Kir1.2, KAB-2, BIR10, BIRK-
10, BIRK-1, KCNJ13-PEN 
Gilal ATP-dependent  
 Kir4.2 KCNJ15 21q22.2 Kir1.3, IRKK   
       
       
 Kir5.1 KCNJ16 17q23.1 BIR 9   
       
       
 Kir6.1 KCNJ8 12p11.23 uKATP-1  
 Kir6.2 KCNJ11 11p15.1 BIR ATP-sensitive K
+ channel  
       
       
 Kir7.1 KCNJ13 2q37 Kir1.4   
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Appendix II. Modulators of K+ channels. 
 
 Compounds 
used 
concentration 
Effects (IC50 or EC50)  
 4-AP 50 µM - 2 mM inhibits Kv channels 
Kv1.3 (195 µM), Kv1.4 (13 µM), Kv1.5 (270 µM), Kv1.6 (1.5 mM), 
Kv1.7 (150 µM), Kv1.8 (1.5 mM), Kv2.2 (1.5 mM), Kv3.1 (29 µM), 
Kv3.3 (1.2 mM) 
 
 Astemizole 0.5 nM - 5 µM inhibits members of the ether à go-go Kv family (Eag, Erg, Elk)  
 AVE0118 0.005 - 50 µM inhibits Kv1.3, Kv1.5 (5.6 µM), Kv2.1, Kv3.1, Kv4.3  
 AVE1231 0.005 - 50 µM inhibits Kv1.5 (3.6 µM), Kv4.3/KChIP2.2b (5.9 µM) 
IKACh current (Kir3.4) (8.4 µM), 
IKr current (Erg-1) (30 µM) 
KATP current (Kir6.1, 6.2) 
 
 BaCl2 5 mM non selective K+ channel blocker  
 BDS-I 0.01 - 100 nM inhibits Kv3.4  
 293B 0.001 - 10 µM inhibits KvLQT1 (Kv7.1)  
 Charybdotoxin 0.01 - 100 nM inhibits Kv1.2 (14 nM), Kv1.3 (3 nM), Kv1.8 (100 nM), BK (2.9 
nM), SK4 (5nM) 
 
 Clotrimazole 10 nM - 1 µM inhibits SK4 (70 nM)  
 Iberiotoxin 0.001 - 10 nM inhibits BK (10 nM)  
 Paxillin 1 µM - 5 µM inhibits BK (less than10 nM)  
 Quinidine 0.01 - 100 µM inhibits Kv1.4 (10 µM-1 mM), Kv1.5 (0.6 µM). Kv1.7 (15 µM), 
Eag-1 (1.4 µM) 
 
 Riluzole 1 nM - 1 mM activate SK1 (2 µM), SK2 (2 µM), SK3 (3 µM), SK4 (1 µM) 
inhibits Kv1.4 (70 µM) 
 
 Scyllatoxin 0.001 - 20 nM inhibits SK1 (325 nM), SK2 (200 pM), SK3 (1.1 nM)  
 TRAM-34 0.1 - 100 nM inhibits SK4 (20 nM)  
 Terfenadine 0.001 - 10 µM inhibits members of the ether-à-go-go Kv family, inhibits Eag, 
Erg-1 (56 nM), Elk-2 (1.µM) 
 
 TPeA 0.1 – 100 µM non selective K+ channel blocker  
 NS1619 10 µM activates BK (10-30 µM)  
 17β-estradiol 10 µM activates BK  
 note: 
4-AP = 4-aminopyridine  
TPeA = Tetrapentylammonium chloride 
IKACh current = acetylcholine-activated K+ current 
IKr current = the fast delayed outward rectifying K+ current 
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